
<html lang="en"     class="pb-page"  data-request-id="5d10e2d1-0403-4018-b28d-381c620001a0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2021.64.issue-10;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c01949;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="One Atom Makes All the Difference: Getting a Foot in the Door between SOS1 and KRAS" /></meta><meta name="dc.Creator" content="Juergen  Ramharter" /></meta><meta name="dc.Creator" content="Dirk  Kessler" /></meta><meta name="dc.Creator" content="Peter  Ettmayer" /></meta><meta name="dc.Creator" content="Marco H.  Hofmann" /></meta><meta name="dc.Creator" content="Thomas  Gerstberger" /></meta><meta name="dc.Creator" content="Michael  Gmachl" /></meta><meta name="dc.Creator" content="Tobias  Wunberg" /></meta><meta name="dc.Creator" content="Christiane  Kofink" /></meta><meta name="dc.Creator" content="Michael  Sanderson" /></meta><meta name="dc.Creator" content="Heribert  Arnhof" /></meta><meta name="dc.Creator" content="Gerd  Bader" /></meta><meta name="dc.Creator" content="Klaus  Rumpel" /></meta><meta name="dc.Creator" content="Andreas  Zöphel" /></meta><meta name="dc.Creator" content="Renate  Schnitzer" /></meta><meta name="dc.Creator" content="Jark  Böttcher" /></meta><meta name="dc.Creator" content="Jonathan C.  O’Connell" /></meta><meta name="dc.Creator" content="Rachel L.  Mendes" /></meta><meta name="dc.Creator" content="David  Richard" /></meta><meta name="dc.Creator" content="Nikolai  Pototschnig" /></meta><meta name="dc.Creator" content="Irene  Weiner" /></meta><meta name="dc.Creator" content="Wolfgang  Hela" /></meta><meta name="dc.Creator" content="Katja  Hauer" /></meta><meta name="dc.Creator" content="Daniela  Haering" /></meta><meta name="dc.Creator" content="Lyne  Lamarre" /></meta><meta name="dc.Creator" content="Bernhard  Wolkerstorfer" /></meta><meta name="dc.Creator" content="Christian  Salamon" /></meta><meta name="dc.Creator" content="Patrick  Werni" /></meta><meta name="dc.Creator" content="Silvia  Munico-Martinez" /></meta><meta name="dc.Creator" content="Reiner  Meyer" /></meta><meta name="dc.Creator" content="Matthew D.  Kennedy" /></meta><meta name="dc.Creator" content="Norbert  Kraut" /></meta><meta name="dc.Creator" content="Darryl B.  McConnell" /></meta><meta name="dc.Description" content="KRAS, the most common oncogenic driver in human cancers, is controlled and signals primarily through protein–protein interactions (PPIs). The interaction between KRAS and SOS1, crucial for the acti..." /></meta><meta name="Description" content="KRAS, the most common oncogenic driver in human cancers, is controlled and signals primarily through protein–protein interactions (PPIs). The interaction between KRAS and SOS1, crucial for the acti..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 15, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01949" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01949" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01949" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01949" /></link>
        
    
    

<title>One Atom Makes All the Difference: Getting a Foot in the Door between SOS1 and KRAS | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01949" /></meta><meta property="og:title" content="One Atom Makes All the Difference: Getting a Foot in the Door between SOS1 and KRAS" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0015.jpeg" /></meta><meta property="og:description" content="KRAS, the most common oncogenic driver in human cancers, is controlled and signals primarily through protein–protein interactions (PPIs). The interaction between KRAS and SOS1, crucial for the activation of KRAS, is a typical, challenging PPI with a large contact surface area and high affinity. Here, we report that the addition of only one atom placed between Y884SOS1 and A73KRAS is sufficient to convert SOS1 activators into SOS1 inhibitors. We also disclose the discovery of BI-3406. Combination with the upstream EGFR inhibitor afatinib shows in vivo efficacy against KRASG13D mutant colorectal tumor cells, demonstrating the utility of BI-3406 to probe SOS1 biology. These findings challenge the dogma that large molecules are required to disrupt challenging PPIs. Instead, a “foot in the door” approach, whereby single atoms or small functional groups placed between key PPI interactions, can lead to potent inhibitors even for challenging PPIs such as SOS1-KRAS." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01949"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01949">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01949&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01949&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01949&amp;href=/doi/10.1021/acs.jmedchem.0c01949" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 6569-6580</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.1c00698" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Featured Article</span><a href="/doi/10.1021/acs.jmedchem.0c01104" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">One Atom Makes All the Difference: Getting a Foot in the Door between SOS1 and KRAS</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Juergen Ramharter</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Juergen Ramharter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#fd9788988f9a9893d38f9c90959c8f89988fbd9f9298958f94939a988fd094939a989195989490d39e9290"><span class="__cf_email__" data-cfemail="abc1deced9cccec585d9cac6c3cad9dfced9ebc9c4cec3d9c2c5ccced986c2c5cccec7c3cec2c685c8c4c6">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Juergen++Ramharter">Juergen Ramharter</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7618-1862" title="Orcid link">http://orcid.org/0000-0001-7618-1862</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dirk Kessler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dirk Kessler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dirk++Kessler">Dirk Kessler</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peter Ettmayer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter Ettmayer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Ettmayer">Peter Ettmayer</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8422-2625" title="Orcid link">http://orcid.org/0000-0002-8422-2625</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marco H. Hofmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marco H. Hofmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marco+H.++Hofmann">Marco H. Hofmann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thomas Gerstberger</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thomas Gerstberger</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Gerstberger">Thomas Gerstberger</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael Gmachl</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Gmachl</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Gmachl">Michael Gmachl</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tobias Wunberg</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tobias Wunberg</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tobias++Wunberg">Tobias Wunberg</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christiane Kofink</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christiane Kofink</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christiane++Kofink">Christiane Kofink</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael Sanderson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Sanderson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Sanderson">Michael Sanderson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Heribert Arnhof</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Heribert Arnhof</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Heribert++Arnhof">Heribert Arnhof</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gerd Bader</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gerd Bader</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gerd++Bader">Gerd Bader</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Klaus Rumpel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Klaus Rumpel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Klaus++Rumpel">Klaus Rumpel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andreas Zöphel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andreas Zöphel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andreas++Z%C3%B6phel">Andreas Zöphel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Renate Schnitzer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Renate Schnitzer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Renate++Schnitzer">Renate Schnitzer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jark Böttcher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jark Böttcher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jark++B%C3%B6ttcher">Jark Böttcher</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jonathan C. O’Connell</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jonathan C. O’Connell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Forma Therapeutics, 500 Arsenal Street, Suite 100, Watertown, Massachusetts 02472, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan+C.++O%E2%80%99Connell">Jonathan C. O’Connell</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rachel L. Mendes</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rachel L. Mendes</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Forma Therapeutics, 500 Arsenal Street, Suite 100, Watertown, Massachusetts 02472, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rachel+L.++Mendes">Rachel L. Mendes</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David Richard</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David Richard</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Forma Therapeutics, 500 Arsenal Street, Suite 100, Watertown, Massachusetts 02472, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David++Richard">David Richard</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nikolai Pototschnig</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nikolai Pototschnig</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nikolai++Pototschnig">Nikolai Pototschnig</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Irene Weiner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Irene Weiner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Irene++Weiner">Irene Weiner</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wolfgang Hela</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wolfgang Hela</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wolfgang++Hela">Wolfgang Hela</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Katja Hauer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Katja Hauer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Katja++Hauer">Katja Hauer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniela Haering</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniela Haering</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniela++Haering">Daniela Haering</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lyne Lamarre</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lyne Lamarre</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lyne++Lamarre">Lyne Lamarre</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bernhard Wolkerstorfer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bernhard Wolkerstorfer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bernhard++Wolkerstorfer">Bernhard Wolkerstorfer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christian Salamon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christian Salamon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Salamon">Christian Salamon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Patrick Werni</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Patrick Werni</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Werni">Patrick Werni</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Silvia Munico-Martinez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Silvia Munico-Martinez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Silvia++Munico-Martinez">Silvia Munico-Martinez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Reiner Meyer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Reiner Meyer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Reiner++Meyer">Reiner Meyer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matthew D. Kennedy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthew D. Kennedy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+D.++Kennedy">Matthew D. Kennedy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Norbert Kraut</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Norbert Kraut</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Norbert++Kraut">Norbert Kraut</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Darryl B. McConnell</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Darryl B. McConnell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#f89c998a8a8194d6959b9b9796969d9494b89a979d908a91969f9d8ad591969f9d94909d9195d69b9795"><span class="__cf_email__" data-cfemail="4b2f2a39393227652628282425252e27270b29242e233922252c2e396622252c2e27232e222665282426">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Darryl+B.++McConnell">Darryl B. McConnell</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01949&amp;href=/doi/10.1021%2Facs.jmedchem.0c01949" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 6569–6580</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 15, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 November 2020</li><li><span class="item_label"><b>Published</b> online</span>15 March 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 May 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01949" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01949</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6569%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJuergen%2BRamharter%252C%2BDirk%2BKessler%252C%2BPeter%2BEttmayer%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D10%26contentID%3Dacs.jmedchem.0c01949%26title%3DOne%2BAtom%2BMakes%2BAll%2Bthe%2BDifference%253A%2BGetting%2Ba%2BFoot%2Bin%2Bthe%2BDoor%2Bbetween%2BSOS1%2Band%2BKRAS%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6580%26publicationDate%3DMay%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01949"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4627</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">3</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01949" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;One Atom Makes All the Difference: Getting a Foot in the Door between SOS1 and KRAS&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Juergen&quot;,&quot;last_name&quot;:&quot;Ramharter&quot;},{&quot;first_name&quot;:&quot;Dirk&quot;,&quot;last_name&quot;:&quot;Kessler&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Ettmayer&quot;},{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;H. Hofmann&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Gerstberger&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Gmachl&quot;},{&quot;first_name&quot;:&quot;Tobias&quot;,&quot;last_name&quot;:&quot;Wunberg&quot;},{&quot;first_name&quot;:&quot;Christiane&quot;,&quot;last_name&quot;:&quot;Kofink&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Sanderson&quot;},{&quot;first_name&quot;:&quot;Heribert&quot;,&quot;last_name&quot;:&quot;Arnhof&quot;},{&quot;first_name&quot;:&quot;Gerd&quot;,&quot;last_name&quot;:&quot;Bader&quot;},{&quot;first_name&quot;:&quot;Klaus&quot;,&quot;last_name&quot;:&quot;Rumpel&quot;},{&quot;first_name&quot;:&quot;Andreas&quot;,&quot;last_name&quot;:&quot;Zöphel&quot;},{&quot;first_name&quot;:&quot;Renate&quot;,&quot;last_name&quot;:&quot;Schnitzer&quot;},{&quot;first_name&quot;:&quot;Jark&quot;,&quot;last_name&quot;:&quot;Böttcher&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;C. O’Connell&quot;},{&quot;first_name&quot;:&quot;Rachel&quot;,&quot;last_name&quot;:&quot;L. Mendes&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Richard&quot;},{&quot;first_name&quot;:&quot;Nikolai&quot;,&quot;last_name&quot;:&quot;Pototschnig&quot;},{&quot;first_name&quot;:&quot;Irene&quot;,&quot;last_name&quot;:&quot;Weiner&quot;},{&quot;first_name&quot;:&quot;Wolfgang&quot;,&quot;last_name&quot;:&quot;Hela&quot;},{&quot;first_name&quot;:&quot;Katja&quot;,&quot;last_name&quot;:&quot;Hauer&quot;},{&quot;first_name&quot;:&quot;Daniela&quot;,&quot;last_name&quot;:&quot;Haering&quot;},{&quot;first_name&quot;:&quot;Lyne&quot;,&quot;last_name&quot;:&quot;Lamarre&quot;},{&quot;first_name&quot;:&quot;Bernhard&quot;,&quot;last_name&quot;:&quot;Wolkerstorfer&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Salamon&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Werni&quot;},{&quot;first_name&quot;:&quot;Silvia&quot;,&quot;last_name&quot;:&quot;Munico-Martinez&quot;},{&quot;first_name&quot;:&quot;Reiner&quot;,&quot;last_name&quot;:&quot;Meyer&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;D. Kennedy&quot;},{&quot;first_name&quot;:&quot;Norbert&quot;,&quot;last_name&quot;:&quot;Kraut&quot;},{&quot;first_name&quot;:&quot;Darryl&quot;,&quot;last_name&quot;:&quot;B. McConnell&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;6569-6580&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01949&quot;},&quot;abstract&quot;:&quot;KRAS, the most common oncogenic driver in human cancers, is controlled and signals primarily through protein–protein interactions (PPIs). The interaction between KRAS and SOS1, crucial for the activation of KRAS, is a typical, challenging PPI with a large contact surface area and high affinity. Here, we report that the addition of only one atom placed between Y884SOS1 and A73KRAS is sufficient to convert SOS1 activators into SOS1 inhibitors. We also disclose the discovery of BI-3406. Combination with the upstream EGFR inhibitor afatinib shows in vivo efficacy against KRASG13D mutant colorectal tumor cells, demonstrating the utility of BI-3406 to probe SOS1 biology. These findings challenge the dogma that large molecules are required to disrupt challenging PPIs. Instead, a “foot in the door” approach, whereby single atoms or small functional groups placed between key PPI interactions, can lead to potent inhibitors even for challenging PPIs such as SOS1-KRAS.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01949&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01949" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01949&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01949" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01949&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01949" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01949&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01949&amp;href=/doi/10.1021/acs.jmedchem.0c01949" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01949" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01949" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01949%26sid%3Dliteratum%253Aachs%26pmid%3D33719426%26genre%3Darticle%26aulast%3DRamharter%26date%3D2021%26atitle%3DOne%2BAtom%2BMakes%2BAll%2Bthe%2BDifference%253A%2BGetting%2Ba%2BFoot%2Bin%2Bthe%2BDoor%2Bbetween%2BSOS1%2Band%2BKRAS%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D10%26spage%3D6569%26epage%3D6580%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/jmcmar.2021.64.issue-10/20210527/jmcmar.2021.64.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01949&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">KRAS, the most common oncogenic driver in human cancers, is controlled and signals primarily through protein–protein interactions (PPIs). The interaction between KRAS and SOS1, crucial for the activation of KRAS, is a typical, challenging PPI with a large contact surface area and high affinity. Here, we report that the addition of only one atom placed between Y884<sup>SOS1</sup> and A73<sup>KRAS</sup> is sufficient to convert SOS1 activators into SOS1 inhibitors. We also disclose the discovery of <b>BI-3406</b>. Combination with the upstream EGFR inhibitor afatinib shows <i>in vivo</i> efficacy against KRAS<sup>G13D</sup> mutant colorectal tumor cells, demonstrating the utility of <b>BI-3406</b> to probe SOS1 biology. These findings challenge the dogma that large molecules are required to disrupt challenging PPIs. Instead, a “foot in the door” approach, whereby single atoms or small functional groups placed between key PPI interactions, can lead to potent inhibitors even for challenging PPIs such as SOS1-KRAS.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32308" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32308" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">With more than 500,000 estimated interactions in humans,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> protein–protein interactions (PPIs) are important for essentially all biological processes. PPI networks contain indispensable proteins, which are often targeted by disease-causing mutations, viruses, and drugs.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6">(2−6)</a> With mutation rates of 86–96% in pancreatic cancers, 40–54% in colorectal cancers, and 27–39% in lung adenocarcinomas,<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> one such cancer driver is the KRAS oncogene. Now, after decades of research, the first inhibitors against the KRAS<sup>G12C</sup> mutant are showing promise in clinical trials,<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> but no clinical agents against the most prevalent mutants KRAS<sup>G12D</sup> and KRAS<sup>G12V</sup> have been discovered to date.</div><div class="NLM_p">Cycling between active (GTP-bound) and inactive (GDP-bound) forms, KRAS is best understood as a molecular switch (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). If mutated, intrinsic or GAP-induced GTPase activity of KRAS is reduced and the amount of GTP-bound KRAS increases. Key regulators of KRAS are the guanine nucleotide exchange factors (GEFs) son of sevenless homolog 1 and son of sevenless homolog 2 (SOS1 and SOS2). Both SOS1 and SOS2 are involved in distinct PPIs with RAS.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a> The catalytic sites of SOS1/2 bind GDP-bound KRAS, promote GDP exchange to GTP, and activate downstream signaling of the MAP kinase pathway. Interestingly, only SOS1 seems to be subject to allosteric activation.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Binding of GTP-bound KRAS to the allosteric site leads to upregulation of the activity of the catalytic site of SOS1. In contrast, no evidence for SOS2 allosteric activation exists beyond the high similarity of the allosteric site region to that of SOS1.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. SOS1/2-mediated nucleotide exchange of KRAS. Binding of inactive KRAS (GDP-bound) to the catalytic site of SOS1/2 catalyzes the exchange of GDP for GTP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01949&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A feedback release mechanism mediated from signaling molecules downstream of KRAS only leads to ERK-mediated phosphorylation of SOS1 but not its paralog SOS2, thereby attenuating the SOS1 GEF activity.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> While SOS1 is only rarely mutated in most cancers,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> SOS1-activating mutations are common in RASopathies,<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> with SOS1 being the second most frequently mutated gene (around 11%) in Noonan Syndrome patients<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> and hereditary gingival fibromatosis.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">Efforts to identify small molecules binding to SOS1 have led to two different classes of SOS1 binders: (1) SOS1 activators, which bind to SOS1 but do not inhibit the PPI between KRAS and SOS1, and (2) SOS1 inhibitors, which bind to SOS1 and sterically prevent KRAS from binding. Fesik’s group has published a series of papers elucidating the discovery and optimization of SOS1 activators,<a onclick="showRef(event, 'ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31">(24–31)</a> demonstrating that aminopiperidine indoles (exemplified by compound <b>3</b> in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) stabilize the interaction of SOS1 and KRAS and increase guanine nucleotide exchange. Shortly thereafter, fragments with a similar binding mode but no measurable effect on the nucleotide exchange were published.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Recently, we and others highlighted the discovery of SOS1 inhibitors,<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> which occupy the same binding site as the aforementioned SOS1 activators with BI 1701963 currently undergoing phase 1 clinical trials.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Starting Points and Comparison to the Previously Described SOS1 Activator 3<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0011.gif" alt="" id="gr10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Biochemical assay (AlphaScreen). Triplicates of all compounds were measured.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Biophysical assay (SPR). Triplicates of compounds <b>1</b> and <b>2</b> were measured. Due to limited compound availability, duplicates were measured for compound <b>3</b>. IC<sub>50</sub> values are shown as arithmetic mean ± standard error of the mean.</p></div></div><div></div></div><div class="NLM_p last">In this paper, we describe the structure-based design of inhibitors of the PPI between SOS1 and KRAS. We hypothesized that inhibiting the catalytic activity of SOS1 by blocking its PPI with KRAS will reduce the levels of active KRAS, counteract cancer-associated activation of the MAPK pathway, and therefore have a selective effect on cancers driven by KRAS-activating mutations. To generate starting points for SOS1 inhibitors, we conducted a high-throughput screen using two complementary biochemical assays and surface plasmon resonance for biophysical validation. A robust system for crystallizing small molecules bound to SOS1 allowed for fast and efficient optimization using structure-based design. The stepwise evolution of our SOS1 inhibitor program culminated in <b>BI-3406</b>, an orally bioavailable, nanomolar potent and selective inhibitor of the SOS1::KRAS PPI, which binds to the catalytic site of SOS1 at the cusp of the RAS binding interface. <b>BI-3406</b> reduces SOS1-catalyzed formation of GTP-KRAS, attenuates downstream signaling (pERK), and impairs cell proliferation of KRAS-driven cancers. Intriguingly, we show that positioning one single atom between key amino acid pairs (R73 on KRAS and Y884 on SOS1) is sufficient to efficiently inhibit a PPI despite its large surface (buried surface area: 3490 A<sup>2</sup>) and micromolar affinity between SOS1 and RAS.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> These findings demonstrate a new paradigm to design inhibitors of protein–protein interactions, which might be generally applicable to GEFs and beyond.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25367" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25367" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In our efforts to identify binders to SOS1, we designed a high-throughput screen (HTS) to search for inhibitors of the SOS1::KRAS<sup>G12D</sup> PPI (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). We implemented rigorous biochemical and biophysical triaging for the fast identification of structurally enabled starting points. The Boehringer Ingelheim and FORMA Therapeutics proprietary libraries consisting of 1.7 million compounds in total were screened using a miniaturized KRAS<sup>G12D</sup>-biotin GST-SOS1 protein interaction assay utilizing AlphaScreen<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and fluorescence resonance energy transfer<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> (TR-FRET) readouts as orthogonal technologies. Due to its superior signal to noise and the better S/N ratio (<i>Z</i>′) compared to the TR-FRET format, the AlphaScreen technology was used in the primary screen. The primary hits were filtered <i>in silico</i> by removing non-drug-like molecules and pan assay interference (PAINS)<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> compounds and subsequently confirmed in the AlphaScreen assay at the screening concentration. From the remaining hits, false-positives were removed using an AlphaScreen shortcut assay utilizing a biotinylated GST protein. Hits that also inhibited the chemoluminescence in the absence of a PPI were considered as singlet oxygen quenchers and removed from further analysis. The resulting 2500 confirmed actives were submitted to dose–response testing in the AlphaScreen and TR-FRET assay format in parallel. Interestingly, only 47 hits (<2%) inhibited the SOS1::KRAS<sup>G12D</sup> interaction with an IC<sub>50</sub> value of less than 10 μM. Despite the shortcut assay in the screening cascade, only 18% of the <10 μM AlphaScreen hits could be confirmed in the TR-FRET assay. This highlights the power of the orthogonal biochemical screening paradigm. To distinguish between SOS1 and KRAS binders, we subsequently measured binding to SOS1 by SPR and to KRAS<sup>G12D</sup> by using HSQC NMR. While none of the hits showed affinity to KRAS<sup>G12D</sup>, 18 hits with SOS1 SPR <i>K</i><sub>D</sub>’s of less than 15 μM were identified. Seventeen of these biophysical confirmed hits belonged to a cluster of structurally closely related quinazolines, exemplified by compound <b>1</b>. In addition, a single compound (<b>2</b>) was obtained from a different structural series (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SOS1::KRAS Hit Finding Campaign: Orthogonal assays significantly reduced the number of hits for SPR and X-ray.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01949&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">X-ray cocrystal structures of initial HTS hits and computational chemistry methods guided selectivity and potency optimization in the next steps. Although structurally unrelated to SOS1 activators, the obtained screening hits bind to the same, previously described pocket, albeit pointing directly toward the SOS1::KRAS interaction site.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">As illustrated in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, both SOS1 activators and inhibitors address a large lipophilic pocket defined by F890, L901, and M878. However, also new interactions between the inhibitors and SOS1 are formed. A hydrogen bond between the anilinic NH and N879 serves as a polar anchor between the inhibitor and the protein. Importantly, π-stacking of the quinazoline core with His905 significantly contributes to the affinity. Finally, the 6-methoxy substituent forms an important CH−π interaction with Y884. Compared to SOS1 activators, the different binding mode of inhibitors leads to a very distinct response. Whereas both activators and inhibitors have comparable affinity to SOS1 (measured by SPR), only <b>1</b> effectively disrupts the SOS1–KRAS interaction and causes inhibition in an AlphaScreen assay, displaying dose–response curves quantified by the half-maximal inhibitory value (IC<sub>50</sub>). In contrast to <b>1</b>, activator <b>3</b> stabilizes the interaction of SOS1 and KRAS. The resulting activation of SOS1 is reflected by an increase in the signal in the AlphaScreen assay and can be quantified by a half-maximal effective concentration value (EC<sub>50</sub>), indicating an increasing signal. For comparison of both modes of action, see <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Overlay of screening hit <b>1</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6SFR">6SFR</a>) with activator <b>3</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NMY">4NMY</a>) demonstrating binding to the same pocket. Helix α2 of RAS (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NYM">4NYM</a>)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> with the interacting amino acid R73 is depicted in yellow. RAS R73 and SOS Y884 interact in the activator-bound form (orange) in the ternary RAS-SOS1-RAS complex similar to apo RAS-SOS1-RAS, whereas in the inhibitor-bound structure (gray), Y884 moves toward the inhibitor, thereby preventing the Y884–R73 interaction. (B) AlphaScreen titration curves of inhibiting screening hit <b>1</b> (gray) and activating compound <b>3</b> (orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01949&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Initial activities to optimize our starting points were focused on the hit series of quinazolines. All members of this series had already shown good potency in the AlphaScreen; however, the compounds originated from the historical EGFR inhibitor program and, as such, displayed strong EGFR inhibition. Profiling against a selected set of 31 kinases confirmed the high affinity of compound <b>1</b> toward EGFR kinase (IC<sub>50</sub>, 1 nM) and other kinases. Docking of <b>1</b> into the protein structure derived from the known cocrystal X-ray structure of EGFR kinase domain and afatinib<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> illustrates that the quinazoline core (especially via positions 1 and 2) forms strong interactions with the hinge motif of EGFR (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Consequently, a methyl substituent was introduced to the 2-position of the quinazoline core to disrupt kinase hinge binding. The resulting compound <b>4</b> displayed a significantly decreased kinase activity toward EGFR as well as a panel of 31 kinases (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).<named-content content-type="anchor" rid="tbl2" type="simple"></named-content></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>1</b> docked into the EGFR crystal structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G5J">4G5J</a>) showing off-target kinase binding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01949&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibitory Activities against SOS1::KRAS and EGFR Kinase, Kinase Activity Data for 31 Selected Kinases (See the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01949/suppl_file/jm0c01949_si_001.pdf" class="ext-link">Supporting Information</a> for More Information), and Efflux Data for Compounds <b>1</b> and <b>4</b>–<b>8</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0012.gif" alt="" id="gr11" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="/" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">#</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char="±">SOS1::KRAS<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> IC<sub>50</sub> [nM]</th><th class="colsep0 rowsep0" align="center" char="±">SOS1<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a><i>K</i><sub>D</sub> (SPR) [nM]</th><th class="colsep0 rowsep0" align="center" char=".">EGFR<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a> IC<sub>50</sub> [nM]</th><th class="colsep0 rowsep0" align="center" char="/">kinase activity<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a> [>50% ctrl]</th><th class="colsep0 rowsep0" align="center" char=".">efflux<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a> [BA/AB]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>1</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1050 ± 130</td><td class="colsep0 rowsep0" align="char" char="±">301 ± 60</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char="/">4/31</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>4</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">453 ± 110</td><td class="colsep0 rowsep0" align="char" char="±">469 ± 26</td><td class="colsep0 rowsep0" align="char" char=".">2800</td><td class="colsep0 rowsep0" align="char" char="/">1/31</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>5</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">56 ± 5</td><td class="colsep0 rowsep0" align="char" char="±">16 ± 3</td><td class="colsep0 rowsep0" align="char" char=".">>20,000</td><td class="colsep0 rowsep0" align="char" char="/">0/31</td><td class="colsep0 rowsep0" align="char" char=".">50.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>6</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">106 ± 32</td><td class="colsep0 rowsep0" align="char" char="±">104 ± 5</td><td class="colsep0 rowsep0" align="char" char=".">>20,000</td><td class="colsep0 rowsep0" align="char" char="/">0/31</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>7</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">355 ± 84</td><td class="colsep0 rowsep0" align="char" char="±">123 ± 12</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="/">0/31</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>8</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">15 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">16 ± 2</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="/">0/31</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Biochemical assay (AlphaScreen).</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Biophysical assay (SPR). Triplicates of all compounds were measured in biochemical and biophysical assays. IC<sub>50</sub> values are shown as arithmetic mean ± standard error of the mean.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Kinase activity was measured by SelectScreen Kinase Profiling Services (Thermo Fisher). Activity on EGFR was evaluated in the form of IC<sub>50</sub> measurements. Overall kinase activity was determined in the form of single-point measurements at 10 μM on 31 kinases.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Efflux was measured using Caco-2 cells at 10 μM.</p></div></div></div><div class="NLM_p">To optimize our SOS1 inhibitors further, we turned our attention toward the second HTS hit, compound <b>2</b>. Although lacking the quinazoline core, its potency was comparable to <b>1</b>. The surprising high affinity of compound <b>2</b> toward SOS1 was assumed to originate from an additional interaction between the sulfonamide substituent and the backbone carbonyl of Lys898 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Combining the superior π-stacking ability of compound <b>4</b> with the sulfonamide substituent of <b>2</b> resulted in ligand <b>5</b>, which showed improved potency and no residual kinase activity (see also <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Unfortunately, compound <b>5</b> suffered from a pronounced efflux ratio of 50, so alternative, less polar <i>meta</i>-substituents were explored. Among the most interesting were the trifluoromethyl and amino groups. The obtained IC<sub>50</sub> and <i>K</i><sub>D</sub> values show that the lipophilic van der Waals interaction of the CF<sub>3</sub> substituent of compound <b>6</b> with Leu901 of SOS1 compensated for the hydrophilic interaction of the sulfonamide with Lys898 while eliminating the unfavorable efflux ratio (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). Interestingly, introduction of a NH<sub>2</sub> group resulted in a flip of the benzene ring and formation of a new H-bond with the backbone carbonyl of Met878 (compound <b>7</b> in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). Although the potency of inhibitor <b>7</b> was only marginally improved compared to compound <b>4</b>, we decided to combine both <i>meta-</i>substituents into a single molecule (compound <b>8</b>) as the overlay of the two crystal structures highlighted the nearly identical binding mode to SOS1 (see also <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C). The sevenfold increase in potency of inhibitor <b>8</b> compared to compound <b>7</b> might be surprising at first but can be rationalized by acidification of the amino substituent by the electron-withdrawing CF<sub>3</sub> group. This highlights the need to consider the overall properties of molecules in drug design rather than rely on the additivity of structure–activity relationships.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Close-up of the SOS1 catalytic site with <b>2</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVI">7AVI</a>). (B) Overlay of compounds <b>2</b> and <b>4</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVI">7AVI</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVL">7AVL</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01949&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Close-ups of the SOS1 binding pocket with (A) compound <b>6</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVS">7AVS</a>) and (B) compound <b>7</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVT">7AVT</a>) with all important amino acids in close proximity. (C) Overlay of compounds <b>6</b> and <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01949&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We next turned our attention to the actual protein–protein interface between SOS1 and KRAS. PPIs usually cover large areas, the interface between SOS1 and KRAS being particularly large at 1750 A<sup>2</sup> on the SOS1 surface (buried surface area of 3490 A<sup>2</sup> for the whole interface area on both proteins; calculated with the PDBe PISA (Proteins, Interfaces, Surfaces, and Assemblies) service at the European Bioinformatics Institute<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a>). We speculated that the cation−π interaction between R73 (KRAS) and Y884 (SOS1) observed in the SOS1 KRAS cocrystal structure (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) plays a pivotal role in the interaction of both proteins.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> To test this hypothesis, the affinity of SOS1 Y884A to KRAS was compared to the affinity of native SOS1 to KRAS. When adding untagged native SOS1, tagged SOS1 Y884A was far easier displaced from KRAS than tagged wild-type SOS1 (factor 30), indicating that the R73-Y884 interaction between SOS1 and KRAS is indeed important (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Comparison of the displacement of tagged SOS1 wt (purple) and SOS1 Y884A (green) by its native untagged SOS1 analog. IC<sub>50</sub>(SOS1 wt) = 4.25 μM; IC<sub>50</sub>(SOS1 Y884A) = 0.13 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01949&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the binding event of compound <b>8</b> to SOS1, R73 of KRAS is displaced by the 6-methoxy substituent. This leads to disruption of the PPI and consequently prevents the nucleotide exchange of KRAS. Intrigued by this simple but effective mode of inhibition of SOS1, we decided to test compounds that do not feature a substituent that is able to address Y884. Strikingly, when a derivative without methoxy substituents (<b>9</b>) was tested, activation instead of inhibition was observed in the AlphaScreen (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). This minimal structural change of two heavy atoms is sufficient to turn an SOS1 activator into an SOS1 inhibitor. It is worth mentioning that the binding affinity measured by SPR of activator <b>9</b> toward SOS1 (<i>K</i><sub>D</sub> = 350 nM) is 20-fold reduced compared to inhibitor <b>8</b> (<i>K</i><sub>D</sub> = 16 nM) and its binding mode to SOS1 is conserved except for the missing interaction with Y884 (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A).<named-content content-type="anchor" rid="fig8" type="simple"></named-content><named-content content-type="anchor" rid="tbl3" type="simple"></named-content></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Close-up of the SOS1 binding pocket with (A) compound <b>9</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVV">7AVV</a>) and (B) overlay of compounds <b>8</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVU">7AVU</a>) and <b>9</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVV">7AVV</a>) highlighting the CH−π interaction of the methoxy substituent to the center of the aromatic Tyr with a distance of 2.9 Å. The small shift of compound <b>8</b> relative to compound <b>9</b> allows for optimal orientation of the methoxy substituent toward Y884.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01949&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Small Variations of the R-Group Leading to Either Activators or Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0013.gif" alt="" id="gr12" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">#</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char="±">SOS1::KRAS<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> IC<sub>50</sub> [nM]</th><th class="colsep0 rowsep0" align="center" char="±">SOS1::KRAS<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> EC<sub>50</sub> [nM]</th><th class="colsep0 rowsep0" align="center" char="±">SOS1<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a><i>K</i><sub>D</sub> (SPR) [nM]</th><th class="colsep0 rowsep0" align="center">mode of action</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>9</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±">289 ± 11</td><td class="colsep0 rowsep0" align="char" char="±">350 ± 32</td><td class="colsep0 rowsep0" align="left">activator</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>10</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±">939 ± 204</td><td class="colsep0 rowsep0" align="char" char="±">751 ± 73</td><td class="colsep0 rowsep0" align="left">activator</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>11</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">3830 ± 1830</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±">1490 ± 104</td><td class="colsep0 rowsep0" align="left">inhibitor</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>12</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char="±">33 ± 7</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±">24 ± 3</td><td class="colsep0 rowsep0" align="left">inhibitor</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Biochemical assay (AlphaScreen).</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Biophysical assay (SPR). Triplicates of all compounds were measured in both assays. IC<sub>50</sub> values are shown as arithmetic mean ± standard error of the mean.</p></div></div></div><div class="NLM_p">To elucidate the exact requirements for inhibition versus activation, a series of compounds with varied substituents at the 6-position and containing hydrogen at position 7 were prepared and measured. Exchanging hydrogen in compound <b>9</b> for fluorine gave compound <b>10</b>, which remained an activator, albeit with a 2–3-fold loss of binding affinity and activator activity. Exchanging the 6-substituent for the larger chlorine atom (compound <b>11</b>) was sufficient to switch the molecule from an activator to an inhibitor despite the 4-fold loss of activity versus the hydrogen-containing compound <b>9</b>. The loss of activity for compound <b>11</b> is likely due to a repulsive interaction between the electronegative chlorine atom and π-electrons of Y884. This clearly shows that PPI inhibition is caused by sterics and is independent of affinity. The addition of a methoxy group capable of forming attractive CH−π interactions with Y884 results in the inhibitor compound <b>12</b>, which displayed a significantly improved affinity (<i>K</i><sub>D</sub> = 24 nM) and activity in the AlphaScreen (IC<sub>50</sub> = 33 nM). Remarkably, the size of a single atom was the decisive factor for the mode of action and exchange of fluorine for a chlorine substituent turned an activator into an inhibitor.</div><div class="NLM_p">To find the optimal analogue to compound <b>8</b>, further derivatives at the 6-postion were explored. The tetrahydrofuryl substituent lead to <b>BI-3406</b>, a 4-fold more potent compound that otherwise displayed sufficient permeability, solubility, and the pharmacokinetic profile for oral daily dosing in rodents (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). <b>BI-3406</b> represents a useful probe compound to investigate SOS1 biology, downstream signaling, and effects on proliferation.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Characterization and Key Parameters of <b>BI-3406</b> (<b>13</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0014.gif" alt="" id="gr13" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="±">SOS1::KRAS<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> IC<sub>50</sub> [nM]</th><th class="colsep0 rowsep0" align="center" char="±">SOS1<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a><i>K</i><sub>D</sub> (SPR) [nM]</th><th class="colsep0 rowsep0" align="center" char="±">pERK (DLD-1)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> KRAS<sup>G13D</sup> IC<sub>50</sub> [nM]</th><th class="colsep0 rowsep0" align="center" char="±">proliferation (DLD-1)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a> KRAS<sup>G13D</sup> IC<sub>50</sub> [nM]</th><th class="colsep0 rowsep0" align="center">proliferation (H520)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a> KRAS<sup>wt</sup> IC<sub>50</sub> [nM]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="±">4 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">3 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">24 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">36 ± 10</td><td class="colsep0 rowsep0" align="left">>10,000</td></tr></tbody></table><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">solubility<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a> pH 4.5/6.8 [μg/mL]</th><th class="colsep0 rowsep0" align="center">efflux<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a> [BA/AB]</th><th class="colsep0 rowsep0" align="center">metabolic stability<a class="ref internalNav" href="#t4fn7" aria-label="g">g</a> hepatocytes, M/R/H [%Qh]</th><th class="colsep0 rowsep0" align="center">clearance<a class="ref internalNav" href="#t4fn8" aria-label="h">h</a> M/R [%Qh]</th><th class="colsep0 rowsep0" align="center">bioavailability<a class="ref internalNav" href="#t4fn9" aria-label="i">i</a> M/R [%]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">>100/84</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">45/28/14</td><td class="colsep0 rowsep0" align="left">61/16</td><td class="colsep0 rowsep0" align="left">100/100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Biochemical assay (AlphaScreen).</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Biophysical assay (SPR).</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Biomarker assay (Surefire).</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">3D proliferation assay (AlamarBlue). Triplicates of all compounds were measured in the biochemical, biophysical, biomarker, and proliferation assays. IC<sub>50</sub> values are shown as arithmetic mean ± standard error of the mean.</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">Solubility measured at different pH values.</p></div><div class="footnote" id="t4fn6"><sup><sup>f</sup></sup><p class="last">Efflux was measured using Caco-2 cells at 10 μM.</p></div><div class="footnote" id="t4fn7"><sup><sup>g</sup></sup><p class="last"><i>In vitro</i> metabolic stability measured in hepatocytes with 50% serum for mice, rats, and humans.</p></div><div class="footnote" id="t4fn8"><sup><sup>h</sup></sup><p class="last"><i>In vivo</i> clearance measured in mice and rats.</p></div><div class="footnote" id="t4fn9"><sup><sup>i</sup></sup><p class="last">Bioavailability measured in mice and rats.</p></div></div></div><div class="NLM_p">We have recently published that inhibition of SOS1 by <b>BI-3406</b> reduces the formation of GTP-loaded KRAS, inhibits MAPK pathway signaling, and exhibits activity in a broad spectrum of KRAS alleles, including all major G12D/V/C and G13D oncoproteins.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Cell lines expressing mutant KRAS, such as DLD1 carrying a G13D mutation, are sensitive in 3D proliferation assays, whereas NCI-H520, a KRAS wild-type cell line, is resistant to <b>BI-3406</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_p">However, due to the role of SOS1 as an important feedback node in the MAP kinase pathway,<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> we expect the biggest impact of SOS1 inhibitors in combination therapy settings. We previously showed that <b>BI-3406</b> blocks the negative feedback relief induced by downstream MEK inhibition.<a onclick="showRef(event, 'ref33 ref42'); return false;" href="javascript:void(0);" class="ref ref33 ref42">(33,42)</a> Accordingly, the combination of <b>BI-3406</b> with the MEK inhibitor trametinib elicited strong antitumor efficacy in KRAS-mutant xenograft models. The concept of dual SOS1 and MEK inhibition is currently being tested in clinical trials.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> To demonstrate the utility of <b>BI-3406</b> as an SOS1 probe molecule and further elaborate the potential of SOS1 inhibition in cancer combination therapies, we tested the effects of vertical pathway co-inhibition by combining <b>BI-3406</b> with the EGFR inhibitor afatinib. In DLD-1 KRAS<sup>G13D</sup> mutant colorectal tumor cells, dual pathway inhibition of SOS1i and afatinib leads to enhanced PARP cleavage, a marker for apoptosis induction (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A). The effect of this combination on PARP cleavage is of similar magnitude as the effect of the <b>BI-3406</b> plus trametinib combination. In agreement with the <i>in vitro</i> data, combination of <b>BI-3406</b> with afatinib resulted in significantly enhanced efficacy compared to both monotherapies in a DLD-1 xenograft model (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B). This combination concept is in line with recent reports describing marked synergy of the anti-EGFR antibody cetuximab with KRAS<sup>G12C</sup> inhibitors in KRAS<sup>G12C</sup> mutant cancer cell lines<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and of the EGFR inhibitor osimertinib with SOS1 inhibitors in EGFR mutant lung cancer cell lines.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Our results highlight the potential of SOS1 inhibitors as a combination backbone to augment the antitumor effect of MAPK pathway inhibitors, such as KRAS, EGFR, and MEK inhibitors through vertical pathway inhibition (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>C).<named-content content-type="anchor" rid="fig9" type="simple"></named-content></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Combined SOS1 and EGFR inhibition leads to stronger antitumor efficacy in KRAS-mutant tumors. (A) Cleaved PARP was analyzed 24 and 48 h following treatment with control, 0.1 nM trametinib, 100 nM afatinib, or the combination with <b>BI-3406</b> (<i>n</i> = 2, means ± s.d.). (B) Antitumor effect of <b>BI-3406</b> (37% TGI), afatinib (7% TGI), or the combination (78% TGI) in the DLD-1 xenograft model after <b>BI-3406</b> treatment (50 mg/kg, bid; <i>n</i> = 7 animals per group; violin dot plot; mean; second quartile; *<i>P</i> ≤ 0.05, one-tailed <i>t</i> test). (C) Proposed model of the effects of combined afatinib and SOS1 inhibition. Dual inhibition of the pathway results in a cytoreductive effect resulting in enhanced apoptosis, which results in stronger antitumor efficacy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01949&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50604" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50604" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">With the emergence of KRAS<sup>G12C</sup>-selective approaches, the need for additional therapies targeting other prevalent oncogenes of KRAS is increasingly coming into focus. One of the key regulators of KRAS is SOS1. To come up with a tool compound for dissecting cellular functions of SOS1 in the tumorigenesis of a broad range of KRAS-driven cancers, a high-throughput screen based on biochemical and biophysical triaging was used to identify suitable starting points. Structure-based drug discovery allowed for efficient rational design and guided selectivity and potency optimization of the corresponding hits early on. Fine-tuning of the resulting SOS1 inhibitors with respect to DMPK properties eventually led to the discovery of <b>BI-3406</b>. The compound binds to the catalytic domain of SOS1 at the periphery of the KRAS binding interface. Positioning of a comparably small substituent between a key amino acid pair formed by KRAS and SOS1 allowed for potent and selective PPI inhibition. Variation of this substituent led to the surprising observation that a single atom determines whether our compounds activate or inhibit SOS1. This is one of the rare examples where reversing the mode of action (activator–inhibitor) by a marginal structural modification has been described.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> These findings demonstrate a new paradigm to design inhibitors of PPIs, which might be generally applicable to small GTPase–guanine nucleotide exchange factor PPIs and beyond. Finally, to tap into synergistic effects of vertical MAPK pathway inhibition, the dual combination of <b>BI-3406</b> with an EGFR inhibitor was examined. This combination concept leads to stronger antitumor efficacy and is consistent with the importance of SOS1 as an important feedback node in cancers driven by a broad range of KRAS-mutant oncoproteins.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52787" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52787" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> General Procedures</h3><div class="NLM_p">Commercial starting materials were used without further purification. Solvents used for reactions were of commercial “dry” or “extra-dry” or “analytical” grade. All other solvents used were of reagent grade. Unless specifically mentioned, all reactions were carried out in standard commercially available glassware using standard synthetic chemistry methods. Air-sensitive and moisture-sensitive reactions were performed under an atmosphere of dry nitrogen or argon with dried glassware. If not explicitly mentioned otherwise, the purity of all tested compounds was ≥95%.</div><div class="NLM_p">Preparative RP-HPLC was carried out on Agilent or Gilson systems using columns from Waters (Sunfire C18 OBD, 5 or 10 μm, 20 mm × 50 mm, 30 mm × 50 mm, or 50 mm × 150 mm; X-Bridge C18 OBD, 5 or 10 μm, 20 mm × 50 mm, 30 mm × 50 mm, or 50 mm × 150 mm) or YMC (Triart C18, 5, or 10 μm, 20 mm × 50 mm, or 30 mm × 50 mm). Unless specifically mentioned, compounds were eluted with MeCN/water gradients using either acidic (0.2% HCOOH or TFA) or basic water (5 mL of 2 M NH<sub>4</sub>HCO<sub>3</sub> + 2 mL of NH<sub>3</sub> (32%) made up to 1 L with water).</div><div class="NLM_p">NMR experiments were recorded on a Bruker Avance HD 500 MHz spectrometer equipped with a TCI cryoprobe. Samples were dissolved in 600 μL of DMSO-<i>d</i><sub>6</sub> and TMS was added as an internal standard. The temperature was set to 298 K. Processing of spectra was performed with Bruker Topspin 3.2 software. The spectra were analyzed with ACD/NMR Workbook 2019. Chemical shifts are reported in ppm on the δ scale. No zero filling was performed and the spectra were manually integrated after automatic baseline correction. The 1D <sup>1</sup>H spectra were acquired with 30° excitation pulses and an interpulse delay of 4.2 s with 64k data points and a 20 ppm sweep width. The 1D <sup>13</sup>C spectra were acquired with broadband composite pulse decoupling (WALTZ16) and an interpulse delay of 3.3 s with 64k data points and a sweep width of 240 ppm. The 2D HSQC spectra were recorded on all samples to aid the interpretation of the data and to identify signals hidden underneath solvent peaks. The spectra were acquired with sweep widths obtained by automatic sweep width detection from the 1D reference spectra in the direct dimension with 1k data points and with 210 ppm and 256 data points in the indirect dimension.</div><div class="NLM_p">All samples were analyzed on an Agilent 1200 series LC system coupled with an Agilent 6140 mass spectrometer. Purity was determined via UV detection with a bandwidth of 170 nm in the range from 230 to 400 nm. LC parameters were as follows: Waters Xbridge C18 column; 2.5 μm particle size; 2.1 × 20 mm; run time, 2.1 min; flow, 1 mL/min; column temperature, 60 °C; 5 μL injections; solvent A (20 mM NH<sub>4</sub>HCO<sub>3</sub>/NH<sub>3</sub>, pH 9) and solvent B (MS-grade acetonitrile); start 10% B, gradient 10% to 95% B from 0.0 to 1.5 min, 95% B from 1.5 to 2.0 min, gradient 95% to 10% B from 2.0 to 2.1 min.</div><div class="NLM_p last">HRMS data was recorded using an LTQ Orbitrap XL (Thermo Scientific) coupled with a Triversa Nanomate Nanospray ion source (ADVION Bioscience Inc.). The mass calibration was performed using the Pierce LTQ Velos ESI positive ion calibration solution from Thermo Scientific (product no. 88323). The scan window was set to 100–500 amu with a maximum injection time of 500 ms and 1 microscan. Resolution of the Orbitrap was 60,000 with a mass accuracy of ≤5 ppm. The ion mode was set to positive with a capillary temperature of 200 °C and a voltage of 60 eV. The tube lens potential was set to 110 eV. The NanoESI voltage was 1.45 kV and the N<sub>2</sub> gas pressure was set to 0.45 psi. The total sample volume was 5 μL and the acquisition time was 60 s, with 15 scans of averaging per spectrum. The sample dilution (10 mM DMSO stock solution) was diluted 1:200 in 50% MeOH + 0.01% formic acid.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Materials</h3><div class="NLM_p">The preparation of compound <b>13</b> (<b>BI-3406</b>) was previously reported.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> General Procedure for the Preparation of Compounds <b>4</b>–<b>12</b></h4><div class="NLM_p last">A 1 M suspension of the corresponding 4-chloroquinazoline in DMSO was treated with diisopropylethylamine (5 equiv) and the respective phenethylamine (1.2 equiv). The reaction mixture was stirred at 80 °C until full conversion of 4-chloroquinazoline was observed. Purification by reversed-phase chromatography provided the desired products.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> (<i>R</i>)-6,7-Dimethoxy-2-methyl-<i>N</i>-(1-phenylethyl)-quinazolin-4-amine (<b>4</b>)</h4><div class="NLM_p last">Compound <b>4</b> was prepared using the general procedure described above. Yield: 83%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 8.50 (br s, 1H), 7.82 (s, 1H), 7.47 (d, 2H, <i>J</i> = 7.6 Hz), 7.34 (t, 2H, <i>J</i> = 7.6 Hz), 7.24 (t, 1H, <i>J</i> = 7.3 Hz), 7.05 (s, 1H), 5.71 (quin, 1H, <i>J</i> = 7.3 Hz), 3.93 (s, 3H), 3.89 (s, 3H), 2.41 (s, 3H), 1.62 (d, 3H, <i>J</i> = 7.3 Hz). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 161.1, 158.2, 154.7, 148.6, 144.9, 128.7, 127.2, 126.8, 106.4, 105.1, 103.0, 56.8, 56.2, 49.5, 25.5, 22.4. HRMS calculated for [M + H]<sup>+</sup> (C<sub>19</sub>H<sub>21</sub>N<sub>3</sub>O<sub>2</sub>): 324.17065; found: 324.17057.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> (<i>R</i>)-3-(1-((6,7-Dimethoxy-2-methylquinazolin-4-yl)amino)ethyl)benzenesulfonamide (<b>5</b>)</h4><div class="NLM_p last">Compound <b>5</b> was prepared using the general procedure described above. Yield: 56%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 8.80 (br s, 1H), 7.95 (t, 1H, <i>J</i> = 1.6 Hz), 7.86 (s, 1H), 7.6–7.8 (m, 2H), 7.55 (t, 1H, <i>J</i> = 7.3 Hz), 7.37 (s, 2H), 7.08 (s, 1H), 5.74 (quin, 1H, <i>J</i> = 7.1 Hz), 3.94 (s, 3H), 3.90 (s, 3H), 2.44 (s, 3H), 1.66 (d, 3H, <i>J</i> = 6.9 Hz). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 160.9, 158.2, 155.0, 148.9, 145.8, 144.6, 130.4, 129.5, 124.7, 123.9, 106.2, 103.1, 56.8, 56.3, 49.8, 25.0, 22.2. HRMS calculated for [M + H]<sup>+</sup> (C<sub>19</sub>H<sub>22</sub>N<sub>4</sub>O<sub>4</sub>S): 403.14345; found: 403.14301.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> (<i>R</i>)-6,7-Dimethoxy-2-methyl-<i>N</i>-(1-(3-(trifluoro-methyl)phenyl)ethyl)quinazolin-4-amine (<b>6</b>)</h4><div class="NLM_p last">Compound <b>6</b> was prepared using the general procedure described above. Yield: 49%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 8.07 (d, 1H, <i>J</i> = 7.6 Hz), 7.81 (s, 1H), 7.76 (br d, 1H, <i>J</i> = 6.6 Hz), 7.69 (s, 1H), 7.5–7.6 (m, 2H), 7.03 (s, 1H), 5.66 (quin, 1H, <i>J</i> = 7.2 Hz), 3.91 (s, 3H), 3.86 (s, 3H), 2.33 (s, 3H), 1.62 (d, 3H, <i>J</i> = 7.3 Hz). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 161.7, 157.9, 154.3, 148.2, 147.3, 147.1, 131.0, 129.8, 129.3, 123.8, 123.5, 124.8, 107.1, 106.7, 102.4, 56.6, 56.1, 49.2, 26.4, 22.5. HRMS calculated for [M + H]<sup>+</sup> (C<sub>20</sub>H<sub>20</sub>F<sub>3</sub>N<sub>3</sub>O<sub>2</sub>): 392.15804; found: 392.15781.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> (<i>R</i>)-<i>N</i>-(1-(3-Aminophenyl)ethyl)-6,7-dimethoxy-2-methylquinazolin-4-amine (<b>7</b>)</h4><div class="NLM_p last">Compound <b>7</b> was prepared using the general procedure described above. Yield: 17%. HPLC purity: 80%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 7.93 (br d, 1H, <i>J</i> = 6.6 Hz), 7.71 (s, 1H), 7.01 (s, 1H), 6.95 (t, 1H, <i>J</i> = 7.7 Hz), 6.62 (s, 1H), 6.59 (d, 1H, <i>J</i> = 7.6 Hz), 6.40 (dd, 1H, <i>J</i> = 1.3, 7.9 Hz), 5.57 (quin, 1H, <i>J</i> = 7.3 Hz), 4.99 (br s, 2H), 3.89 (s, 3H), 3.86 (s, 3H), 2.36 (s, 3H), 1.52 (d, 3H, <i>J</i> = 6.9 Hz). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 161.8, 158.1, 154.1, 148.9, 148.1, 145.9, 129.1, 114.2, 112.7, 112.3, 106.9, 106.8, 102.7, 56.6, 56.0, 48.8, 26.5, 22.4. HRMS calculated for [M + H]<sup>+</sup> (C<sub>19</sub>H<sub>22</sub>N<sub>4</sub>O<sub>2</sub>): 339.18155; found: 339.18137.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> (<i>R</i>)-<i>N</i>-(1-(3-Amino-5-(trifluoromethyl)phenyl)-ethyl)-6,7-dimethoxy-2-methylquinazolin-4-amine (<b>8</b>)</h4><div class="NLM_p last">Compound <b>8</b> was prepared using the general procedure described above. Yield: 45%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 7.97 (d, 1H, <i>J</i> = 7.9 Hz), 7.70 (s, 1H), 7.03 (s, 1H), 6.87 (d, 2H, <i>J</i> = 14.5 Hz), 6.69 (s, 1H), 5.5–5.7 (m, 3H), 3.90 (s, 3H), 3.8–3.9 (m, 3H), 2.35 (s, 3H), 1.55 (d, 3H, <i>J</i> = 6.9 Hz). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 12% MHz) δ 161.8, 158.0, 154.2, 149.8, 148.2, 147.6, 147.3, 130.0, 125.1, 115.6, 110.1, 108.4, 107.1, 106.7, 102.6, 56.6, 56.1, 48.8, 26.5, 22.3. HRMS calculated for [M + H]<sup>+</sup> (C<sub>20</sub>H<sub>21</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub>): 407.16894; found: 407.1685.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> (<i>R</i>)-<i>N</i>-(1-(3-Amino-5-(trifluoromethyl)phenyl)-ethyl)-2-methylquinazolin-4-amine (<b>9</b>)</h4><div class="NLM_p last">Compound <b>9</b> was prepared using the general procedure described above. Yield: 46%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 8.3–8.5 (m, 2H), 7.73 (ddd, 1H, <i>J</i> = 1.3, 6.9, 8.2 Hz), 7.60 (d, 1H, <i>J</i> = 7.9 Hz), 7.47 (ddd, 1H, <i>J</i> = 0.9, 6.9, 8.2 Hz), 6.91 (s, 1H), 6.87 (s, 1H), 6.70 (s, 1H), 5.5–5.7 (m, 3H), 2.42 (s, 3H), 1.56 (d, 3H, <i>J</i> = 7.3 Hz). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 163.6, 159.1, 149.8, 147.1, 133.1, 130.1, 127.0, 125.2, 123.3, 125.1, 115.6, 113.3, 110.1, 108.4, 49.1, 26.6, 22.2. HRMS calculated for [M + H]<sup>+</sup> (C<sub>18</sub>H<sub>17</sub>F<sub>3</sub>N<sub>4</sub>): 347.14781; found: 347.14748.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> (<i>R</i>)-<i>N</i>-(1-(3-Amino-5-(trifluoromethyl)phenyl)-ethyl)-6-fluoro-2-methylquinazolin-4-amine (<b>10</b>)</h4><div class="NLM_p last">Compound <b>10</b> was prepared using the general procedure described above. Yield: 36%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 8.1–8.4 (m, 1H), 7.5–7.7 (m, 1H), 6.87 (d, 1H, <i>J</i> = 21.8 Hz), 6.69 (s, 1H), 5.4–5.6 (m, 1H), 2.40 (s, 7H), 1.54 (d, 6H, <i>J</i> = 7.3 Hz). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 163.2, 160.1, 158.8, 158.2, 149.8, 147.4, 147.0, 130.1, 130.1, 125.1, 122.2, 113.7, 110.1, 108.4, 107.6, 49.2, 26.6, 22.2. HRMS calculated for [M + H]<sup>+</sup> (C<sub>18</sub>H<sub>16</sub>F<sub>4</sub>N<sub>4</sub>): 365.13839; found: 365.13829.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> (<i>R</i>)-<i>N</i>-(1-(3-Amino-5-(trifluoromethyl)phenyl)-ethyl)-6-chloro-2-methylquinazolin-4-amine (<b>11</b>)</h4><div class="NLM_p last">Compound <b>11</b> was prepared using the general procedure described above. Yield: 58%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 8.56 (d, 1H, <i>J</i> = 2.2 Hz), 8.43 (d, 1H, <i>J</i> = 7.9 Hz), 7.73 (dd, 1H, <i>J</i> = 2.4, 9.0 Hz), 7.61 (d, 1H, <i>J</i> = 8.8 Hz), 6.89 (s, 1H), 6.85 (s, 1H), 6.70 (s, 1H), 5.5–5.6 (m, 3H), 2.40 (s, 3H), 1.54 (d, 3H, <i>J</i> = 6.9 Hz). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 164.3, 158.3, 149.9, 149.0, 146.9, 133.3, 130.1, 129.6, 129.2, 125.1, 122.6, 115.5, 114.2, 110.1, 108.4, 49.3, 26.7, 22.2. HRMS calculated for [M + H]<sup>+</sup> (C<sub>18</sub>H<sub>16</sub>ClF<sub>3</sub>N<sub>4</sub>): 381.10883; found: 381.10858.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (<i>R</i>)-<i>N</i>-(1-(3-Amino-5-(trifluoromethyl)phenyl)-ethyl)-6-methoxy-2-methylquinazolin-4-amine (<b>12</b>)</h4><div class="NLM_p last">Compound <b>12</b> was prepared using the general procedure described above. Yield: 60%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 8.15 (d, 1H, <i>J</i> = 7.9 Hz), 7.77 (d, 1H, <i>J</i> = 2.5 Hz), 7.53 (d, 1H, <i>J</i> = 9.1 Hz), 7.3–7.4 (m, 1H), 6.88 (d, 2H, <i>J</i> = 17.0 Hz), 6.70 (s, 1H), 5.4–5.7 (m, 3H), 3.90 (s, 3H), 2.37 (s, 3H), 1.56 (d, 3H, <i>J</i> = 7.3 Hz). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 161.3, 158.5, 156.8, 149.8, 147.3, 145.6, 130.0, 128.9, 125.1, 123.8, 115.5, 113.7, 110.1, 108.4, 102.8, 56.4, 49.0, 26.5, 22.2. HRMS calculated for [M + H]<sup>+</sup> (C<sub>19</sub>H<sub>19</sub>F<sub>3</sub>N<sub>4</sub>O): 377.15837; found: 377.15818.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01949" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88066" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88066" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01949?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01949</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Schemes S1 and S2 illustrating the synthesis of all compounds; protein expression and purification; protein crystallization and structure solution; Tables S1–S6 showing the crystallographic data of all compounds; Figure S1 illustrating the electron density maps of ligands; assay descriptions; HPLC traces of all synthesized compounds; sensorgrams for compounds <b>1</b>–<b>13</b>; data on kinase activity of selected compounds; Table S7 showing the kinase activity of compounds; analysis of cleaved PARP (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01949/suppl_file/jm0c01949_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01949/suppl_file/jm0c01949_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01949/suppl_file/jm0c01949_si_001.pdf">jm0c01949_si_001.pdf (2.99 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01949/suppl_file/jm0c01949_si_002.csv">jm0c01949_si_002.csv (0.86 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01949" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43083" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43083" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juergen Ramharter</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7618-1862" title="Orcid link">http://orcid.org/0000-0001-7618-1862</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#87edf2e2f5e0e2e9a9f5e6eaefe6f5f3e2f5c7e5e8e2eff5eee9e0e2f5aaeee9e0e2ebefe2eeeaa9e4e8ea"><span class="__cf_email__" data-cfemail="731906160114161d5d01121e1b120107160133111c161b011a1d1416015e1a1d14161f1b161a1e5d101c1e">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Darryl B. McConnell</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4125203333382d6f2c22222e2f2f242d2d01232e242933282f2624336c282f26242d2924282c6f222e2c"><span class="__cf_email__" data-cfemail="3054514242495c1e5d53535f5e5e555c5c70525f555842595e5755421d595e57555c5855595d1e535f5d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dirk Kessler</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Ettmayer</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8422-2625" title="Orcid link">http://orcid.org/0000-0002-8422-2625</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco H. Hofmann</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Gerstberger</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Gmachl</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tobias Wunberg</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christiane Kofink</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Sanderson</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heribert Arnhof</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gerd Bader</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Klaus Rumpel</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andreas Zöphel</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Renate Schnitzer</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jark Böttcher</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan C. O’Connell</span> - <span class="hlFld-Affiliation affiliation">Forma
Therapeutics, 500 Arsenal Street, Suite 100, Watertown, Massachusetts 02472, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rachel L. Mendes</span> - <span class="hlFld-Affiliation affiliation">Forma
Therapeutics, 500 Arsenal Street, Suite 100, Watertown, Massachusetts 02472, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Richard</span> - <span class="hlFld-Affiliation affiliation">Forma
Therapeutics, 500 Arsenal Street, Suite 100, Watertown, Massachusetts 02472, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nikolai Pototschnig</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irene Weiner</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wolfgang Hela</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katja Hauer</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniela Haering</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lyne Lamarre</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bernhard Wolkerstorfer</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Salamon</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Werni</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvia Munico-Martinez</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Reiner Meyer</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew D. Kennedy</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Norbert Kraut</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co KG, Dr. Boehringer-Gasse 5-11, A-1121 Vienna, Austria</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.R. and D.K. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Juergen Ramharter, Dirk Kessler, Peter Ettmayer, Marco H. Hofmann, Thomas Gerstberger, Michael Gmachl, Tobias Wunberg, Christiane Kofink, Michael Sanderson, Heribert Arnhof, Gerd Bader, Klaus Rumpel, Andreas Zöphel, Renate Schnitzer, Jark Böttcher, Nikolai Pototschnig, Irene Weiner, Wolfgang Hela, Katja Hauer, Daniela Haering, Lyne Lamarre, Bernhard Wolkerstorfer, Christian Salamon, Patrick Werni, Silvia Munico-Martinez, Reiner Meyer, Matthew D. Kennedy, Norbert Kraut and Darryl B. McConnell were full-time employees for Boehringer Ingelheim at the time the here presented data were collected. Jonathan C. OConnell, Rachel L. Mendes and David Richard were full-time employees for Forma Therapeutics at the time the here presented data were collected.<br /></br><p class="inlineNote">The atomic coordinates of the SOS1 crystal data have been deposited in the Protein Data Bank (<a href="http://www.pdb.org" class="extLink">www.pdb.org</a>) and will be released upon publication of the article (PDB IDs: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVI">7AVI</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVL">7AVL</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVS">7AVS</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVT">7AVT</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVU">7AVU</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVV">7AVV</a>).</p></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53120" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53120" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We would like to thank Gabriele Glendinning, Christoph Harrer, Wolfgang Egermann, and Susanne Mayer from Boehringer Ingelheim for excellent project support. The Austrian Research Promotion Agency (FFG) is acknowledged for the following support awards: 854341, 861507, 867897, and 874517.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">GAP</td><td class="NLM_def"><p class="first last">GTPase-activating proteins</p></td></tr><tr><td class="NLM_term">GEF</td><td class="NLM_def"><p class="first last">guanine nucleotide exchange factors</p></td></tr><tr><td class="NLM_term">KRAS</td><td class="NLM_def"><p class="first last">Kirsten rat sarcoma</p></td></tr><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly(ADP-ribose) polymerase</p></td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">protein–protein interaction</p></td></tr><tr><td class="NLM_term">RAS</td><td class="NLM_def"><p class="first last">rat sarcoma</p></td></tr><tr><td class="NLM_term">SOS1</td><td class="NLM_def"><p class="first last">son of sevenless homolog 1</p></td></tr><tr><td class="NLM_term">SOS2</td><td class="NLM_def"><p class="first last">son of sevenless homolog 2</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34773" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34773" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 45 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wernersson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slodkowicz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapacki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stærfeldt, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lage, K.</span></span> <span> </span><span class="NLM_article-title">A scored human protein–protein interaction network to catalyze genomic interpretation</span>. <i>Nat. Methods</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">61</span>, <span class="refDoi"> DOI: 10.1038/nmeth.4083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1038%2Fnmeth.4083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=27892958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFShtrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=61&author=T.+Liauthor=R.+Wernerssonauthor=R.+B.+Hansenauthor=H.+Hornauthor=J.+Mercerauthor=G.+Slodkowiczauthor=C.+T.+Workmanauthor=O.+Riginaauthor=K.+Rapackiauthor=H.+H.+St%C3%A6rfeldtauthor=S.+Brunakauthor=T.+S.+Jensenauthor=K.+Lage&title=A+scored+human+protein%E2%80%93protein+interaction+network+to+catalyze+genomic+interpretation&doi=10.1038%2Fnmeth.4083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">A scored human protein-protein interaction network to catalyze genomic interpretation</span></div><div class="casAuthors">Li, Taibo; Wernersson, Rasmus; Hansen, Rasmus B.; Horn, Heiko; Mercer, Johnathan; Slodkowicz, Greg; Workman, Christopher T.; Rigina, Olga; Rapacki, Kristoffer; Staerfeldt, Hans H.; Brunak, Soeren; Jensen, Thomas S.; Lage, Kasper</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-64</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Genome-scale human protein-protein interaction networks are crit. to understanding cell biol. and interpreting genomic data, but challenging to produce exptl.  Through data integration and quality control, we provide a scored human protein-protein interaction network (InWeb_InBioMap, or InWeb_IM) with severalfold more interactions (>500,000) and better functional biol. relevance than comparable resources.  We illustrate that InWeb_InBioMap enables functional interpretation of >4,700 cancer genomes and genes involved in autism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpld1mzwEuUvbVg90H21EOLACvtfcHk0lhqVoqxelT7Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFShtrbN&md5=0c5efd419cfae7663c02c080c4ddfa02</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.4083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.4083%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DT.%26aulast%3DWernersson%26aufirst%3DR.%26aulast%3DHansen%26aufirst%3DR.%2BB.%26aulast%3DHorn%26aufirst%3DH.%26aulast%3DMercer%26aufirst%3DJ.%26aulast%3DSlodkowicz%26aufirst%3DG.%26aulast%3DWorkman%26aufirst%3DC.%2BT.%26aulast%3DRigina%26aufirst%3DO.%26aulast%3DRapacki%26aufirst%3DK.%26aulast%3DSt%25C3%25A6rfeldt%26aufirst%3DH.%2BH.%26aulast%3DBrunak%26aufirst%3DS.%26aulast%3DJensen%26aufirst%3DT.%2BS.%26aulast%3DLage%26aufirst%3DK.%26atitle%3DA%2520scored%2520human%2520protein%25E2%2580%2593protein%2520interaction%2520network%2520to%2520catalyze%2520genomic%2520interpretation%26jtitle%3DNat.%2520Methods%26date%3D2017%26volume%3D14%26spage%3D61%26doi%3D10.1038%2Fnmeth.4083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, J. M.</span></span> <span> </span><span class="NLM_article-title">Principles of protein-protein interactions</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.1.13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1073%2Fpnas.93.1.13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=8552589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADyaK28XjslOrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=13-20&author=S.+Jonesauthor=J.+M.+Thornton&title=Principles+of+protein-protein+interactions&doi=10.1073%2Fpnas.93.1.13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Principles of protein-protein interactions</span></div><div class="casAuthors">Jones, Susan; Thornton, Janet M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-20</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review, with 47 refs., examg. protein complexes in the Brookhaven Protein Databank to gain a better understanding of the principles governing the interactions involved in protein-protein recognition.  The factors that influence the formation of protein-protein complexes are explored in four different types of protein-protein complexes: homodimeric proteins, heterodimeric proteins, enzyme-inhibitor complexes, and antibody-protein complexes.  The comparison between the complexes highlights differences that reflect their biol. roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr13RlSj8fKFLVg90H21EOLACvtfcHk0lh6UxX1H8RASg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjslOrsQ%253D%253D&md5=2b03d8f835104e5a7bf5da83afd4a8d1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.1.13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.1.13%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DS.%26aulast%3DThornton%26aufirst%3DJ.%2BM.%26atitle%3DPrinciples%2520of%2520protein-protein%2520interactions%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D13%26epage%3D20%26doi%3D10.1073%2Fpnas.93.1.13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nooren, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, J. M.</span></span> <span> </span><span class="NLM_article-title">Diversity of protein–protein interactions</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3486</span>– <span class="NLM_lpage">3492</span>, <span class="refDoi"> DOI: 10.1093/emboj/cdg359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1093%2Femboj%2Fcdg359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=12853464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlsl2lu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=3486-3492&author=I.+M.+Noorenauthor=J.+M.+Thornton&title=Diversity+of+protein%E2%80%93protein+interactions&doi=10.1093%2Femboj%2Fcdg359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Diversity of protein-protein interactions</span></div><div class="casAuthors">Nooren, Irene M. A.; Thornton, Janet M.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3486-3492</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  The structural and functional diversity of protein-protein interactions (PPIs) is discussed, based primarily on protein families for which 3-dimensional structural data are available.  PPIs play diverse roles in biol. and differ based on the compn., affinity and whether the assocn. is permanent or transient.  In vivo, the protomer localization, concn., and local environment can affect the interaction between protomers and are vital to control the compn. and oligomeric state of protein complexes.  Since a change in quaternary state is often coupled with biol. function or activity, transient PPIs are important biol. regulators.  Structural characteristics of different types of PPIs are discussed and related to their physiol. function, specificity, and evolution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPqeAimeGxIbVg90H21EOLACvtfcHk0lh6UxX1H8RASg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlsl2lu7k%253D&md5=139bedaea418702fe5285ca580d14c5f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Femboj%2Fcdg359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252Fcdg359%26sid%3Dliteratum%253Aachs%26aulast%3DNooren%26aufirst%3DI.%2BM.%26aulast%3DThornton%26aufirst%3DJ.%2BM.%26atitle%3DDiversity%2520of%2520protein%25E2%2580%2593protein%2520interactions%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26spage%3D3486%26epage%3D3492%26doi%3D10.1093%2Femboj%2Fcdg359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors of protein–protein interactions: progressing towards the dream</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1038/nrd1343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1038%2Fnrd1343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=15060526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1GktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=301-317&author=M.+R.+Arkinauthor=J.+A.+Wells&title=Small-molecule+inhibitors+of+protein%E2%80%93protein+interactions%3A+progressing+towards+the+dream&doi=10.1038%2Fnrd1343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of protein-protein interactions: progressing towards the dream</span></div><div class="casAuthors">Arkin, Michelle R.; Wells, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">301-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein-protein interactions have a key role in most biol. processes, and offer attractive opportunities for therapeutic intervention.  Developing small mols. that modulate protein-protein interactions is difficult, owing to issues such as the lack of well-defined binding pockets.  Nevertheless, there was important progress in this endeavor in recent years.  Here, the authors use illustrative examples to discuss general strategies for addressing the challenges inherent in the discovery and characterization of small-mol. inhibitors of protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7MiFDdLJu27Vg90H21EOLACvtfcHk0lh6UxX1H8RASg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1GktrY%253D&md5=3e102c6207be420b4232056b4acdea12</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd1343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1343%26sid%3Dliteratum%253Aachs%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520protein%25E2%2580%2593protein%2520interactions%253A%2520progressing%2520towards%2520the%2520dream%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D301%26epage%3D317%26doi%3D10.1038%2Fnrd1343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pawson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, P.</span></span> <span> </span><span class="NLM_article-title">Assembly of cell regulatory systems through protein interaction domains</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>300</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">452</span>, <span class="refDoi"> DOI: 10.1126/science.1083653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1126%2Fscience.1083653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=12702867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFymsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2003&pages=445-452&author=T.+Pawsonauthor=P.+Nash&title=Assembly+of+cell+regulatory+systems+through+protein+interaction+domains&doi=10.1126%2Fscience.1083653"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Assembly of Cell Regulatory Systems Through Protein Interaction Domains</span></div><div class="casAuthors">Pawson, Tony; Nash, Piers</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">300</span>
        (<span class="NLM_cas:issue">5618</span>),
    <span class="NLM_cas:pages">445-452</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  The sequencing of complete genomes provides a list that includes the proteins responsible for cellular regulation.  However, this does not immediately reveal what these proteins do, nor how they are assembled into the mol. machines and functional networks that control cellular behavior.  The regulation of many different cellular processes requires the use of protein interaction domains to direct the assocn. of polypeptides with one another and with phospholipids, small mols., or nucleic acids.  The modular nature of these domains, and the flexibility of their binding properties, have likely facilitated the evolution of cellular pathways.  Conversely, aberrant interactions can induce abnormal cellular behavior and disease.  The fundamental properties of protein interaction domains are discussed in this review and in detailed reviews on individual domains at Science's STKE at http://www.sciencemag.org/cgi/content/full/300/5618/445/DC1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrDUJdWBAiYrVg90H21EOLACvtfcHk0lh6UxX1H8RASg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFymsL0%253D&md5=b500533683256e2a28e905e07961e68e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1083653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1083653%26sid%3Dliteratum%253Aachs%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DNash%26aufirst%3DP.%26atitle%3DAssembly%2520of%2520cell%2520regulatory%2520systems%2520through%2520protein%2520interaction%2520domains%26jtitle%3DScience%26date%3D2003%26volume%3D300%26spage%3D445%26epage%3D452%26doi%3D10.1126%2Fscience.1083653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolch, W.</span></span> <span> </span><span class="NLM_article-title">Meaningful relationships: the regulation of the RAS/RAF/MEK/ERK pathway by protein interactions</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>351</i></span>,  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1042/bj3510289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1042%2Fbj3510289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=11023813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvFSqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2000&pages=289-305&author=W.+Kolch&title=Meaningful+relationships%3A+the+regulation+of+the+RAS%2FRAF%2FMEK%2FERK+pathway+by+protein+interactions&doi=10.1042%2Fbj3510289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions</span></div><div class="casAuthors">Kolch, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">289-305</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review, with 184 refs.  The Ras/Raf/MEK (mitogen-activated protein kinase/ERK kinase)/ERK (extracellular-signal-regulated kinase) pathway is at the heart of signaling networks that govern proliferation, differentiation and cell survival.  Although the basic regulatory steps have been elucidated, many features of this pathway are only beginning to emerge.  This review focuses on the role of protein-protein interactions in the regulation of this pathway, and how they contribute to coordinate activation steps, subcellular redistribution, substrate phosphorylation and cross-talk with other signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Xj1Jp8fvHrVg90H21EOLACvtfcHk0li4eRKXEjZ8dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvFSqt78%253D&md5=5d895f03da4dc6c64355a541185fe675</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1042%2Fbj3510289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3510289%26sid%3Dliteratum%253Aachs%26aulast%3DKolch%26aufirst%3DW.%26atitle%3DMeaningful%2520relationships%253A%2520the%2520regulation%2520of%2520the%2520RAS%252FRAF%252FMEK%252FERK%2520pathway%2520by%2520protein%2520interactions%26jtitle%3DBiochem.%2520J.%26date%3D2000%26volume%3D351%26spage%3D289%26epage%3D305%26doi%3D10.1042%2Fbj3510289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cerami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogrusoz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumer, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aksoy, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byrne, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuer, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antipin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reva, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sander, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, N.</span></span> <span> </span><span class="NLM_article-title">The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">404</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-12-0095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1158%2F2159-8290.CD-12-0095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=22588877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A280%3ADC%252BC38njsVertQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=401-404&author=E.+Ceramiauthor=J.+Gaoauthor=U.+Dogrusozauthor=B.+E.+Grossauthor=S.+O.+Sumerauthor=B.+A.+Aksoyauthor=A.+Jacobsenauthor=C.+J.+Byrneauthor=M.+L.+Heuerauthor=E.+Larssonauthor=Y.+Antipinauthor=B.+Revaauthor=A.+P.+Goldbergauthor=C.+Sanderauthor=N.+Schultz&title=The+cBio+cancer+genomics+portal%3A+an+open+platform+for+exploring+multidimensional+cancer+genomics+data&doi=10.1158%2F2159-8290.CD-12-0095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data</span></div><div class="casAuthors">Cerami Ethan; Gao Jianjiong; Dogrusoz Ugur; Gross Benjamin E; Sumer Selcuk Onur; Aksoy Bulent Arman; Jacobsen Anders; Byrne Caitlin J; Heuer Michael L; Larsson Erik; Antipin Yevgeniy; Reva Boris; Goldberg Arthur P; Sander Chris; Schultz Nikolaus</div><div class="citationInfo"><span class="NLM_cas:title">Cancer discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">401-4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The cBio Cancer Genomics Portal (http://cbioportal.org) is an open-access resource for interactive exploration of multidimensional cancer genomics data sets, currently providing access to data from more than 5,000 tumor samples from 20 cancer studies.  The cBio Cancer Genomics Portal significantly lowers the barriers between complex genomic data and cancer researchers who want rapid, intuitive, and high-quality access to molecular profiles and clinical attributes from large-scale cancer genomics projects and empowers researchers to translate these rich data sets into biologic insights and clinical applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAgVg5djDIxr7NkxioyDXTfW6udTcc2eZQZ42Uj4iE4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38njsVertQ%253D%253D&md5=d56ed7ecde08297f11dd0ae8e1c4b47c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-12-0095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-12-0095%26sid%3Dliteratum%253Aachs%26aulast%3DCerami%26aufirst%3DE.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DDogrusoz%26aufirst%3DU.%26aulast%3DGross%26aufirst%3DB.%2BE.%26aulast%3DSumer%26aufirst%3DS.%2BO.%26aulast%3DAksoy%26aufirst%3DB.%2BA.%26aulast%3DJacobsen%26aufirst%3DA.%26aulast%3DByrne%26aufirst%3DC.%2BJ.%26aulast%3DHeuer%26aufirst%3DM.%2BL.%26aulast%3DLarsson%26aufirst%3DE.%26aulast%3DAntipin%26aufirst%3DY.%26aulast%3DReva%26aufirst%3DB.%26aulast%3DGoldberg%26aufirst%3DA.%2BP.%26aulast%3DSander%26aufirst%3DC.%26aulast%3DSchultz%26aufirst%3DN.%26atitle%3DThe%2520cBio%2520cancer%2520genomics%2520portal%253A%2520an%2520open%2520platform%2520for%2520exploring%2520multidimensional%2520cancer%2520genomics%2520data%26jtitle%3DCancer%2520Discovery%26date%3D2012%26volume%3D2%26spage%3D401%26epage%3D404%26doi%3D10.1158%2F2159-8290.CD-12-0095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">AACR
Project Genie Consortium</span> <span> </span><span class="NLM_article-title">AACR Project GENIE: powering precision medicine through an international
consortium</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">818</span>– <span class="NLM_lpage">831</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-17-0151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1158%2F2159-8290.CD-17-0151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=28572459" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=818-831&author=AACR%0AProject+Genie+Consortium&title=AACR+Project+GENIE%3A+powering+precision+medicine+through+an+international%0Aconsortium&doi=10.1158%2F2159-8290.CD-17-0151"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-17-0151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-17-0151%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DAACR%2520Project%2520GENIE%253A%2520powering%2520precision%2520medicine%2520through%2520an%2520international%250Aconsortium%26jtitle%3DCancer%2520Discovery%26date%3D2017%26volume%3D7%26spage%3D818%26epage%3D831%26doi%3D10.1158%2F2159-8290.CD-17-0151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hallin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engstrom, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calinisan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aranda, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briere, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudhakar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowcut, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baer, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkard, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigers, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Banet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlicek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velastagui, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierobon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petricoin, E. F.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rybkin, I. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, S.-H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lito, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulos, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jänne, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, J. G.</span></span> <span> </span><span class="NLM_article-title">The KRAS<sup>G12C</sup> inhibitor MRTX849 provides insight toward therapeutic susceptibility of KRAS-mutant cancers in mouse models and patients</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">54</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-19-1167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1158%2F2159-8290.CD-19-1167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=31658955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtleitbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=54-71&author=J.+Hallinauthor=L.+D.+Engstromauthor=L.+Hargisauthor=A.+Calinisanauthor=R.+Arandaauthor=D.+M.+Briereauthor=N.+Sudhakarauthor=V.+Bowcutauthor=B.+R.+Baerauthor=J.+A.+Ballardauthor=M.+R.+Burkardauthor=J.+B.+Fellauthor=J.+P.+Fischerauthor=G.+P.+Vigersauthor=Y.+Xueauthor=S.+Gattoauthor=J.+Fernandez-Banetauthor=A.+Pavlicekauthor=K.+Velastaguiauthor=R.+C.+Chaoauthor=J.+Bartonauthor=M.+Pierobonauthor=E.+Baldelliauthor=E.+F.+Petricoinauthor=D.+P.+Cassidyauthor=M.+A.+Marxauthor=I.+I.+Rybkinauthor=M.+L.+Johnsonauthor=S.-H.+I.+Ouauthor=P.+Litoauthor=K.+P.+Papadopoulosauthor=P.+A.+J%C3%A4nneauthor=P.+Olsonauthor=J.+G.+Christensen&title=The+KRASG12C+inhibitor+MRTX849+provides+insight+toward+therapeutic+susceptibility+of+KRAS-mutant+cancers+in+mouse+models+and+patients&doi=10.1158%2F2159-8290.CD-19-1167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The KRASG12C inhibitor MRTX849 provides insight toward therapeutic susceptibility of KRAS-mutant cancers in mouse models and patients</span></div><div class="casAuthors">Hallin, Jill; Engstrom, Lars D.; Hargis, Lauren; Calinisan, Andrew; Aranda, Ruth; Briere, David M.; Sudhakar, Niranjan; Bowcut, Vickie; Baer, Brian R.; Ballard, Joshua A.; Burkard, Michael R.; Fell, Jay B.; Fischer, John P.; Vigers, Guy P.; Xue, Yaohua; Gatto, Sole; Fernandez-Banet, Julio; Pavlicek, Adam; Velastagui, Karen; Chao, Richard C.; Barton, Jeremy; Pierobon, Mariaelena; Baldelli, Elisa; Patricoin, Emanuel F., III; Cassidy, Douglas P.; Marx, Matthew A.; Rybkin, Igor I.; Johnson, Melissa L.; Ou, Sai-Hong Ignatius; Lito, Piro; Papadopoulos, Kyriakos P.; Janne, Pasi A.; Olson, Peter; Christensen, James G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-71</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Despite decades of research, efforts to directly target KRAS have been challenging.  MRTX849 was identified as a potent, selective, and covalent KRASG12C inhibitor that exhibits favorable drug-like properties, selectively modifies mutant cysteine 12 in GDP-bound KRASG12C, and inhibits KRAS-dependent signaling.  MRTX849 demonstrated pronounced tumor regression in 17 of 26 (65%) KRASG12C-pos. cell line- and patient-derived xenograft models from multiple tumor types, and objective responses have been obsd. in patients with KRASG12C-pos. lung and colon adenocarcinomas.  Comprehensive pharmacodynamic and pharmacogenomic profiling in sensitive and partially resistant nonclin. models identified mechanisms implicated in limiting antitumor activity including KRAS nucleotide cycling and pathways that induce feedback reactivation and/or bypass KRAS dependence.  These factors included activation of receptor tyrosine kinases (RTK), bypass of KRAS dependence, and genetic dysregulation of cell cycle.  Combinations of MRTX849 with agents that target RTKs, mTOR, or cell cycle demonstrated enhanced response and marked tumor regression in several tumor models, including MRTX849-refractory models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxAUhi3n75ULVg90H21EOLACvtfcHk0lhlQdq2yHokXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtleitbfL&md5=48f4c34e757385eed89b47f19cbb10db</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-19-1167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-19-1167%26sid%3Dliteratum%253Aachs%26aulast%3DHallin%26aufirst%3DJ.%26aulast%3DEngstrom%26aufirst%3DL.%2BD.%26aulast%3DHargis%26aufirst%3DL.%26aulast%3DCalinisan%26aufirst%3DA.%26aulast%3DAranda%26aufirst%3DR.%26aulast%3DBriere%26aufirst%3DD.%2BM.%26aulast%3DSudhakar%26aufirst%3DN.%26aulast%3DBowcut%26aufirst%3DV.%26aulast%3DBaer%26aufirst%3DB.%2BR.%26aulast%3DBallard%26aufirst%3DJ.%2BA.%26aulast%3DBurkard%26aufirst%3DM.%2BR.%26aulast%3DFell%26aufirst%3DJ.%2BB.%26aulast%3DFischer%26aufirst%3DJ.%2BP.%26aulast%3DVigers%26aufirst%3DG.%2BP.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DGatto%26aufirst%3DS.%26aulast%3DFernandez-Banet%26aufirst%3DJ.%26aulast%3DPavlicek%26aufirst%3DA.%26aulast%3DVelastagui%26aufirst%3DK.%26aulast%3DChao%26aufirst%3DR.%2BC.%26aulast%3DBarton%26aufirst%3DJ.%26aulast%3DPierobon%26aufirst%3DM.%26aulast%3DBaldelli%26aufirst%3DE.%26aulast%3DPetricoin%26aufirst%3DE.%2BF.%26aulast%3DCassidy%26aufirst%3DD.%2BP.%26aulast%3DMarx%26aufirst%3DM.%2BA.%26aulast%3DRybkin%26aufirst%3DI.%2BI.%26aulast%3DJohnson%26aufirst%3DM.%2BL.%26aulast%3DOu%26aufirst%3DS.-H.%2BI.%26aulast%3DLito%26aufirst%3DP.%26aulast%3DPapadopoulos%26aufirst%3DK.%2BP.%26aulast%3DJ%25C3%25A4nne%26aufirst%3DP.%2BA.%26aulast%3DOlson%26aufirst%3DP.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26atitle%3DThe%2520KRASG12C%2520inhibitor%2520MRTX849%2520provides%2520insight%2520toward%2520therapeutic%2520susceptibility%2520of%2520KRAS-mutant%2520cancers%2520in%2520mouse%2520models%2520and%2520patients%26jtitle%3DCancer%2520Discovery%26date%3D2020%26volume%3D10%26spage%3D54%26epage%3D71%26doi%3D10.1158%2F2159-8290.CD-19-1167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Canon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rex, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saiki, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knutson, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanman, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapaport, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">San Miguel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osgood, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarter, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volak, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houk, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakih, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falchook, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govindan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henary, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvedson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipford, J. R.</span></span> <span> </span><span class="NLM_article-title">The clinical KRAS (G12C) inhibitor AMG 510 drives anti-tumour immunity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>575</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1694-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1038%2Fs41586-019-1694-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=31666701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitV2hsb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=575&publication_year=2019&pages=217-223&author=J.+Canonauthor=K.+Rexauthor=A.+Y.+Saikiauthor=C.+Mohrauthor=K.+Cookeauthor=D.+Bagalauthor=K.+Gaidaauthor=T.+Holtauthor=C.+G.+Knutsonauthor=N.+Koppadaauthor=B.+A.+Lanmanauthor=J.+Wernerauthor=A.+S.+Rapaportauthor=T.+San+Miguelauthor=R.+Ortizauthor=T.+Osgoodauthor=J.-R.+Sunauthor=X.+Zhuauthor=J.+D.+McCarterauthor=L.+P.+Volakauthor=B.+E.+Houkauthor=M.+G.+Fakihauthor=B.+H.+O%E2%80%99Neilauthor=T.+J.+Priceauthor=G.+S.+Falchookauthor=J.+Desaiauthor=J.+Kuoauthor=R.+Govindanauthor=D.+S.+Hongauthor=W.+Ouyangauthor=H.+Henaryauthor=T.+Arvedsonauthor=V.+J.+Ceeauthor=J.+R.+Lipford&title=The+clinical+KRAS+%28G12C%29+inhibitor+AMG+510+drives+anti-tumour+immunity&doi=10.1038%2Fs41586-019-1694-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity</span></div><div class="casAuthors">Canon, Jude; Rex, Karen; Saiki, Anne Y.; Mohr, Christopher; Cooke, Keegan; Bagal, Dhanashri; Gaida, Kevin; Holt, Tyler; Knutson, Charles G.; Koppada, Neelima; Lanman, Brian A.; Werner, Jonathan; Rapaport, Aaron S.; San Miguel, Tisha; Ortiz, Roberto; Osgood, Tao; Sun, Ji-Rong; Zhu, Xiaochun; McCarter, John D.; Volak, Laurie P.; Houk, Brett E.; Fakih, Marwan G.; O'Neil, Bert H.; Price, Timothy J.; Falchook, Gerald S.; Desai, Jayesh; Kuo, James; Govindan, Ramaswamy; Hong, David S.; Ouyang, Wenjun; Henary, Haby; Arvedson, Tara; Cee, Victor J.; Lipford, J. Russell</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">575</span>
        (<span class="NLM_cas:issue">7781</span>),
    <span class="NLM_cas:pages">217-223</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">KRAS is the most frequently mutated oncogene in cancer and encodes a key signalling protein in tumors1,2.  The KRAS(G12C) mutant has a cysteine residue that has been exploited to design covalent inhibitors that have promising preclin. activity3-5.  Here we optimized a series of inhibitors, using novel binding interactions to markedly enhance their potency and selectivity.  Our efforts have led to the discovery of AMG 510, which is, to our knowledge, the first KRAS(G12C) inhibitor in clin. development.  In preclin. analyses, treatment with AMG 510 led to the regression of KRASG12C tumors and improved the anti-tumor efficacy of chemotherapy and targeted agents.  In immune-competent mice, treatment with AMG 510 resulted in a pro-inflammatory tumor microenvironment and produced durable cures alone as well as in combination with immune-checkpoint inhibitors.  Cured mice rejected the growth of isogenic KRASG12D tumors, which suggests adaptive immunity against shared antigens.  Furthermore, in clin. trials, AMG 510 demonstrated anti-tumor activity in the first dosing cohorts and represents a potentially transformative therapy for patients for whom effective treatments are lacking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTHdBftQfnhbVg90H21EOLACvtfcHk0lhlQdq2yHokXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitV2hsb7F&md5=3819175980905976ba87ff545b9506e1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1694-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1694-1%26sid%3Dliteratum%253Aachs%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DMohr%26aufirst%3DC.%26aulast%3DCooke%26aufirst%3DK.%26aulast%3DBagal%26aufirst%3DD.%26aulast%3DGaida%26aufirst%3DK.%26aulast%3DHolt%26aufirst%3DT.%26aulast%3DKnutson%26aufirst%3DC.%2BG.%26aulast%3DKoppada%26aufirst%3DN.%26aulast%3DLanman%26aufirst%3DB.%2BA.%26aulast%3DWerner%26aufirst%3DJ.%26aulast%3DRapaport%26aufirst%3DA.%2BS.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DOrtiz%26aufirst%3DR.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DJ.-R.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DMcCarter%26aufirst%3DJ.%2BD.%26aulast%3DVolak%26aufirst%3DL.%2BP.%26aulast%3DHouk%26aufirst%3DB.%2BE.%26aulast%3DFakih%26aufirst%3DM.%2BG.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DB.%2BH.%26aulast%3DPrice%26aufirst%3DT.%2BJ.%26aulast%3DFalchook%26aufirst%3DG.%2BS.%26aulast%3DDesai%26aufirst%3DJ.%26aulast%3DKuo%26aufirst%3DJ.%26aulast%3DGovindan%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DD.%2BS.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DHenary%26aufirst%3DH.%26aulast%3DArvedson%26aufirst%3DT.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DLipford%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520clinical%2520KRAS%2520%2528G12C%2529%2520inhibitor%2520AMG%2520510%2520drives%2520anti-tumour%2520immunity%26jtitle%3DNature%26date%3D2019%26volume%3D575%26spage%3D217%26epage%3D223%26doi%3D10.1038%2Fs41586-019-1694-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boriack-Sjodin, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margarit, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bar-Sagi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuriyan, J.</span></span> <span> </span><span class="NLM_article-title">The structural basis of the activation of RAS by SOS</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>394</i></span>,  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1038/28548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1038%2F28548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=9690470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADyaK1cXkvFKnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=1998&pages=337-343&author=P.+A.+Boriack-Sjodinauthor=S.+M.+Margaritauthor=D.+Bar-Sagiauthor=J.+Kuriyan&title=The+structural+basis+of+the+activation+of+RAS+by+SOS&doi=10.1038%2F28548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The structural basis of the activation of Ras by Sos</span></div><div class="casAuthors">Boriack-Sjodin, P. Ann; Margarit, S. Mariana; Bar-Sagi, Dafna; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">6691</span>),
    <span class="NLM_cas:pages">337-343</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The crystal structure of human H-Ras complexed with the Ras guanine-nucleotide-exchange-factor region of the Son of sevenless (Sos) protein has been detd. at 2.8 Å resoln.  The normally tight interaction of nucleotides with Ras is disrupted by Sos in two ways.  First, the insertion into Ras of an α-helix from Sos results in the displacement of the Switch 1 region of Ras, opening up the nucleotide-binding site.  Second, side chains presented by this helix and by a distorted conformation of the Switch 2 region of Ras alter the chem. environment of the binding site for the phosphate groups of the nucleotide and the assocd. magnesium in, so that their binding is no longer favored.  Sos does not impede the binding sites for the base and the ribose of GTP or GDP, so the Ras-Sos complex adopts a structure that allows nucleotide release and rebinding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZY4Ffb8--JbVg90H21EOLACvtfcHk0liPm6LUCUrd5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvFKnsLs%253D&md5=1b0a7879011c1fc1148e7f870e0ded11</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2F28548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F28548%26sid%3Dliteratum%253Aachs%26aulast%3DBoriack-Sjodin%26aufirst%3DP.%2BA.%26aulast%3DMargarit%26aufirst%3DS.%2BM.%26aulast%3DBar-Sagi%26aufirst%3DD.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DThe%2520structural%2520basis%2520of%2520the%2520activation%2520of%2520RAS%2520by%2520SOS%26jtitle%3DNature%26date%3D1998%26volume%3D394%26spage%3D337%26epage%3D343%26doi%3D10.1038%2F28548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sondermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedland, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortemme, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bar-Sagi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marqusee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuriyan, J.</span></span> <span> </span><span class="NLM_article-title">A RAS-induced conformational switch in the RAS activator Son of sevenless</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">16692</span>– <span class="NLM_lpage">16697</span>, <span class="refDoi"> DOI: 10.1073/pnas.0608127103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1073%2Fpnas.0608127103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=17075039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1egtbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=16692-16697&author=T.+S.+Freedmanauthor=H.+Sondermannauthor=G.+D.+Friedlandauthor=T.+Kortemmeauthor=D.+Bar-Sagiauthor=S.+Marquseeauthor=J.+Kuriyan&title=A+RAS-induced+conformational+switch+in+the+RAS+activator+Son+of+sevenless&doi=10.1073%2Fpnas.0608127103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A Ras-induced conformational switch in the Ras activator Son of sevenless</span></div><div class="casAuthors">Freedman, Tanya S.; Sondermann, Holger; Friedland, Gregory D.; Kortemme, Tanja; Bar-Sagi, Dafna; Marqusee, Susan; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">16692-16697</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The Ras-specific guanine nucleotide-exchange factors Son of sevenless (Sos) and Ras guanine nucleotide-releasing factor 1 (RasGRF1) transduce extracellular stimuli into Ras activation by catalyzing the exchange of Ras-bound GDP for GTP.  A truncated form of RasGRF1 contg. only the core catalytic Cdc25 domain is sufficient for stimulating Ras nucleotide exchange, whereas the isolated Cdc25 domain of Sos is inactive.  At a site distal to the catalytic site, nucleotide-bound Ras binds to Sos, making contacts with the Cdc25 domain and with a Ras exchanger motif (Rem) domain.  This allosteric Ras binding stimulates nucleotide exchange by Sos, but the mechanism by which this stimulation occurs has not been defined.  We present a crystal structure of the Rem and Cdc25 domains of Sos detd. at 2.0-Å resoln. in the absence of Ras.  Differences between this structure and that of Sos bound to two Ras mols. show that allosteric activation of Sos by Ras occurs through a rotation of the Rem domain that is coupled to a rotation of a helical hairpin at the Sos catalytic site.  This motion relieves steric occlusion of the catalytic site, allowing substrate Ras binding and nucleotide exchange.  A structure of the isolated RasGRF1 Cdc25 domain detd. at 2.2-Å resoln., combined with computational analyses, suggests that the Cdc25 domain of RasGRF1 is able to maintain an active conformation in isolation because the helical hairpin has strengthened interactions with the Cdc25 domain core.  These results indicate that RasGRF1 lacks the allosteric activation switch that is crucial for Sos activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozurSc1qOIr7Vg90H21EOLACvtfcHk0liPm6LUCUrd5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1egtbbP&md5=712e91319dd4f31eb4cc8f06978e7236</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0608127103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0608127103%26sid%3Dliteratum%253Aachs%26aulast%3DFreedman%26aufirst%3DT.%2BS.%26aulast%3DSondermann%26aufirst%3DH.%26aulast%3DFriedland%26aufirst%3DG.%2BD.%26aulast%3DKortemme%26aufirst%3DT.%26aulast%3DBar-Sagi%26aufirst%3DD.%26aulast%3DMarqusee%26aufirst%3DS.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DA%2520RAS-induced%2520conformational%2520switch%2520in%2520the%2520RAS%2520activator%2520Son%2520of%2520sevenless%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D16692%26epage%3D16697%26doi%3D10.1073%2Fpnas.0608127103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vigil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherfils, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossman, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Der, C. J.</span></span> <span> </span><span class="NLM_article-title">RAS superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">842</span>– <span class="NLM_lpage">857</span>, <span class="refDoi"> DOI: 10.1038/nrc2960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1038%2Fnrc2960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=21102635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOrsbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=842-857&author=D.+Vigilauthor=J.+Cherfilsauthor=K.+L.+Rossmanauthor=C.+J.+Der&title=RAS+superfamily+GEFs+and+GAPs%3A+validated+and+tractable+targets+for+cancer+therapy%3F&doi=10.1038%2Fnrc2960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?</span></div><div class="casAuthors">Vigil, Dominico; Cherfils, Jacqueline; Rossman, Kent L.; Der, Channing J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">842-857</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is now considerable and increasing evidence for a causal role for aberrant activity of the Ras superfamily of small GTPases in human cancers.  These GTPases function as GDP-GTP-regulated binary switches that control many fundamental cellular processes.  A common mechanism of GTPase deregulation in cancer is the deregulated expression and/or activity of their regulatory proteins, guanine nucleotide exchange factors (GEFs) that promote formation of the active GTP-bound state and GTPase-activating proteins (GAPs) that return the GTPase to its GDP-bound inactive state.  In this Review, we assess the assocn. of GEFs and GAPs with cancer and their druggability for cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwbf8B7sLmb7Vg90H21EOLACvtfcHk0liPm6LUCUrd5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOrsbrM&md5=b7ad81f2fe0f7f7eaa5f015188f62e85</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrc2960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2960%26sid%3Dliteratum%253Aachs%26aulast%3DVigil%26aufirst%3DD.%26aulast%3DCherfils%26aufirst%3DJ.%26aulast%3DRossman%26aufirst%3DK.%2BL.%26aulast%3DDer%26aufirst%3DC.%2BJ.%26atitle%3DRAS%2520superfamily%2520GEFs%2520and%2520GAPs%253A%2520validated%2520and%2520tractable%2520targets%2520for%2520cancer%2520therapy%253F%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D842%26epage%3D857%26doi%3D10.1038%2Fnrc2960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheffels, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sealover, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazirani, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrell, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortum, R. L.</span></span> <span> </span><span class="NLM_article-title">Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">eaar8371</span> <span class="refDoi"> DOI: 10.1126/scisignal.aar8371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1126%2Fscisignal.aar8371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=30181243" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2018&author=E.+Sheffelsauthor=N.+E.+Sealoverauthor=C.+Wangauthor=D.+H.+Kimauthor=I.+A.+Vaziraniauthor=E.+Leeauthor=E.+M.+Tyrellauthor=D.+K.+Morrisonauthor=J.+Luoauthor=R.+L.+Kortum&title=Oncogenic+RAS+isoforms+show+a+hierarchical+requirement+for+the+guanine+nucleotide+exchange+factor+SOS2+to+mediate+cell+transformation&doi=10.1126%2Fscisignal.aar8371"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.aar8371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.aar8371%26sid%3Dliteratum%253Aachs%26aulast%3DSheffels%26aufirst%3DE.%26aulast%3DSealover%26aufirst%3DN.%2BE.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DVazirani%26aufirst%3DI.%2BA.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DTyrell%26aufirst%3DE.%2BM.%26aulast%3DMorrison%26aufirst%3DD.%2BK.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DKortum%26aufirst%3DR.%2BL.%26atitle%3DOncogenic%2520RAS%2520isoforms%2520show%2520a%2520hierarchical%2520requirement%2520for%2520the%2520guanine%2520nucleotide%2520exchange%2520factor%2520SOS2%2520to%2520mediate%2520cell%2520transformation%26jtitle%3DSci.%2520Signaling%26date%3D2018%26volume%3D11%26doi%3D10.1126%2Fscisignal.aar8371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Margarit, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sondermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirruccello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bar-Sagi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuriyan, J.</span></span> <span> </span><span class="NLM_article-title">Structural evidence for feedback activation by RAS· GTP of the RAS-specific nucleotide exchange factor SOS</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">685</span>– <span class="NLM_lpage">695</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(03)00149-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1016%2FS0092-8674%2803%2900149-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=12628188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitFyku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2003&pages=685-695&author=S.+M.+Margaritauthor=H.+Sondermannauthor=B.+E.+Hallauthor=B.+Nagarauthor=A.+Hoelzauthor=M.+Pirruccelloauthor=D.+Bar-Sagiauthor=J.+Kuriyan&title=Structural+evidence+for+feedback+activation+by+RAS%C2%B7+GTP+of+the+RAS-specific+nucleotide+exchange+factor+SOS&doi=10.1016%2FS0092-8674%2803%2900149-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Structural evidence for feedback activation by Ras·GTP of the Ras-specific nucleotide exchange factor SOS</span></div><div class="casAuthors">Margarit, S. Mariana; Sondermann, Holger; Hall, Brian E.; Nagar, Bhushan; Hoelz, Andre; Pirruccello, Michelle; Bar-Sagi, Dafna; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">685-695</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Growth factor receptors activate Ras by recruiting the nucleotide exchange factor son of sevenless (SOS) to the cell membrane, thereby triggering the prodn. of GTP-loaded Ras.  Crystallog. analyses of Ras bound to the catalytic module of SOS have led to the unexpected discovery of a highly conserved Ras binding site on SOS that is located distal to the active site and is specific for Ras·GTP.  The crystal structures suggest that Ras·GTP stabilizes the active site of SOS allosterically, and we show that Ras·GTP forms ternary complexes with SOScat in soln. and increases significantly the rate of SOScat-stimulated nucleotide release from Ras.  These results demonstrate the existence of a pos. feedback mechanism for the spatial and temporal regulation of Ras.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvs-3O6BC4lrVg90H21EOLACvtfcHk0lhioOEWgRrcXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitFyku78%253D&md5=491026c9943c3d3cdec5b0ca90ff1b7c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2803%2900149-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252803%252900149-1%26sid%3Dliteratum%253Aachs%26aulast%3DMargarit%26aufirst%3DS.%2BM.%26aulast%3DSondermann%26aufirst%3DH.%26aulast%3DHall%26aufirst%3DB.%2BE.%26aulast%3DNagar%26aufirst%3DB.%26aulast%3DHoelz%26aufirst%3DA.%26aulast%3DPirruccello%26aufirst%3DM.%26aulast%3DBar-Sagi%26aufirst%3DD.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DStructural%2520evidence%2520for%2520feedback%2520activation%2520by%2520RAS%25C2%25B7%2520GTP%2520of%2520the%2520RAS-specific%2520nucleotide%2520exchange%2520factor%2520SOS%26jtitle%3DCell%26date%3D2003%26volume%3D112%26spage%3D685%26epage%3D695%26doi%3D10.1016%2FS0092-8674%2803%2900149-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corbalan-Garcia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degenhardt, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bar-Sagi, D.</span></span> <span> </span><span class="NLM_article-title">Identification of the mitogen-activated protein kinase phosphorylation sites on human SOS1 that regulate interaction with Grb2</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5674</span>– <span class="NLM_lpage">5682</span>, <span class="refDoi"> DOI: 10.1128/MCB.16.10.5674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1128%2FMCB.16.10.5674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=8816480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADyaK28XlvFamu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=5674-5682&author=S.+Corbalan-Garciaauthor=S.+S.+Yangauthor=K.+R.+Degenhardtauthor=D.+Bar-Sagi&title=Identification+of+the+mitogen-activated+protein+kinase+phosphorylation+sites+on+human+SOS1+that+regulate+interaction+with+Grb2&doi=10.1128%2FMCB.16.10.5674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the mitogen-activated protein kinase phosphorylation sites on human Sos1 that regulate interaction with Grb2</span></div><div class="casAuthors">Corbalan-Garcia, S.; Yang, S.-S.; Degenhardt, K. R.; Bar-Sagi, D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5674-5682</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The Son of sevenless proteins (Sos) are guanine nucleotide exchange factors involved in the activation of Ras by cytoplasmic and receptor tyrosine kinases.  Growth factor stimulation rapidly induces the phosphorylation of Sos on multiple serine and threonine sites.  Previous studies have demonstrated that growth factor-induced Sos phosphorylation occurs at the C-terminal region of the protein and is mediated, in part, by mitogen-activated protein (MAP) kinase.  In this report, we describe the identification of five MAP kinase sites (S-1137, S-1167, S-1178, S-1193, and S-1197) on hSos1.  We demonstrate that four of these sites, S-1132, S-1167, S-1178, and S-1193, become phosphorylated following growth factor stimulation.  The MAP kinase phosphorylation sites are clustered within a region encompassing three proline-rich SH3-binding sites in the C-terminal domain of hSos1.  Replacing the MAP kinase phosphorylation sites with alanine residues results in an increase in the binding affinity of Grb2 to hSos1.  Interestingly, hSos2 contains only one MAP kinase phosphorylation site and, as demonstrated previously, has an increased affinity toward Grb2 compared with hSos1.  These results suggest a role for MAP kinase in the regulation of Grb2-Sos interactions.  Since the binding of Grb2 is important for Sos function, the phosphorylation-dependent modulation of Grb2-Sos assocn. may provide a means of controlling Ras activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe0XtVYcEZ3LVg90H21EOLACvtfcHk0lhioOEWgRrcXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvFamu70%253D&md5=ec1aa5ec4086858ce2dc2578c36b2e65</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1128%2FMCB.16.10.5674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.16.10.5674%26sid%3Dliteratum%253Aachs%26aulast%3DCorbalan-Garcia%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DS.%2BS.%26aulast%3DDegenhardt%26aufirst%3DK.%2BR.%26aulast%3DBar-Sagi%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520the%2520mitogen-activated%2520protein%2520kinase%2520phosphorylation%2520sites%2520on%2520human%2520SOS1%2520that%2520regulate%2520interaction%2520with%2520Grb2%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D16%26spage%3D5674%26epage%3D5682%26doi%3D10.1128%2FMCB.16.10.5674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rozakis-Adcock, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Geer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mbamalu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawson, T.</span></span> <span> </span><span class="NLM_article-title">MAP kinase phosphorylation of mSOS1 promotes dissociation of mSOS1-Shc and mSOS1-EGF receptor complexes</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1417</span>– <span class="NLM_lpage">1426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=7478566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADyaK2MXptVWntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1995&pages=1417-1426&author=M.+Rozakis-Adcockauthor=P.+Van+der+Geerauthor=G.+Mbamaluauthor=T.+Pawson&title=MAP+kinase+phosphorylation+of+mSOS1+promotes+dissociation+of+mSOS1-Shc+and+mSOS1-EGF+receptor+complexes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">MAP kinase phosphorylation of mSos1 promotes dissociation of mSos1-Shc and mSos1-EGF receptor complexes</span></div><div class="casAuthors">Rozakis-Adcock, Maria; van der Geer, Peter; Mbamalu, Geraldine; Pawson, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1417-26</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">The mouse protein mSos1 has a central Ras guanine nucleotide exchange domain, and a long proline-rich C-terminal tail which contains several potential binding sites for the SH3 domains of the adaptor protein, Grb2.  In fibroblasts, growth factor stimulation results in the recruitment of Grb-2-mSos1 into complexes with activated receptors and cytoplasmic phosphoproteins such as Shc, which are apparently involved in Ras activation, and subsequently to an increase in mSos1 phosphorylation on serine and threonine.  The catalytic and C-terminal domains of mSos1 contain several potential sites for phosphorylation by mitogen-activated protein kinases.  In vitro, purified p42/p44 MAP-kinase selectively phosphorylated the C-terminal tail of mSos1.  Comparative tryptic phosphopeptide mapping of mSos1 phosphorylated in vitro by MAP kinase and of mSos1 immunopptd. from EGF-stimulated cells, revealed several phosphopeptides in common.  These common phosphorylation sites have been mapped to a region encompassing the first three proline (pro)-rich motifs in the tail of mSos1.  Furthermore, a region of mSos1 contg. the first two pro-rich motifs could assoc. with MBP kinase activity in vitro.  Phosphorylation of mSos1 did not affect binding of Grb2 to mSos1, but appeared to decrease binding of the mSos1-Grb2 complex to Shc and the EGF-receptor.  These findings suggest a potential inhibitory role for MAP-kinase in attenuating nucleotide exchange on Ras, by uncoupling mSos1 from membrane-bound receptor complexes that lead to Ras activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5hvLyKdwZabVg90H21EOLACvtfcHk0lhHx8jFBvnOIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptVWntLg%253D&md5=b4b38ddb72bd899d9eba39f960fdfbbb</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRozakis-Adcock%26aufirst%3DM.%26aulast%3DVan%2Bder%2BGeer%26aufirst%3DP.%26aulast%3DMbamalu%26aufirst%3DG.%26aulast%3DPawson%26aufirst%3DT.%26atitle%3DMAP%2520kinase%2520phosphorylation%2520of%2520mSOS1%2520promotes%2520dissociation%2520of%2520mSOS1-Shc%2520and%2520mSOS1-EGF%2520receptor%2520complexes%26jtitle%3DOncogene%26date%3D1995%26volume%3D11%26spage%3D1417%26epage%3D1426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentires-Alj, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greulich, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grewal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yassin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iartchouk, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitman, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caligiuri, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliland, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Look, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucherlapati, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">SOS1 mutations are rare in human malignancies: implications for Noonan Syndrome patients</span>. <i>Genes, Chromosomes Cancer</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">259</span>, <span class="refDoi"> DOI: 10.1002/gcc.20527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1002%2Fgcc.20527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=18064648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFSgtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=253-259&author=K.+D.+Swansonauthor=J.+M.+Winterauthor=M.+Reisauthor=M.+Bentires-Aljauthor=H.+Greulichauthor=R.+Grewalauthor=R.+H.+Hrubanauthor=C.+J.+Yeoauthor=Y.+Yassinauthor=O.+Iartchoukauthor=K.+Montgomeryauthor=S.+P.+Whitmanauthor=M.+A.+Caligiuriauthor=M.+L.+Lohauthor=D.+G.+Gillilandauthor=A.+T.+Lookauthor=R.+Kucherlapatiauthor=S.+E.+Kernauthor=M.+Meyersonauthor=B.+G.+Neel&title=SOS1+mutations+are+rare+in+human+malignancies%3A+implications+for+Noonan+Syndrome+patients&doi=10.1002%2Fgcc.20527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">SOS1 mutations are rare in human malignancies: implications for Noonan Syndrome patients</span></div><div class="casAuthors">Swanson, Kenneth D.; Winter, Jordan M.; Reis, Marcelo; Bentires-Alj, Mohamed; Greulich, Heidi; Grewal, Rupinder; Hruban, Ralph H.; Yeo, Charles J.; Yassin, Yosuf; Iartchouk, Oleg; Montgomery, Kate; Whitman, Susan P.; Caligiuri, Michael A.; Loh, Mignon L.; Gilliland, D. Gary; Look, A. Thomas; Kucherlapati, Raju; Kern, Scott E.; Meyerson, Matthew; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Genes, Chromosomes & Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">253-259</span>CODEN:
                <span class="NLM_cas:coden">GCCAES</span>;
        ISSN:<span class="NLM_cas:issn">1045-2257</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Germ line gain-of-function mutations in several members of the RAS/ERK pathway, including PTPN11, KRAS, and RAF1, cause the autosomal dominant genetic disorder Noonan Syndrome (NS).  NS patients are at increased risk of leukemia/myeloproliferative disease and possibly some solid tumors, such as neuroblastoma.  Recently, SOS1 gain of function mutations were also shown to cause NS.  Somatic PTPN11, KRAS, and RAF1 mutations occur (although at different frequencies) in a variety of sporadic neoplasms, but whether SOS1 mutations are assocd. with human cancer was not evaluated.  The authors sequenced DNA from a total of 810 primary malignancies, including pancreatic, lung, breast, and colon carcinomas, and acute myelogenous leukemia, as well as several neuroblastoma cell lines.  From this large, diverse series, missense SOS1 mutations were identified in a single pancreatic tumor, one lung adenocarcinoma, and a T-cell acute lymphoblastic leukemia cell line.  The authors' findings suggest that SOS1 is not a significant human oncogene in most cancers.  Furthermore, NS patients with SOS1 mutations may not be at increased risk of developing cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK0B9lJSRpP7Vg90H21EOLACvtfcHk0lhKeQAhmdWryA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFSgtrs%253D&md5=5680adada422beac465b15ab26b3d87c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fgcc.20527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fgcc.20527%26sid%3Dliteratum%253Aachs%26aulast%3DSwanson%26aufirst%3DK.%2BD.%26aulast%3DWinter%26aufirst%3DJ.%2BM.%26aulast%3DReis%26aufirst%3DM.%26aulast%3DBentires-Alj%26aufirst%3DM.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DGrewal%26aufirst%3DR.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DYeo%26aufirst%3DC.%2BJ.%26aulast%3DYassin%26aufirst%3DY.%26aulast%3DIartchouk%26aufirst%3DO.%26aulast%3DMontgomery%26aufirst%3DK.%26aulast%3DWhitman%26aufirst%3DS.%2BP.%26aulast%3DCaligiuri%26aufirst%3DM.%2BA.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DLook%26aufirst%3DA.%2BT.%26aulast%3DKucherlapati%26aufirst%3DR.%26aulast%3DKern%26aufirst%3DS.%2BE.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DSOS1%2520mutations%2520are%2520rare%2520in%2520human%2520malignancies%253A%2520implications%2520for%2520Noonan%2520Syndrome%2520patients%26jtitle%3DGenes%252C%2520Chromosomes%2520Cancer%26date%3D2008%26volume%3D47%26spage%3D253%26epage%3D259%26doi%3D10.1002%2Fgcc.20527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tidyman, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauen, K. A.</span></span> <span> </span><span class="NLM_article-title">The RASopathies: developmental syndromes of RAS/MAPK pathway dysregulation</span>. <i>Curr. Opin. Genet. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1016/j.gde.2009.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1016%2Fj.gde.2009.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=19467855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Gmurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=230-236&author=W.+E.+Tidymanauthor=K.+A.+Rauen&title=The+RASopathies%3A+developmental+syndromes+of+RAS%2FMAPK+pathway+dysregulation&doi=10.1016%2Fj.gde.2009.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation</span></div><div class="casAuthors">Tidyman, William E.; Rauen, Katherine A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Genetics & Development</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">230-236</span>CODEN:
                <span class="NLM_cas:coden">COGDET</span>;
        ISSN:<span class="NLM_cas:issn">0959-437X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Ras/mitogen activated protein kinase (MAPK) pathway is essential in the regulation of the cell cycle, differentiation, growth and cell senescence, all of which are crit. to normal development.  It is therefore not surprising that its dysregulation has profound effects on development.  A class of developmental syndromes, the RASopathies', is caused by germline mutations in genes that encode protein components of the Ras/MAPK pathway.  The vast majority of these mutations result in increased signal transduction down the Ras/MAPK pathway, but usually to a lesser extent than somatic mutations assocd. with oncogenesis.  Each syndrome exhibits unique phenotypic features, however, since they all cause dysregulation of the Ras/MAPK pathway, there are numerous overlapping phenotypic features between the syndromes, including characteristic facial features, cardiac defects, cutaneous abnormalities, neurocognitive delay and a predisposition to malignancies.  Here we review the clin. and underlying mol. basis for each of these syndromes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQRPIBdM9nkbVg90H21EOLACvtfcHk0lhKeQAhmdWryA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Gmurs%253D&md5=765a765d743125af820969a502b246e6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2009.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2009.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DTidyman%26aufirst%3DW.%2BE.%26aulast%3DRauen%26aufirst%3DK.%2BA.%26atitle%3DThe%2520RASopathies%253A%2520developmental%2520syndromes%2520of%2520RAS%252FMAPK%2520pathway%2520dysregulation%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2009%26volume%3D19%26spage%3D230%26epage%3D236%26doi%3D10.1016%2Fj.gde.2009.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Medarde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, E.</span></span> <span> </span><span class="NLM_article-title">RAS in cancer and developmental diseases</span>. <i>Genes Cancer</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">344</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1177/1947601911411084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1177%2F1947601911411084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=21779504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFWlsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=344-358&author=A.+Fern%C3%A1ndez-Medardeauthor=E.+Santos&title=RAS+in+cancer+and+developmental+diseases&doi=10.1177%2F1947601911411084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Ras in cancer and developmental diseases</span></div><div class="casAuthors">Fernandez-Medarde, Alberto; Santos, Eugenio</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">344-358</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Somatic, gain-of-function mutations in ras genes were the first specific genetic alterations identified in human cancer about 3 decades ago.  Studies during the last quarter century have characterized the Ras proteins as essential components of signaling networks controlling cellular proliferation, differentiation, or survival.  The oncogenic mutations of the H-ras, N-ras, or K-ras genes frequently found in human tumors are known to throw off balance the normal outcome of those signaling pathways, thus leading to tumor development.  Oncogenic mutations in a no. of other upstream or downstream components of Ras signaling pathways (including membrane RTKs or cytosolic kinases) have been detected more recently in assocn. with a variety of cancers.  Interestingly, the oncogenic Ras mutations and the mutations in other components of Ras/MAPK signaling pathways appear to be mutually exclusive events in most tumors, indicating that deregulation of Ras-dependent signaling is the essential requirement for tumorigenesis.  In contrast to sporadic tumors, sep. studies have identified germline mutations in Ras and various other components of Ras signaling pathways that occur in specific assocn. with a no. of different familial, developmental syndromes frequently sharing common phenotypic cardiofaciocutaneous features.  Finally, even without being a causative force, defective Ras signaling has been cited as a contributing factor to many other human illnesses, including diabetes and immunol. and inflammatory disorders.  We aim this review at summarizing and updating current knowledge on the contribution of Ras mutations and altered Ras signaling to development of various tumoral and nontumoral pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC8FC347lm6bVg90H21EOLACvtfcHk0lhKeQAhmdWryA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFWlsbs%253D&md5=048ad92dd5959250e4a2b8e0319ff225</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1177%2F1947601911411084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1947601911411084%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Medarde%26aufirst%3DA.%26aulast%3DSantos%26aufirst%3DE.%26atitle%3DRAS%2520in%2520cancer%2520and%2520developmental%2520diseases%26jtitle%3DGenes%2520Cancer%26date%3D2011%26volume%3D2%26spage%3D344%26epage%3D358%26doi%3D10.1177%2F1947601911411084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiripo, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yassin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamburino, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucherlapati, R. S.</span></span> <span> </span><span class="NLM_article-title">Germline gain-of-function mutations in SOS1 cause Noonan syndrome</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1038/ng1926</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1038%2Fng1926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=17143285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252Fmtlyhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=70-74&author=A.+E.+Robertsauthor=T.+Arakiauthor=K.+D.+Swansonauthor=K.+T.+Montgomeryauthor=T.+A.+Schiripoauthor=V.+A.+Joshiauthor=L.+Liauthor=Y.+Yassinauthor=A.+M.+Tamburinoauthor=B.+G.+Neelauthor=R.+S.+Kucherlapati&title=Germline+gain-of-function+mutations+in+SOS1+cause+Noonan+syndrome&doi=10.1038%2Fng1926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Germline gain-of-function mutations in SOS1 cause Noonan syndrome</span></div><div class="casAuthors">Roberts Amy E; Araki Toshiyuki; Swanson Kenneth D; Montgomery Kate T; Schiripo Taryn A; Joshi Victoria A; Li Li; Yassin Yosuf; Tamburino Alex M; Neel Benjamin G; Kucherlapati Raju S</div><div class="citationInfo"><span class="NLM_cas:title">Nature genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-4</span>
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    </div><div class="casAbstract">Noonan syndrome, the most common single-gene cause of congenital heart disease, is characterized by short stature, characteristic facies, learning problems and leukemia predisposition.  Gain-of-function mutations in PTPN11, encoding the tyrosine phosphatase SHP2, cause approximately 50% of Noonan syndrome cases.  SHP2 is required for RAS-ERK MAP kinase (MAPK) cascade activation, and Noonan syndrome mutants enhance ERK activation ex vivo and in mice.  KRAS mutations account for <5% of cases of Noonan syndrome, but the gene(s) responsible for the remainder are unknown.  We identified missense mutations in SOS1, which encodes an essential RAS guanine nucleotide-exchange factor (RAS-GEF), in approximately 20% of cases of Noonan syndrome without PTPN11 mutation.  The prevalence of specific cardiac defects differs in SOS1 mutation-associated Noonan syndrome.  Noonan syndrome-associated SOS1 mutations are hypermorphs encoding products that enhance RAS and ERK activation.  Our results identify SOS1 mutants as a major cause of Noonan syndrome, representing the first example of activating GEF mutations associated with human disease and providing new insights into RAS-GEF regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRksUzgn8R7h0NoizSOkG_FfW6udTcc2ebKzrJKTf0Bibntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252Fmtlyhsg%253D%253D&md5=98b41bbffcb21bb5303dab02e3eaecd3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fng1926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1926%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DA.%2BE.%26aulast%3DAraki%26aufirst%3DT.%26aulast%3DSwanson%26aufirst%3DK.%2BD.%26aulast%3DMontgomery%26aufirst%3DK.%2BT.%26aulast%3DSchiripo%26aufirst%3DT.%2BA.%26aulast%3DJoshi%26aufirst%3DV.%2BA.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DYassin%26aufirst%3DY.%26aulast%3DTamburino%26aufirst%3DA.%2BM.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26aulast%3DKucherlapati%26aufirst%3DR.%2BS.%26atitle%3DGermline%2520gain-of-function%2520mutations%2520in%2520SOS1%2520cause%2520Noonan%2520syndrome%26jtitle%3DNat.%2520Genet.%26date%3D2007%26volume%3D39%26spage%3D70%26epage%3D74%26doi%3D10.1038%2Fng1926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tartaglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennacchio, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodale, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkozy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schackwitz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ustaszewska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasta, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siguero, J. P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Digilio, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zampino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallapiccola, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bar-Sagi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, B. D.</span></span> <span> </span><span class="NLM_article-title">Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.1038/ng1939</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1038%2Fng1939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=17143282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A280%3ADC%252BD28jlsF2gtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=75-79&author=M.+Tartagliaauthor=L.+A.+Pennacchioauthor=C.+Zhaoauthor=K.+K.+Yadavauthor=V.+Fodaleauthor=A.+Sarkozyauthor=B.+Panditauthor=K.+Oishiauthor=S.+Martinelliauthor=W.+Schackwitzauthor=A.+Ustaszewskaauthor=J.+Martinauthor=J.+Bristowauthor=C.+Cartaauthor=F.+Lepriauthor=C.+Neriauthor=I.+Vastaauthor=K.+Gibsonauthor=C.+J.+Curryauthor=J.+P.+L.+Sigueroauthor=M.+C.+Digilioauthor=G.+Zampinoauthor=B.+Dallapiccolaauthor=D.+Bar-Sagiauthor=B.+D.+Gelb&title=Gain-of-function+SOS1+mutations+cause+a+distinctive+form+of+Noonan+syndrome&doi=10.1038%2Fng1939"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome</span></div><div class="casAuthors">Tartaglia Marco; Pennacchio Len A; Zhao Chen; Yadav Kamlesh K; Fodale Valentina; Sarkozy Anna; Pandit Bhaswati; Oishi Kimihiko; Martinelli Simone; Schackwitz Wendy; Ustaszewska Anna; Martin Joel; Bristow James; Carta Claudio; Lepri Francesca; Neri Cinzia; Vasta Isabella; Gibson Kate; Curry Cynthia J; Siguero Juan Pedro Lopez; Digilio Maria Cristina; Zampino Giuseppe; Dallapiccola Bruno; Bar-Sagi Dafna; Gelb Bruce D</div><div class="citationInfo"><span class="NLM_cas:title">Nature genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-9</span>
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    </div><div class="casAbstract">Noonan syndrome is a developmental disorder characterized by short stature, facial dysmorphia, congenital heart defects and skeletal anomalies.  Increased RAS-mitogen-activated protein kinase (MAPK) signaling due to PTPN11 and KRAS mutations causes 50% of cases of Noonan syndrome.  Here, we report that 22 of 129 individuals with Noonan syndrome without PTPN11 or KRAS mutation have missense mutations in SOS1, which encodes a RAS-specific guanine nucleotide exchange factor.  SOS1 mutations cluster at codons encoding residues implicated in the maintenance of SOS1 in its autoinhibited form.  In addition, ectopic expression of two Noonan syndrome-associated mutants induces enhanced RAS and ERK activation.  The phenotype associated with SOS1 defects lies within the Noonan syndrome spectrum but is distinctive, with a high prevalence of ectodermal abnormalities but generally normal development and linear growth.  Our findings implicate gain-of-function mutations in a RAS guanine nucleotide exchange factor in disease for the first time and define a new mechanism by which upregulation of the RAS pathway can profoundly change human development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHWugWFFBYm9-cVm4E2RlLfW6udTcc2ebKzrJKTf0Bibntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jlsF2gtA%253D%253D&md5=6640f23266076d6746f118bf7fd73cd3</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fng1939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1939%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DPennacchio%26aufirst%3DL.%2BA.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DYadav%26aufirst%3DK.%2BK.%26aulast%3DFodale%26aufirst%3DV.%26aulast%3DSarkozy%26aufirst%3DA.%26aulast%3DPandit%26aufirst%3DB.%26aulast%3DOishi%26aufirst%3DK.%26aulast%3DMartinelli%26aufirst%3DS.%26aulast%3DSchackwitz%26aufirst%3DW.%26aulast%3DUstaszewska%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DJ.%26aulast%3DBristow%26aufirst%3DJ.%26aulast%3DCarta%26aufirst%3DC.%26aulast%3DLepri%26aufirst%3DF.%26aulast%3DNeri%26aufirst%3DC.%26aulast%3DVasta%26aufirst%3DI.%26aulast%3DGibson%26aufirst%3DK.%26aulast%3DCurry%26aufirst%3DC.%2BJ.%26aulast%3DSiguero%26aufirst%3DJ.%2BP.%2BL.%26aulast%3DDigilio%26aufirst%3DM.%2BC.%26aulast%3DZampino%26aufirst%3DG.%26aulast%3DDallapiccola%26aufirst%3DB.%26aulast%3DBar-Sagi%26aufirst%3DD.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DGain-of-function%2520SOS1%2520mutations%2520cause%2520a%2520distinctive%2520form%2520of%2520Noonan%2520syndrome%26jtitle%3DNat.%2520Genet.%26date%3D2007%26volume%3D39%26spage%3D75%26epage%3D79%26doi%3D10.1038%2Fng1939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hart, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorry, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marazita, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortelli, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallos, D.</span></span> <span> </span><span class="NLM_article-title">A mutation in the SOS1 gene causes hereditary gingival fibromatosis type 1</span>. <i>Am. J. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">943</span>– <span class="NLM_lpage">954</span>, <span class="refDoi"> DOI: 10.1086/339689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1086%2F339689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=11868160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BD38XivFClu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2002&pages=943-954&author=T.+C.+Hartauthor=Y.+Zhangauthor=M.+C.+Gorryauthor=P.+S.+Hartauthor=M.+Cooperauthor=M.+L.+Marazitaauthor=J.+M.+Marksauthor=J.+R.+Cortelliauthor=D.+Pallos&title=A+mutation+in+the+SOS1+gene+causes+hereditary+gingival+fibromatosis+type+1&doi=10.1086%2F339689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in the SOS1 gene causes hereditary gingival fibromatosis type 1</span></div><div class="casAuthors">Hart, Thomas C.; Zhang, Yingze; Gorry, Michael C.; Hart, P. Suzanne; Cooper, Margaret; Marazita, Mary L.; Marks, Jared M.; Cortelli, Jose R.; Pallos, Debora</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">943-954</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Hereditary gingival fibromatosis (HGF) is a rare, autosomal dominant form of gingival overgrowth.  Affected individuals have a benign, slowly progressive, nonhemorrhagic, fibrous enlargement of the oral masticatory mucosa.  Genetic loci for autosomal dominant forms of HGF have been localized to chromosome 2p21-p22 (HGF1) and chromosome 5q13-q22 (HGF2).  To identify the gene responsible for HGF1, the authors extended genetic linkage studies to refine the chromosome 2p21-p22 candidate interval to ∼2.3 Mb.  Development of an integrated phys. and genetic map of the interval identified 16 genes.  Sequencing of these genes, in affected and unaffected HGF1 family members, identified a mutation in the Son of sevenless-1 (SOS1) gene in affected individuals.  In this report, the authors describe the genomic structure of the SOS1 gene and present evidence that insertion of a cytosine between nucleotides 126,142 and 126,143 in codon 1083 of the SOS1 gene is responsible for HGF1.  This insertion mutation, which segregates in a dominant manner over four generations, introduces a frameshift and creates a premature stop codon, abolishing four functionally important proline-rich SH3 binding domains normally present in the carboxyl-terminal region of the SOS1 protein.  The resultant protein chimera contains the wild-type SOS1 protein for the N-terminal amino acids 1-1083 fused to a novel 22-amino acid carboxyl terminus.  Similar SOS1 deletion constructs are functional in animal models, and a transgenic mouse construct with a comparable SOS1 chimera produces a phenotype with skin hypertrophy.  Clarification of the functional role of this SOS1 mutant has implications for understanding other forms of gingival fibromatosis and corrective gingival-tissue management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrws-ZFkg6I0LVg90H21EOLACvtfcHk0liNY2yMPfwO1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivFClu74%253D&md5=e552fc8803afabaebd8dd3aca8f63707</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1086%2F339689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F339689%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DT.%2BC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGorry%26aufirst%3DM.%2BC.%26aulast%3DHart%26aufirst%3DP.%2BS.%26aulast%3DCooper%26aufirst%3DM.%26aulast%3DMarazita%26aufirst%3DM.%2BL.%26aulast%3DMarks%26aufirst%3DJ.%2BM.%26aulast%3DCortelli%26aufirst%3DJ.%2BR.%26aulast%3DPallos%26aufirst%3DD.%26atitle%3DA%2520mutation%2520in%2520the%2520SOS1%2520gene%2520causes%2520hereditary%2520gingival%2520fibromatosis%2520type%25201%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2002%26volume%3D70%26spage%3D943%26epage%3D954%26doi%3D10.1086%2F339689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camper, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Approach for targeting RAS with small molecules that activate SOS-mediated nucleotide exchange</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">3401</span>– <span class="NLM_lpage">3406</span>, <span class="refDoi"> DOI: 10.1073/pnas.1315798111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1073%2Fpnas.1315798111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=24550516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtl2mtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=3401-3406&author=M.+C.+Burnsauthor=Q.+Sunauthor=R.+N.+Danielsauthor=D.+Camperauthor=J.+P.+Kennedyauthor=J.+Phanauthor=E.+T.+Olejniczakauthor=T.+Leeauthor=A.+G.+Watersonauthor=O.+W.+Rossaneseauthor=S.+W.+Fesik&title=Approach+for+targeting+RAS+with+small+molecules+that+activate+SOS-mediated+nucleotide+exchange&doi=10.1073%2Fpnas.1315798111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Approach for targeting Ras with small molecules that activate SOS-mediated nucleotide exchange</span></div><div class="casAuthors">Burns, Michael C.; Sun, Qi; Daniels, R. Nathan; Camper, DeMarco; Kennedy, J. Phillip; Phan, Jason; Olejniczak, Edward T.; Lee, Taekyu; Waterson, Alex G.; Rossanese, Olivia W.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3401-3406</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Aberrant activation of the small GTPase Ras by oncogenic mutation or constitutively active upstream receptor tyrosine kinases results in the deregulation of cellular signals governing growth and survival in ∼30% of all human cancers.  However, the discovery of potent inhibitors of Ras has been difficult to achieve.  Here, we report the identification of small mols. that bind to a unique pocket on the Ras:Son of Sevenless (SOS):Ras complex, increase the rate of SOS-catalyzed nucleotide exchange in vitro, and modulate Ras signaling pathways in cells.  X-ray crystallog. of Ras:SOS:Ras in complex with these mols. reveals that the compds. bind in a hydrophobic pocket in the CDC25 domain of SOS adjacent to the Switch II region of Ras.  The structure-activity relationships exhibited by these compds. can be rationalized on the basis of multiple x-ray cocrystal structures.  Mutational analyses confirmed the functional relevance of this binding site and showed it to be essential for compd. activity.  These mols. increase Ras-GTP levels and disrupt MAPK and PI3K signaling in cells at low micromolar concns.  These small mols. represent tools to study the acute activation of Ras and highlight a pocket on SOS that may be exploited to modulate Ras signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl9pTZ-cO_8rVg90H21EOLACvtfcHk0li3VZ3V5pdBlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtl2mtrc%253D&md5=aefb332e4acb9de6731f206383bcca6f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1315798111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1315798111%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DDaniels%26aufirst%3DR.%2BN.%26aulast%3DCamper%26aufirst%3DD.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DApproach%2520for%2520targeting%2520RAS%2520with%2520small%2520molecules%2520that%2520activate%2520SOS-mediated%2520nucleotide%2520exchange%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D3401%26epage%3D3406%26doi%3D10.1073%2Fpnas.1315798111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camper, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">High-throughput screening identifies small molecules that bind to the RAS: SOS: RAS complex and perturb RAS signaling</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>548</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2018.01.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1016%2Fj.ab.2018.01.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=29444450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFaju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=548&publication_year=2018&pages=44-52&author=M.+C.+Burnsauthor=J.+E.+Howesauthor=Q.+Sunauthor=A.+J.+Littleauthor=D.+V.+Camperauthor=J.+R.+Abbottauthor=J.+Phanauthor=T.+Leeauthor=A.+G.+Watersonauthor=O.+W.+Rossaneseauthor=S.+W.+Fesik&title=High-throughput+screening+identifies+small+molecules+that+bind+to+the+RAS%3A+SOS%3A+RAS+complex+and+perturb+RAS+signaling&doi=10.1016%2Fj.ab.2018.01.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput screening identifies small molecules that bind to the RAS:SOS:RAS complex and perturb RAS signaling</span></div><div class="casAuthors">Burns, Michael C.; Howes, Jennifer E.; Sun, Qi; Little, Andrew J.; Camper, DeMarco V.; Abbott, Jason R.; Phan, Jason; Lee, Taekyu; Waterson, Alex G.; Rossanese, Olivia W.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">548</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44-52</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">K-RAS is mutated in approx. 30% of human cancers, resulting in increased RAS signaling and tumor growth.  Thus, RAS is a highly validated therapeutic target, esp. in tumors of the pancreas, lung and colon.  Although directly targeting RAS has proven to be challenging, it may be possible to target other proteins involved in RAS signaling, such as the guanine nucleotide exchange factor Son of Sevenless (SOS).  We have previously reported on the discovery of small mols. that bind to SOS1, activate SOS-mediated nucleotide exchange on RAS, and paradoxically inhibit ERK phosphorylation (Burns et al., PNAS, 2014).  Here, we describe the discovery of addnl., structurally diverse small mols. that also bind to SOS1 in the same pocket and elicit similar biol. effects.  We tested >160,000 compds. in a fluorescence-based assay to assess their effects on SOS-mediated nucleotide exchange.  X-Ray structures revealed that these small mols. bind to the CDC25 domain of SOS1.  Compds. that elicited high levels of nucleotide exchange activity in vitro increased RAS-GTP levels in cells, and inhibited phospho ERK levels at higher treatment concns.  The identification of structurally diverse SOS1 binding ligands may assist in the discovery of new mols. designed to target RAS-driven tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdp7gmEwzlMLVg90H21EOLACvtfcHk0li3VZ3V5pdBlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFaju70%253D&md5=af853c79022b68839f53bfb11303b97a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2018.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2018.01.025%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DHowes%26aufirst%3DJ.%2BE.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DLittle%26aufirst%3DA.%2BJ.%26aulast%3DCamper%26aufirst%3DD.%2BV.%26aulast%3DAbbott%26aufirst%3DJ.%2BR.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DHigh-throughput%2520screening%2520identifies%2520small%2520molecules%2520that%2520bind%2520to%2520the%2520RAS%253A%2520SOS%253A%2520RAS%2520complex%2520and%2520perturb%2520RAS%2520signaling%26jtitle%3DAnal.%2520Biochem.%26date%3D2018%26volume%3D548%26spage%3D44%26epage%3D52%26doi%3D10.1016%2Fj.ab.2018.01.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Small molecule–mediated activation of RAS elicits biphasic modulation of phospho-ERK levels that are regulated through negative feedback on SOS1</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1051</span>– <span class="NLM_lpage">1060</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-17-0666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1158%2F1535-7163.MCT-17-0666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=29440291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosF2qsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=1051-1060&author=J.+E.+Howesauthor=D.+T.+Akanauthor=M.+C.+Burnsauthor=O.+W.+Rossaneseauthor=A.+G.+Watersonauthor=S.+W.+Fesik&title=Small+molecule%E2%80%93mediated+activation+of+RAS+elicits+biphasic+modulation+of+phospho-ERK+levels+that+are+regulated+through+negative+feedback+on+SOS1&doi=10.1158%2F1535-7163.MCT-17-0666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule-Mediated Activation of RAS Elicits Biphasic Modulation of Phospho-ERK Levels that Are Regulated through Negative Feedback on SOS1</span></div><div class="casAuthors">Howes, Jennifer E.; Akan, Denis T.; Burns, Michael C.; Rossanese, Olivia W.; Waterson, Alex G.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1051-1060</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Oncogenic mutation of RAS results in aberrant cellular signaling and is responsible for more than 30% of all human tumors.  Therefore, pharmacol. modulation of RAS has attracted great interest as a therapeutic strategy.  Our lab. has recently discovered small mols. that activate Son of Sevenless (SOS)-catalyzed nucleotide exchange on RAS and inhibit downstream signaling.  Here, we describe how pharmacol. targeting SOS1 induced biphasic modulation of RAS-GTP and ERK phosphorylation levels, which we obsd. in a variety of cell lines expressing different RAS-mutant isoforms.  We show that compd. treatment caused an increase in phosphorylation at ERK consensus motifs on SOS1 that was not obsd. with the expression of a non-phosphorylatable S1178A SOS1 mutant or after pretreatment with an ERK inhibitor.  Phosphorylation at S1178 on SOS1 is known to inhibit the assocn. between SOS1 and GRB2 and disrupt SOS1 membrane localization.  Consistent with this, we show that wild-type SOS1 and GRB2 dissocd. in a time-dependent fashion in response to compd. treatment, and conversely, this interaction was enhanced with the expression of an S1178A SOS1 mutant.  Furthermore, in cells expressing either S1178A SOS1 or a constitutively membrane-bound CAAX box tagged SOS1 mutant, we obsd. elevated RAS-GTP levels over time in response to compd., as compared with the biphasic changes in RAS-GTP exhibited in cells expressing wild-type SOS1.  These results suggest that small mol. targeting of SOS1 can elicit a biphasic modulation of RAS-GTP and phospho-ERK levels through neg. feedback on SOS1 that regulates the interaction between SOS1 and GRB2.  Mol Cancer Ther; 17(5); 1051-60. ©2018 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa-L8W-8tgq7Vg90H21EOLACvtfcHk0lhFMlI2APsaBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosF2qsLc%253D&md5=e9a4fedac54fd873438cde20ce28f37d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-17-0666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-17-0666%26sid%3Dliteratum%253Aachs%26aulast%3DHowes%26aufirst%3DJ.%2BE.%26aulast%3DAkan%26aufirst%3DD.%2BT.%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DSmall%2520molecule%25E2%2580%2593mediated%2520activation%2520of%2520RAS%2520elicits%2520biphasic%2520modulation%2520of%2520phospho-ERK%2520levels%2520that%2520are%2520regulated%2520through%2520negative%2520feedback%2520on%2520SOS1%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2018%26volume%3D17%26spage%3D1051%26epage%3D1060%26doi%3D10.1158%2F1535-7163.MCT-17-0666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodges, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobolik, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beesetty, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of aminopiperidine indoles that activate the guanine nucleotide exchange factor SOS1 and modulate RAS signaling</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6002</span>– <span class="NLM_lpage">6017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00360</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00360" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKktbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6002-6017&author=J.+R.+Abbottauthor=T.+R.+Hodgesauthor=R.+N.+Danielsauthor=P.+A.+Patelauthor=J.+P.+Kennedyauthor=J.+E.+Howesauthor=D.+T.+Akanauthor=M.+C.+Burnsauthor=J.+Saiauthor=T.+Sobolikauthor=Y.+Beesettyauthor=T.+Leeauthor=O.+W.+Rossaneseauthor=J.+Phanauthor=A.+G.+Watersonauthor=S.+W.+Fesik&title=Discovery+of+aminopiperidine+indoles+that+activate+the+guanine+nucleotide+exchange+factor+SOS1+and+modulate+RAS+signaling&doi=10.1021%2Facs.jmedchem.8b00360"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Aminopiperidine Indoles That Activate the Guanine Nucleotide Exchange Factor SOS1 and Modulate RAS Signaling</span></div><div class="casAuthors">Abbott, Jason R.; Hodges, Timothy R.; Daniels, R. Nathan; Patel, Pratiq A.; Kennedy, J. Phillip; Howes, Jennifer E.; Akan, Denis T.; Burns, Michael C.; Sai, Jiqing; Sobolik, Tammy; Beesetty, Yugandhar; Lee, Taekyu; Rossanese, Olivia W.; Phan, Jason; Waterson, Alex G.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6002-6017</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indole-substituted tryptophan amides such as I were prepd. through optimization of aminopiperidine-substituted indoles as activators of the guanine nucleotide exchange factor (GEF) son of sevenless homolog 1 (SOS1) for use in modulating RAS signaling and thus as potential antitumor agents.  Substitution patterns on the indole nucleus, the pendant amino acid moiety, and the linker unit connecting these two fragments were modified to det. structure-activity relations for the SOS1-mediated activation of nucleotide exchange.  Effective compds. such as I activated the nucleotide exchange process at sub-micromolar concns. in vitro (IC50 for I = 0.8 ± 0.36 μM), increased levels of active RAS-GTP in HeLa cells, and elicited signaling changes in the mitogen-activated protein kinase/extracellular regulated kinase (MAPK/ERK) pathway, resulting in a decrease in pERK1/2T202/Y204 protein levels at higher compd. concns.  The structures of selected compds. bound to the ternary complex of RAS, SOS1, and RAS were detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKmqxqetLkarVg90H21EOLACvtfcHk0lhFMlI2APsaBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKktbvN&md5=cc878f4907f63c0a397b11a4e044654d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00360%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DJ.%2BR.%26aulast%3DHodges%26aufirst%3DT.%2BR.%26aulast%3DDaniels%26aufirst%3DR.%2BN.%26aulast%3DPatel%26aufirst%3DP.%2BA.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DHowes%26aufirst%3DJ.%2BE.%26aulast%3DAkan%26aufirst%3DD.%2BT.%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DSai%26aufirst%3DJ.%26aulast%3DSobolik%26aufirst%3DT.%26aulast%3DBeesetty%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520aminopiperidine%2520indoles%2520that%2520activate%2520the%2520guanine%2520nucleotide%2520exchange%2520factor%2520SOS1%2520and%2520modulate%2520RAS%2520signaling%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6002%26epage%3D6017%26doi%3D10.1021%2Facs.jmedchem.8b00360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browning, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of quinazolines that activate SOS1-mediated nucleotide exchange on RAS</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">941</span>– <span class="NLM_lpage">946</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00296</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00296" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOjsLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=941-946&author=J.+R.+Abbottauthor=P.+A.+Patelauthor=J.+E.+Howesauthor=D.+T.+Akanauthor=J.+P.+Kennedyauthor=M.+C.+Burnsauthor=C.+F.+Browningauthor=Q.+Sunauthor=O.+W.+Rossaneseauthor=J.+Phanauthor=A.+G.+Watersonauthor=S.+W.+Fesik&title=Discovery+of+quinazolines+that+activate+SOS1-mediated+nucleotide+exchange+on+RAS&doi=10.1021%2Facsmedchemlett.8b00296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Quinazolines That Activate SOS1-Mediated Nucleotide Exchange on RAS</span></div><div class="casAuthors">Abbott, Jason R.; Patel, Pratiq A.; Howes, Jennifer E.; Akan, Denis T.; Kennedy, J. Phillip; Burns, Michael C.; Browning, Carrie F.; Sun, Qi; Rossanese, Olivia W.; Phan, Jason; Waterson, Alex G.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">941-946</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proteins in the RAS family are important regulators of cellular signaling and, when mutated, can drive cancer pathogenesis.  Despite considerable effort over the last 30 years, RAS proteins have proven to be recalcitrant therapeutic targets.  One approach for modulating RAS signaling is to target proteins that interact with RAS, such as the guanine nucleotide exchange factor (GEF) son of sevenless homolog 1 (SOS1).  Here, we report hit-to-lead studies on quinazoline-contg. compds. that bind to SOS1 and activate nucleotide exchange on RAS.  Using structure-based design, we refined the substituents attached to the quinazoline nucleus and built in addnl. interactions not present in the initial HTS hit.  Optimized compds. activate nucleotide exchange at single-digit micromolar concns. in vitro.  In HeLa cells, these quinazolines increase the levels of RAS-GTP and cause signaling changes in the mitogen-activated protein kinase/extracellular regulated kinase (MAPK/ERK) pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQa6QZIgWHVrVg90H21EOLACvtfcHk0ljSSBjMYXMoWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOjsLzN&md5=54b395566e713f8debbc2de33cb92363</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00296%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DJ.%2BR.%26aulast%3DPatel%26aufirst%3DP.%2BA.%26aulast%3DHowes%26aufirst%3DJ.%2BE.%26aulast%3DAkan%26aufirst%3DD.%2BT.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DBrowning%26aufirst%3DC.%2BF.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520quinazolines%2520that%2520activate%2520SOS1-mediated%2520nucleotide%2520exchange%2520on%2520RAS%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D941%26epage%3D946%26doi%3D10.1021%2Facsmedchemlett.8b00296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hodges, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salovich, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browning, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobolik, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beesetty, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scharn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stadtmueller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure-based optimization of benzimidazole-derived activators of SOS1-mediated nucleotide exchange on RAS</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8875</span>– <span class="NLM_lpage">8894</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01108</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01108" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs12isrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8875-8894&author=T.+R.+Hodgesauthor=J.+R.+Abbottauthor=A.+J.+Littleauthor=D.+Sarkarauthor=J.+M.+Salovichauthor=J.+E.+Howesauthor=D.+T.+Akanauthor=J.+Saiauthor=A.+L.+Arnoldauthor=C.+Browningauthor=M.+C.+Burnsauthor=T.+Sobolikauthor=Q.+Sunauthor=Y.+Beesettyauthor=J.+A.+Cokerauthor=D.+Scharnauthor=H.+Stadtmuellerauthor=O.+W.+Rossaneseauthor=J.+Phanauthor=A.+G.+Watersonauthor=D.+B.+McConnellauthor=S.+W.+Fesik&title=Discovery+and+structure-based+optimization+of+benzimidazole-derived+activators+of+SOS1-mediated+nucleotide+exchange+on+RAS&doi=10.1021%2Facs.jmedchem.8b01108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Structure-Based Optimization of Benzimidazole-Derived Activators of SOS1-Mediated Nucleotide Exchange on RAS</span></div><div class="casAuthors">Hodges, Timothy R.; Abbott, Jason R.; Little, Andrew J.; Sarkar, Dhruba; Salovich, James M.; Howes, Jennifer E.; Akan, Denis T.; Sai, Jiqing; Arnold, Allison L.; Browning, Carrie; Burns, Michael C.; Sobolik, Tammy; Sun, Qi; Beesetty, Yugandhar; Coker, Jesse A.; Scharn, Dirk; Stadtmueller, Heinz; Rossanese, Olivia W.; Phan, Jason; Waterson, Alex G.; McConnell, Darryl B.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8875-8894</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Son of sevenless homolog 1 (SOS1) is a guanine nucleotide exchange factor that catalyzes the exchange of GDP for GTP on RAS.  In its active form, GTP-bound RAS is responsible for numerous crit. cellular processes.  Aberrant RAS activity is involved in ∼30% of all human cancers; hence, SOS1 is an attractive therapeutic target for its role in modulating RAS activation.  Here, we describe a new series of benzimidazole-derived SOS1 agonists.  Using structure-guided design, we discovered small mols. that increase nucleotide exchange on RAS in vitro at submicromolar concns., bind to SOS1 with low double-digit nanomolar affinity, rapidly enhance cellular RAS-GTP levels, and invoke biphasic signaling changes in phosphorylation of ERK 1/2.  These compds. represent the most potent series of SOS1 agonists reported to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnQbL1ADAtRrVg90H21EOLACvtfcHk0ljSSBjMYXMoWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs12isrnL&md5=3051827da87f015c260000ea7b2c7c34</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01108%26sid%3Dliteratum%253Aachs%26aulast%3DHodges%26aufirst%3DT.%2BR.%26aulast%3DAbbott%26aufirst%3DJ.%2BR.%26aulast%3DLittle%26aufirst%3DA.%2BJ.%26aulast%3DSarkar%26aufirst%3DD.%26aulast%3DSalovich%26aufirst%3DJ.%2BM.%26aulast%3DHowes%26aufirst%3DJ.%2BE.%26aulast%3DAkan%26aufirst%3DD.%2BT.%26aulast%3DSai%26aufirst%3DJ.%26aulast%3DArnold%26aufirst%3DA.%2BL.%26aulast%3DBrowning%26aufirst%3DC.%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DSobolik%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DBeesetty%26aufirst%3DY.%26aulast%3DCoker%26aufirst%3DJ.%2BA.%26aulast%3DScharn%26aufirst%3DD.%26aulast%3DStadtmueller%26aufirst%3DH.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DMcConnell%26aufirst%3DD.%2BB.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520and%2520structure-based%2520optimization%2520of%2520benzimidazole-derived%2520activators%2520of%2520SOS1-mediated%2520nucleotide%2520exchange%2520on%2520RAS%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8875%26epage%3D8894%26doi%3D10.1021%2Facs.jmedchem.8b01108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beesetty, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Small molecule SOS1 agonists modulate MAPK and PI3K signaling via independent cellular responses</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">331</span>, <span class="refDoi"> DOI: 10.1021/acschembio.8b00869</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.8b00869" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC1MXis1antLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=325-331&author=D.+T.+Akanauthor=J.+E.+Howesauthor=J.+Saiauthor=A.+L.+Arnoldauthor=Y.+Beesettyauthor=J.+Phanauthor=E.+T.+Olejniczakauthor=A.+G.+Watersonauthor=S.+W.+Fesik&title=Small+molecule+SOS1+agonists+modulate+MAPK+and+PI3K+signaling+via+independent+cellular+responses&doi=10.1021%2Facschembio.8b00869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule SOS1 Agonists Modulate MAPK and PI3K Signaling via Independent Cellular Responses</span></div><div class="casAuthors">Akan, Denis T.; Howes, Jennifer E.; Sai, Jiqing; Arnold, Allison L.; Beesetty, Yugandhar; Phan, Jason; Olejniczak, Edward T.; Waterson, Alex G.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">325-331</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activating mutations in RAS can lead to oncogenesis by enhancing downstream signaling, such as through the MAPK and PI3K pathways.  Therefore, therapeutically targeting RAS may perturb multiple signaling pathways simultaneously.  One method for modulating RAS signaling is to target the activity of the guanine nucleotide exchange factor SOS1.  Our lab. has discovered compds. that bind to SOS1 and activate RAS.  Interestingly, these SOS1 agonist compds. elicit biphasic modulation of ERK phosphorylation and simultaneous inhibition of AKT phosphorylation levels.  Here, we utilized multiple chem. distinct compds. to elucidate whether these effects on MAPK and PI3K signaling by SOS1 agonists were mechanistically linked.  In addn., we used CRISPR/Cas9 gene-editing to generate clonally derived SOS1 knockout cells and identified a potent SOS1 agonist that rapidly elicited on-target mol. effects at substantially lower concns. than those causing off-target effects.  Our findings will allow us to further define the on-target utility of SOS1 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM2e71hyVUI7Vg90H21EOLACvtfcHk0lhFYIGPVadSUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXis1antLo%253D&md5=7363a92e067335fbeeaef3c8ab12120f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facschembio.8b00869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.8b00869%26sid%3Dliteratum%253Aachs%26aulast%3DAkan%26aufirst%3DD.%2BT.%26aulast%3DHowes%26aufirst%3DJ.%2BE.%26aulast%3DSai%26aufirst%3DJ.%26aulast%3DArnold%26aufirst%3DA.%2BL.%26aulast%3DBeesetty%26aufirst%3DY.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DSmall%2520molecule%2520SOS1%2520agonists%2520modulate%2520MAPK%2520and%2520PI3K%2520signaling%2520via%2520independent%2520cellular%2520responses%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2019%26volume%3D14%26spage%3D325%26epage%3D331%26doi%3D10.1021%2Facschembio.8b00869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beesetty, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of sulfonamide-derived agonists of SOS1-mediated nucleotide exchange on RAS using fragment-based methods</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">8325</span>– <span class="NLM_lpage">8337</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00511</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00511" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVSms7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=8325-8337&author=D.+Sarkarauthor=E.+T.+Olejniczakauthor=J.+Phanauthor=J.+A.+Cokerauthor=J.+Saiauthor=A.+Arnoldauthor=Y.+Beesettyauthor=A.+G.+Watersonauthor=S.+W.+Fesik&title=Discovery+of+sulfonamide-derived+agonists+of+SOS1-mediated+nucleotide+exchange+on+RAS+using+fragment-based+methods&doi=10.1021%2Facs.jmedchem.0c00511"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Sulfonamide-Derived Agonists of SOS1-Mediated Nucleotide Exchange on RAS Using Fragment-Based Methods</span></div><div class="casAuthors">Sarkar, Dhruba; Olejniczak, Edward T.; Phan, Jason; Coker, Jesse A.; Sai, Jiqing; Arnold, Allison; Beesetty, Yugandhar; Waterson, Alex G.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8325-8337</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The nucleotide exchange factor Son of Sevenless (SOS) catalyzes the activation of RAS by converting it from its inactive GDP-bound state to its active GTP-bound state.  Recently, we have reported the discovery of small-mol. allosteric activators of SOS1 that can increase the amt. of RAS-GTP in cells.  The compds. can inhibit ERK phosphorylation at higher concns. by engaging a feedback mechanism.  To further study this process, we sought different chem. matter from an NMR-based fragment screen using selective Me labeling.  To aid this process, several Ile Me groups located in different binding sites of the protein were assigned and used to categorize the NMR hits into different classes.  Hit to lead optimization using an iterative structure-based design paradigm resulted in compds. with improvements in binding affinity.  These improved mols. of a different chem. class increase SOS1cat-mediated nucleotide exchange on RAS and display cellular action consistent with our prior results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPzTCn-rMbv7Vg90H21EOLACvtfcHk0lhFYIGPVadSUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVSms7rJ&md5=e317ae691b93e62df16db2cade902a1a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00511%26sid%3Dliteratum%253Aachs%26aulast%3DSarkar%26aufirst%3DD.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DCoker%26aufirst%3DJ.%2BA.%26aulast%3DSai%26aufirst%3DJ.%26aulast%3DArnold%26aufirst%3DA.%26aulast%3DBeesetty%26aufirst%3DY.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520sulfonamide-derived%2520agonists%2520of%2520SOS1-mediated%2520nucleotide%2520exchange%2520on%2520RAS%2520using%2520fragment-based%2520methods%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D8325%26epage%3D8337%26doi%3D10.1021%2Facs.jmedchem.0c00511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winter, J. J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blades, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brassington, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breeze, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chresta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Embrey, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairley, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faulder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, M. R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettle, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spadola, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigley, G.</span></span> <span> </span><span class="NLM_article-title">Small molecule binding sites on the RAS: SOS complex can be exploited for inhibition of RAS activation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2265</span>– <span class="NLM_lpage">2274</span>, <span class="refDoi"> DOI: 10.1021/jm501660t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501660t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivF2qu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2265-2274&author=J.+J.+G.+Winterauthor=M.+Andersonauthor=K.+Bladesauthor=C.+Brassingtonauthor=A.+L.+Breezeauthor=C.+Chrestaauthor=K.+Embreyauthor=G.+Fairleyauthor=P.+Faulderauthor=M.+R.+V.+Finlayauthor=J.+G.+Kettleauthor=T.+Nowakauthor=R.+Overmanauthor=S.+J.+Patelauthor=P.+Perkinsauthor=L.+Spadolaauthor=J.+Tartauthor=J.+A.+Tuckerauthor=G.+Wrigley&title=Small+molecule+binding+sites+on+the+RAS%3A+SOS+complex+can+be+exploited+for+inhibition+of+RAS+activation&doi=10.1021%2Fjm501660t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Binding Sites on the Ras:SOS Complex Can Be Exploited for Inhibition of Ras Activation</span></div><div class="casAuthors">Winter, Jon J. G.; Anderson, Malcolm; Blades, Kevin; Brassington, Claire; Breeze, Alexander L.; Chresta, Christine; Embrey, Kevin; Fairley, Gary; Faulder, Paul; Finlay, M. Raymond V.; Kettle, Jason G.; Nowak, Thorsten; Overman, Ross; Patel, S. Joe; Perkins, Paula; Spadola, Loredana; Tart, Jonathan; Tucker, Julie A.; Wrigley, Gail</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2265-2274</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Constitutively active mutant KRas displays a reduced rate of GTP hydrolysis via both intrinsic and GTPase-activating protein-catalyzed mechanisms, resulting in the perpetual activation of Ras pathways.  We describe a fragment screening campaign using X-ray crystallog. that led to the discovery of three fragment binding sites on the Ras:SOS complex.  The identification of tool compds. binding at each of these sites allowed exploration of two new approaches to Ras pathway inhibition by stabilizing or covalently modifying the Ras:SOS complex to prevent the reloading of Ras with GTP.  Initially, we identified ligands that bound reversibly to the Ras:SOS complex in two distinct sites, but these compds. were not sufficiently potent inhibitors to validate our stabilization hypothesis.  We conclude by demonstrating that covalent modification of Cys118 on Ras leads to a novel mechanism of inhibition of the SOS-mediated interaction between Ras and Raf and is effective at inhibiting the exchange of labeled GDP in both mutant (G12C and G12V) and wild type Ras.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfpT9XplX1v7Vg90H21EOLACvtfcHk0lhFYIGPVadSUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivF2qu7w%253D&md5=b3747c8c9bb530d39c03ad56998d90f1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm501660t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501660t%26sid%3Dliteratum%253Aachs%26aulast%3DWinter%26aufirst%3DJ.%2BJ.%2BG.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DBrassington%26aufirst%3DC.%26aulast%3DBreeze%26aufirst%3DA.%2BL.%26aulast%3DChresta%26aufirst%3DC.%26aulast%3DEmbrey%26aufirst%3DK.%26aulast%3DFairley%26aufirst%3DG.%26aulast%3DFaulder%26aufirst%3DP.%26aulast%3DFinlay%26aufirst%3DM.%2BR.%2BV.%26aulast%3DKettle%26aufirst%3DJ.%2BG.%26aulast%3DNowak%26aufirst%3DT.%26aulast%3DOverman%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%2BJ.%26aulast%3DPerkins%26aufirst%3DP.%26aulast%3DSpadola%26aufirst%3DL.%26aulast%3DTart%26aufirst%3DJ.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DWrigley%26aufirst%3DG.%26atitle%3DSmall%2520molecule%2520binding%2520sites%2520on%2520the%2520RAS%253A%2520SOS%2520complex%2520can%2520be%2520exploited%2520for%2520inhibition%2520of%2520RAS%2520activation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2265%26epage%3D2274%26doi%3D10.1021%2Fjm501660t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmachl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramharter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savarese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marszalek, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnhof, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumpel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botesteanu, D.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ettmayer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerstberger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kofink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wunberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoephel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teh, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böttcher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pototschnig, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schachinger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schipany, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieb, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellano, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendes, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moll, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petronczki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffernan, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraut, N.</span></span> <span> </span><span class="NLM_article-title">BI-3406, a potent and selective SOS1–KRAS interaction inhibitor, is effective in KRAS-driven cancers through combined MEK inhibition</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">142</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-20-0142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1158%2F2159-8290.CD-20-0142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=32816843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BB3MXmvVaksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2021&pages=142-157&author=M.+H.+Hofmannauthor=M.+Gmachlauthor=J.+Ramharterauthor=F.+Savareseauthor=D.+Gerlachauthor=J.+R.+Marszalekauthor=M.+P.+Sandersonauthor=D.+Kesslerauthor=F.+Trapaniauthor=H.+Arnhofauthor=K.+Rumpelauthor=D.-A.+Botesteanuauthor=P.+Ettmayerauthor=T.+Gerstbergerauthor=C.+Kofinkauthor=T.+Wunbergauthor=A.+Zoephelauthor=S.-C.+Fuauthor=J.+L.+Tehauthor=J.+B%C3%B6ttcherauthor=N.+Pototschnigauthor=F.+Schachingerauthor=K.+Schipanyauthor=S.+Liebauthor=C.+P.+Vellanoauthor=J.+C.+O%E2%80%99Connellauthor=R.+L.+Mendesauthor=J.+Mollauthor=M.+Petronczkiauthor=T.+P.+Heffernanauthor=M.+Pearsonauthor=D.+B.+McConnellauthor=N.+Kraut&title=BI-3406%2C+a+potent+and+selective+SOS1%E2%80%93KRAS+interaction+inhibitor%2C+is+effective+in+KRAS-driven+cancers+through+combined+MEK+inhibition&doi=10.1158%2F2159-8290.CD-20-0142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">BI-3406, a potent and selective S0S1-KRAS interaction inhibitor, is effective in KRAS-driven cancers through combined MEK inhibition</span></div><div class="casAuthors">Hofmann, Marco H.; Gmachl, Michael; Ramharter, Juergen; Savarese, Fabio; Gerlach, Daniel; Marszalek, Joseph R.; Sanderson, Michael P.; Kessler, Dirk; Trapani, Francesca; Arnhof, Heribert; Rumpel, Klaus; Botesteanu, Dana-Adriana; Ettmayer, Peter; Gerstberger, Thomas; Kofink, Christiane; Wunberg, Tobias; Zoephel, Andreas; Fu, Szu-Chin; Teh, Jessica L.; Bottcher, Jark; Pototschnig, Nikolai; Schachinger, Franziska; Schipany, Katharina; Lieb, Simone; Vellano, Christopher P.; O'Connell, Jonathan C.; Mendes, Rachel L.; Moll, Jurgen; Petronczki, Mark; Heffernan, Timothy R.; Pearson, Mark; McConnell, Darryl B.; Kraut, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">142-157</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">KRAS is the most frequently mutated driver of pancreatic, colorectal, and non-small cell lung cancers.  Direct KRAS blockade has proved challenging, and inhibition of a key downstream effector pathway, the RAF-MEK-ERK cascade, has shown limited success because of activation of feedback networks that keep the pathway in check.  We hypothesized that inhibiting SOS1, a KRAS activator and important feedback node, represents an effective approach to treat KRAS-driven cancers.  We report the discovery of a highly potent, selective, and orally bioavailable small-mol. SOS1 inhibitor, BI-3406, that binds to the catalytic domain of SOS1, thereby preventing the interaction with KRAS.  BI-3406 reduces formation of GTP-loaded RAS and limits cellular proliferation of a broad range of KRAS-driven cancers.  Importantly, BI-3406 attenuates feedback reactivation induced by MEK inhibitors and thereby enhances sensitivity of KRAS-dependent cancers to MEK inhibition.  Combined SOS1 and MEK inhibition represents a novel and effective therapeutic concept to address KRAS-driven tumors.  SIGNIFICANCE: To date, there are no effective targeted pan-KRAS therapies.  In-depth characterization of BI-3406 activity and identification of MEK inhibitors as effective combination partners provide an attractive therapeutic concept for the majority of KRAS-mutant cancers, including those fueled by the most prevalent mutant KRAS oncoproteins, G12D, G12V, G12C, and G13D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpniXCOKijflrVg90H21EOLACvtfcHk0lhizNGtFchp3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXmvVaksrY%253D&md5=3585ea93f4caddfe09e30b396c286e60</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-20-0142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-20-0142%26sid%3Dliteratum%253Aachs%26aulast%3DHofmann%26aufirst%3DM.%2BH.%26aulast%3DGmachl%26aufirst%3DM.%26aulast%3DRamharter%26aufirst%3DJ.%26aulast%3DSavarese%26aufirst%3DF.%26aulast%3DGerlach%26aufirst%3DD.%26aulast%3DMarszalek%26aufirst%3DJ.%2BR.%26aulast%3DSanderson%26aufirst%3DM.%2BP.%26aulast%3DKessler%26aufirst%3DD.%26aulast%3DTrapani%26aufirst%3DF.%26aulast%3DArnhof%26aufirst%3DH.%26aulast%3DRumpel%26aufirst%3DK.%26aulast%3DBotesteanu%26aufirst%3DD.-A.%26aulast%3DEttmayer%26aufirst%3DP.%26aulast%3DGerstberger%26aufirst%3DT.%26aulast%3DKofink%26aufirst%3DC.%26aulast%3DWunberg%26aufirst%3DT.%26aulast%3DZoephel%26aufirst%3DA.%26aulast%3DFu%26aufirst%3DS.-C.%26aulast%3DTeh%26aufirst%3DJ.%2BL.%26aulast%3DB%25C3%25B6ttcher%26aufirst%3DJ.%26aulast%3DPototschnig%26aufirst%3DN.%26aulast%3DSchachinger%26aufirst%3DF.%26aulast%3DSchipany%26aufirst%3DK.%26aulast%3DLieb%26aufirst%3DS.%26aulast%3DVellano%26aufirst%3DC.%2BP.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%2BC.%26aulast%3DMendes%26aufirst%3DR.%2BL.%26aulast%3DMoll%26aufirst%3DJ.%26aulast%3DPetronczki%26aufirst%3DM.%26aulast%3DHeffernan%26aufirst%3DT.%2BP.%26aulast%3DPearson%26aufirst%3DM.%26aulast%3DMcConnell%26aufirst%3DD.%2BB.%26aulast%3DKraut%26aufirst%3DN.%26atitle%3DBI-3406%252C%2520a%2520potent%2520and%2520selective%2520SOS1%25E2%2580%2593KRAS%2520interaction%2520inhibitor%252C%2520is%2520effective%2520in%2520KRAS-driven%2520cancers%2520through%2520combined%2520MEK%2520inhibition%26jtitle%3DCancer%2520Discovery%26date%3D2021%26volume%3D11%26spage%3D142%26epage%3D157%26doi%3D10.1158%2F2159-8290.CD-20-0142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hillig, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moosmayer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmann, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werbeck, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briem, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boemer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiske, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badock, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mastouri, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemeister, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahmann, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegener, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böhnke, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wortmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Nussbaum, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, B.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS–SOS1 interaction</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">2551</span>– <span class="NLM_lpage">2560</span>, <span class="refDoi"> DOI: 10.1073/pnas.1812963116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1073%2Fpnas.1812963116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=30683722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivVajs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=2551-2560&author=R.+C.+Hilligauthor=B.+Sautierauthor=J.+Schroederauthor=D.+Moosmayerauthor=A.+Hilpmannauthor=C.+M.+Stegmannauthor=N.+D.+Werbeckauthor=H.+Briemauthor=U.+Boemerauthor=J.+Weiskeauthor=V.+Badockauthor=J.+Mastouriauthor=K.+Petersenauthor=G.+Siemeisterauthor=J.+D.+Kahmannauthor=D.+Wegenerauthor=N.+B%C3%B6hnkeauthor=K.+Eisauthor=K.+Grahamauthor=L.+Wortmannauthor=F.+von+Nussbaumauthor=B.+Bader&title=Discovery+of+potent+SOS1+inhibitors+that+block+RAS+activation+via+disruption+of+the+RAS%E2%80%93SOS1+interaction&doi=10.1073%2Fpnas.1812963116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interaction</span></div><div class="casAuthors">Hillig, Roman C.; Sautier, Brice; Schroeder, Jens; Moosmayer, Dieter; Hilpmann, AndrA; Stegmann, Christian M.; Werbeck, Nicolas D.; Briem, Hans; Boemer, Ulf; Weiske, Joerg; Badock, Volker; Mastouri, Julia; Petersen, Kirstin; Siemeister, Gerhard; Kahmann, Jan D.; Wegener, Dennis; Boehnke, Niels; Eis, Knut; Graham, Keith; Wortmann, Lars; von Nussbaum, Franz; Bader, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2551-2560</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Since the late 1980s, mutations in the RAS genes have been recognized as major oncogenes with a high occurrence rate in human cancers.  Such mutations reduce the ability of the small GTPase RAS to hydrolyze GTP, keeping this mol. switch in a constitutively active GTP-bound form that drives, unchecked, oncogenic downstream signaling.  One strategy to reduce the levels of active RAS is to target guanine nucleotide exchange factors, which allow RAS to cycle from the inactive GDP-bound state to the active GTP-bound form.  Here, we describe the identification of potent and cell-active small-mol. inhibitors which efficiently disrupt the interaction between KRAS and its exchange factor SOS1, a mode of action confirmed by a series of biophys. techniques.  The binding sites, mode of action, and selectivity were elucidated using crystal structures of KRASG12C-SOS1, SOS1, and SOS2.  By preventing formation of the KRAS-SOS1 complex, these inhibitors block reloading of KRAS with GTP, leading to antiproliferative activity.  The final compd. 23(I, BAY-293) selectively inhibits the KRAS-SOS1 interaction with an IC50 of 21 nM and is a valuable chem. probe for future investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTMAcBZFHkBrVg90H21EOLACvtfcHk0lhizNGtFchp3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivVajs7w%253D&md5=f3150723049c15986cea1d7f93cb89af</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1812963116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1812963116%26sid%3Dliteratum%253Aachs%26aulast%3DHillig%26aufirst%3DR.%2BC.%26aulast%3DSautier%26aufirst%3DB.%26aulast%3DSchroeder%26aufirst%3DJ.%26aulast%3DMoosmayer%26aufirst%3DD.%26aulast%3DHilpmann%26aufirst%3DA.%26aulast%3DStegmann%26aufirst%3DC.%2BM.%26aulast%3DWerbeck%26aufirst%3DN.%2BD.%26aulast%3DBriem%26aufirst%3DH.%26aulast%3DBoemer%26aufirst%3DU.%26aulast%3DWeiske%26aufirst%3DJ.%26aulast%3DBadock%26aufirst%3DV.%26aulast%3DMastouri%26aufirst%3DJ.%26aulast%3DPetersen%26aufirst%3DK.%26aulast%3DSiemeister%26aufirst%3DG.%26aulast%3DKahmann%26aufirst%3DJ.%2BD.%26aulast%3DWegener%26aufirst%3DD.%26aulast%3DB%25C3%25B6hnke%26aufirst%3DN.%26aulast%3DEis%26aufirst%3DK.%26aulast%3DGraham%26aufirst%3DK.%26aulast%3DWortmann%26aufirst%3DL.%26aulast%3Dvon%2BNussbaum%26aufirst%3DF.%26aulast%3DBader%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520potent%2520SOS1%2520inhibitors%2520that%2520block%2520RAS%2520activation%2520via%2520disruption%2520of%2520the%2520RAS%25E2%2580%2593SOS1%2520interaction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26spage%3D2551%26epage%3D2560%26doi%3D10.1073%2Fpnas.1812963116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gort, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dünzinger, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riemann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitzing, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janne, P. A.</span></span> <span> </span><span class="NLM_article-title">A phase I, open-label, dose-escalation trial of BI 1701963 as monotherapy and in combination with trametinib in patients with KRAS mutated advanced or metastatic solid tumors</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">TPS3651</span>, <span class="refDoi"> DOI: 10.1200/JCO.2020.38.15_suppl.TPS3651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1200%2FJCO.2020.38.15_suppl.TPS3651" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=TPS3651&author=E.+Gortauthor=M.+L.+Johnsonauthor=J.+J.+Hwangauthor=S.+Pantauthor=U.+D%C3%BCnzingerauthor=K.+Riemannauthor=T.+Kitzingauthor=P.+A.+Janne&title=A+phase+I%2C+open-label%2C+dose-escalation+trial+of+BI+1701963+as+monotherapy+and+in+combination+with+trametinib+in+patients+with+KRAS+mutated+advanced+or+metastatic+solid+tumors&doi=10.1200%2FJCO.2020.38.15_suppl.TPS3651"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1200%2FJCO.2020.38.15_suppl.TPS3651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2020.38.15_suppl.TPS3651%26sid%3Dliteratum%253Aachs%26aulast%3DGort%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DM.%2BL.%26aulast%3DHwang%26aufirst%3DJ.%2BJ.%26aulast%3DPant%26aufirst%3DS.%26aulast%3DD%25C3%25BCnzinger%26aufirst%3DU.%26aulast%3DRiemann%26aufirst%3DK.%26aulast%3DKitzing%26aufirst%3DT.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26atitle%3DA%2520phase%2520I%252C%2520open-label%252C%2520dose-escalation%2520trial%2520of%2520BI%25201701963%2520as%2520monotherapy%2520and%2520in%2520combination%2520with%2520trametinib%2520in%2520patients%2520with%2520KRAS%2520mutated%2520advanced%2520or%2520metastatic%2520solid%2520tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2020%26spage%3DTPS3651%26doi%3D10.1200%2FJCO.2020.38.15_suppl.TPS3651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vo, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajpai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flavell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobby, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breeze, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Embrey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golovanov, A. P.</span></span> <span> </span><span class="NLM_article-title">Monitoring RAS interactions with the nucleotide exchange factor Son of Sevenless (SOS) using site-specific NMR reporter signals and intrinsic fluorescence</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">1703</span>– <span class="NLM_lpage">1718</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.691238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1074%2Fjbc.M115.691238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=26565026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Oiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=1703-1718&author=U.+Voauthor=N.+Vajpaiauthor=L.+Flavellauthor=R.+Bobbyauthor=A.+L.+Breezeauthor=K.+J.+Embreyauthor=A.+P.+Golovanov&title=Monitoring+RAS+interactions+with+the+nucleotide+exchange+factor+Son+of+Sevenless+%28SOS%29+using+site-specific+NMR+reporter+signals+and+intrinsic+fluorescence&doi=10.1074%2Fjbc.M115.691238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Monitoring Ras Interactions with the Nucleotide Exchange Factor Son of Sevenless (Sos) Using Site-specific NMR Reporter Signals and Intrinsic Fluorescence</span></div><div class="casAuthors">Vo, Uybach; Vajpai, Navratna; Flavell, Liz; Bobby, Romel; Breeze, Alexander L.; Embrey, Kevin J.; Golovanov, Alexander P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1703-1718</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The activity of Ras is controlled by the interconversion between GTP- and GDP-bound forms partly regulated by the binding of the guanine nucleotide exchange factor Son of Sevenless (Sos).  The details of Sos binding, leading to nucleotide exchange and subsequent dissocn. of the complex, are not completely understood.  Here, we used uniformly 15N-labeled Ras as well as [13C]methyl-Met,Ile-labeled Sos for observing site-specific details of Ras-Sos interactions in soln.  Binding of various forms of Ras (loaded with GDP and mimics of GTP or nucleotide-free) at the allosteric and catalytic sites of Sos was comprehensively characterized by monitoring signal perturbations in the NMR spectra.  The overall affinity of binding between these protein variants as well as their selected functional mutants was also investigated using intrinsic fluorescence.  The data support a pos. feedback activation of Sos by Ras·GTP with Ras·GTP binding as a substrate for the catalytic site of activated Sos more weakly than Ras·GDP, suggesting that Sos should actively promote unidirectional GDP → GTP exchange on Ras in preference of passive homonucleotide exchange.  Ras·GDP weakly binds to the catalytic but not to the allosteric site of Sos.  This confirms that Ras·GDP cannot properly activate Sos at the allosteric site.  The novel site-specific assay described may be useful for design of drugs aimed at perturbing Ras-Sos interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC4WLlh0gWRrVg90H21EOLACvtfcHk0lgFM_8RlRJQZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Oiu7c%253D&md5=b18d6754805fed13189f663eef60d704</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.691238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.691238%26sid%3Dliteratum%253Aachs%26aulast%3DVo%26aufirst%3DU.%26aulast%3DVajpai%26aufirst%3DN.%26aulast%3DFlavell%26aufirst%3DL.%26aulast%3DBobby%26aufirst%3DR.%26aulast%3DBreeze%26aufirst%3DA.%2BL.%26aulast%3DEmbrey%26aufirst%3DK.%2BJ.%26aulast%3DGolovanov%26aufirst%3DA.%2BP.%26atitle%3DMonitoring%2520RAS%2520interactions%2520with%2520the%2520nucleotide%2520exchange%2520factor%2520Son%2520of%2520Sevenless%2520%2528SOS%2529%2520using%2520site-specific%2520NMR%2520reporter%2520signals%2520and%2520intrinsic%2520fluorescence%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D1703%26epage%3D1718%26doi%3D10.1074%2Fjbc.M115.691238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ullman, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirakossian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvin, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pease, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Switchenko, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dafforn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skold, C. N.</span></span> <span> </span><span class="NLM_article-title">Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">5426</span>– <span class="NLM_lpage">5430</span>, <span class="refDoi"> DOI: 10.1073/pnas.91.12.5426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1073%2Fpnas.91.12.5426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=8202502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADyaK2cXkslOltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=5426-5430&author=E.+F.+Ullmanauthor=H.+Kirakossianauthor=S.+Singhauthor=Z.+P.+Wuauthor=B.+R.+Irvinauthor=J.+S.+Peaseauthor=A.+C.+Switchenkoauthor=J.+D.+Irvineauthor=A.+Daffornauthor=C.+N.+Skold&title=Luminescent+oxygen+channeling+immunoassay%3A+measurement+of+particle+binding+kinetics+by+chemiluminescence&doi=10.1073%2Fpnas.91.12.5426"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence</span></div><div class="casAuthors">Ullman, Edwin F.; Kirakossian, Hrair; Singh, Sharat; Wu, Z. Ping; Irvin, Benjamin R.; Pease, John S.; Switchenko, Arthur C.; Irvine, Jennifer D.; Dafforn, Alan; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5426-30</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A method for monitoring formation of latex particle pairs by chemiluminescence is described.  Mol. oxygen is excited by a photosensitizer and an antenna dye that are dissolved in one of the particles.  1ΔgO2 diffuses to the second particle and initiates a high quantum yield chemiluminescent reaction of an olefin that is dissolved in it.  The efficiency of 1ΔgO2 transfer between particles is ≈3.5%.  The technique permits real-time measurement of particle binding kinetics.  Second-order rate consts. increase with the no. of receptor binding sites on the particles and approach diffusion control.  By using antibody-coated particles, a homogeneous immunoassay capable of detecting ≈4 amol of TSH in 12 min was demonstrated.  Single mols. of analyte produce particle heterodimers that are detected even when no larger aggregates are formed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwMnBw0EdzeLVg90H21EOLACvtfcHk0lgFM_8RlRJQZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslOltLc%253D&md5=3e4120f789cab9d35dbe7586c584fcbe</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.12.5426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.12.5426%26sid%3Dliteratum%253Aachs%26aulast%3DUllman%26aufirst%3DE.%2BF.%26aulast%3DKirakossian%26aufirst%3DH.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DZ.%2BP.%26aulast%3DIrvin%26aufirst%3DB.%2BR.%26aulast%3DPease%26aufirst%3DJ.%2BS.%26aulast%3DSwitchenko%26aufirst%3DA.%2BC.%26aulast%3DIrvine%26aufirst%3DJ.%2BD.%26aulast%3DDafforn%26aufirst%3DA.%26aulast%3DSkold%26aufirst%3DC.%2BN.%26atitle%3DLuminescent%2520oxygen%2520channeling%2520immunoassay%253A%2520measurement%2520of%2520particle%2520binding%2520kinetics%2520by%2520chemiluminescence%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D5426%26epage%3D5430%26doi%3D10.1073%2Fpnas.91.12.5426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manly, S. P.</span></span> <span> </span><span class="NLM_article-title">Use of a novel homogeneous fluorescent technology in high throughput screening</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1177/108705719600100407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1177%2F108705719600100407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADyaK2sXkslentQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1996&pages=203-210&author=J.+M.+Kolbauthor=G.+Yamanakaauthor=S.+P.+Manly&title=Use+of+a+novel+homogeneous+fluorescent+technology+in+high+throughput+screening&doi=10.1177%2F108705719600100407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Use of a novel homogeneous fluorescent technology in high throughput screening</span></div><div class="casAuthors">Kolb, Janet M.; Yamanaka, Gregory; Manly, Susan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">203-210</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Liebert</span>)
        </div><div class="casAbstract">A new fluorescent technol. called homogeneous time-resolved fluorescence (HTRF) is sensitive, homogeneous, and quite tolerant to extremes in reaction conditions.  These characteristics make this technique an attractive candidate for use in high throughput screens.  The assay system uses a pair of fluorescent compds. to label biomols.  The long-lived nature of the fluorescence of one of them, europium cryptate, facilitates the homogeneous nature of the assay.  Furthermore, the introduction of a time delay in reading the signal eliminates the principal difficulty in applying fluorescence to screening formats, that of endogenous fluorescence of samples tested (esp. natural products).  This technique is robust and sensitive, and we report here its utility in a high throughput screening format.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR0vwlq8y4nrVg90H21EOLACvtfcHk0li3zlARHxuErg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkslentQ%253D%253D&md5=a5987378faf61c2baebfb2d9fd3d58be</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1177%2F108705719600100407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705719600100407%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DJ.%2BM.%26aulast%3DYamanaka%26aufirst%3DG.%26aulast%3DManly%26aufirst%3DS.%2BP.%26atitle%3DUse%2520of%2520a%2520novel%2520homogeneous%2520fluorescent%2520technology%2520in%2520high%2520throughput%2520screening%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D1996%26volume%3D1%26spage%3D203%26epage%3D210%26doi%3D10.1177%2F108705719600100407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruns, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, I. A.</span></span> <span> </span><span class="NLM_article-title">Rules for identifying potentially reactive or promiscuous compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9763</span>– <span class="NLM_lpage">9772</span>, <span class="refDoi"> DOI: 10.1021/jm301008n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301008n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFSgs7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9763-9772&author=R.+F.+Brunsauthor=I.+A.+Watson&title=Rules+for+identifying+potentially+reactive+or+promiscuous+compounds&doi=10.1021%2Fjm301008n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Rules for Identifying Potentially Reactive or Promiscuous Compounds</span></div><div class="casAuthors">Bruns, Robert F.; Watson, Ian A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9763-9772</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This article describes a set of 275 rules, developed over an 18-yr period, used to identify compds. that may interfere with biol. assays, allowing their removal from screening sets.  Reasons for rejection include reactivity (e.g., acyl halides), interference with assay measurements (fluorescence, absorbance, quenching), activities that damage proteins (oxidizers, detergents), instability (e.g., latent aldehydes), and lack of druggability (e.g., compds. lacking both oxygen and nitrogen).  The structural queries were profiled for frequency of occurrence in druglike and nondruglike compd. sets and were extensively reviewed by a panel of experienced medicinal chemists.  As a means of profiling the rules and as a filter in its own right, an index of biol. promiscuity was developed.  The 584 gene targets with screening data at Lilly were assigned to 17 subfamilies, and the no. of subfamilies at which a compd. was active was used as a promiscuity index.  For certain compds., promiscuous activity disappeared after sample repurifn., indicating interference from occult contaminants.  Because this type of interference is not amenable to substructure search, a "nuisance list" was developed to flag interfering compds. that passed the substructure rules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNvXr0QeH2l7Vg90H21EOLACvtfcHk0li3zlARHxuErg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFSgs7bP&md5=3c37f5513b3859e0180686e99d83d30c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm301008n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301008n%26sid%3Dliteratum%253Aachs%26aulast%3DBruns%26aufirst%3DR.%2BF.%26aulast%3DWatson%26aufirst%3DI.%2BA.%26atitle%3DRules%2520for%2520identifying%2520potentially%2520reactive%2520or%2520promiscuous%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9763%26epage%3D9772%26doi%3D10.1021%2Fjm301008n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoephel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraemer, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himmelsbach, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haaksma, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adolf, G. R.</span></span> <span> </span><span class="NLM_article-title">Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blocker</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>343</i></span>,  <span class="NLM_fpage">342</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1124/jpet.112.197756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1124%2Fjpet.112.197756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=22888144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKktbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2012&pages=342-350&author=F.+Solcaauthor=G.+Dahlauthor=A.+Zoephelauthor=G.+Baderauthor=M.+Sandersonauthor=C.+Kleinauthor=O.+Kraemerauthor=F.+Himmelsbachauthor=E.+Haaksmaauthor=G.+R.+Adolf&title=Target+binding+properties+and+cellular+activity+of+afatinib+%28BIBW+2992%29%2C+an+irreversible+ErbB+family+blocker&doi=10.1124%2Fjpet.112.197756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blocker</span></div><div class="casAuthors">Solca, Flavio; Dahl, Goeran; Zoephel, Andreas; Bader, Gerd; Sanderson, Michael; Klein, Christian; Kraemer, Oliver; Himmelsbach, Frank; Haaksma, Eric; Adolf, Guenther R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">342-350</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Deregulation of the ErbB (proto-oncogene B of the avian erythroblastosis virus AEV-H strain) receptor network is well recognized as an oncogenic driver in epithelial cancers.  Several targeted drugs have been developed, including antibodies and small-mol. kinase inhibitors, each of them characterized by distinct patterns of ErbB receptor interactions.  Understanding the precise pharmacol. properties of these compds. is important for optimal use in clin. practice.  Afatinib [BIBW 2992; N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide] is an ATP-competitive anilinoquinazoline deriv. harboring a reactive acrylamide group.  It was designed to covalently bind and irreversibly block enzymically active ErbB receptor family members.  Here, we show by X-ray crystallog. the covalent binding of afatinib to wild-type epidermal growth factor receptor (EGFR) and by mass spectrometry the covalent interaction with EGFR, EGFRL858R/T790M, human epidermal growth factor receptor 2 (HER2), and ErbB-4.  Afatinib potently inhibits the enzymatic activity of ErbB-4 (EC50 = 1 nM) and the proliferation of cancer cell lines driven by multiple ErbB receptor aberrations at concns. below 100 nM.  N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butanamide (BI 37781), a close analog of afatinib lacking the acrylamide group and thus incapable of covalent bond formation, had similar potency on cells driven by EGFR or EGFRL858R, but less or no detectable activity on cells expressing EGFRL858R/T790M HER2 or ErbB-4.  These results stress the importance of the acrylamide group and show that afatinib differs from approved ErbB targeting agents by irreversibly inhibiting the kinase activity of all ErbB family members.  They provide a mechanistic rationale for the distinct pharmacol. features of this compd. and explain the clin. activity seen in some patients who are resistant to antibody or kinase inhibitor therapy because of secondary mutations or ErbB receptor "reprogramming.".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofXgQqaKXv-bVg90H21EOLACvtfcHk0li3zlARHxuErg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKktbzE&md5=4a57df32abe8101f287fc6251f63f92d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.197756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.197756%26sid%3Dliteratum%253Aachs%26aulast%3DSolca%26aufirst%3DF.%26aulast%3DDahl%26aufirst%3DG.%26aulast%3DZoephel%26aufirst%3DA.%26aulast%3DBader%26aufirst%3DG.%26aulast%3DSanderson%26aufirst%3DM.%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DKraemer%26aufirst%3DO.%26aulast%3DHimmelsbach%26aufirst%3DF.%26aulast%3DHaaksma%26aufirst%3DE.%26aulast%3DAdolf%26aufirst%3DG.%2BR.%26atitle%3DTarget%2520binding%2520properties%2520and%2520cellular%2520activity%2520of%2520afatinib%2520%2528BIBW%25202992%2529%252C%2520an%2520irreversible%2520ErbB%2520family%2520blocker%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D343%26spage%3D342%26epage%3D350%26doi%3D10.1124%2Fjpet.112.197756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krissinel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrick, K.</span></span> <span> </span><span class="NLM_article-title">Inference of macromolecular assemblies from crystalline state</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>372</i></span>,  <span class="NLM_fpage">774</span>– <span class="NLM_lpage">797</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2007.05.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1016%2Fj.jmb.2007.05.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=17681537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvFGktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2007&pages=774-797&author=E.+Krissinelauthor=K.+Henrick&title=Inference+of+macromolecular+assemblies+from+crystalline+state&doi=10.1016%2Fj.jmb.2007.05.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Inference of Macromolecular Assemblies from Crystalline State</span></div><div class="casAuthors">Krissinel, Evgeny; Henrick, Kim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">774-797</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The authors discuss basic phys.-chem. principles underlying the formation of stable macromol. complexes, which in many cases are likely to be the biol. units performing a certain physiol. function.  The authors also consider available theor. approaches to the calcn. of macromol. affinity and entropy of complexation.  The latter is shown to play an important role and make a major effect on complex size and symmetry.  The authors develop a new method, based on chem. thermodn., for automatic detection of macromol. assemblies in the Protein Data Bank (PDB) entries that are the results of x-ray diffraction expts.  As found, biol. units may be recovered at 80-90% success rate, which makes x-ray crystallog. an important source of exptl. data on macromol. complexes and protein-protein interactions.  The method is implemented as a public WWW service (http://www.ebi.ac.uk/msd-srv/prot_int/pistart.html).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3cilBvVoBS7Vg90H21EOLACvtfcHk0lilSrDoYYHp6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvFGktb8%253D&md5=a5c764cfc7dc129f53ddc31ef9d475fa</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2007.05.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2007.05.022%26sid%3Dliteratum%253Aachs%26aulast%3DKrissinel%26aufirst%3DE.%26aulast%3DHenrick%26aufirst%3DK.%26atitle%3DInference%2520of%2520macromolecular%2520assemblies%2520from%2520crystalline%2520state%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2007%26volume%3D372%26spage%3D774%26epage%3D797%26doi%3D10.1016%2Fj.jmb.2007.05.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lake, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corrêa, S. A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, J.</span></span> <span> </span><span class="NLM_article-title">Negative feedback regulation of the ERK1/2 MAPK pathway</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">4397</span>– <span class="NLM_lpage">4413</span>, <span class="refDoi"> DOI: 10.1007/s00018-016-2297-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1007%2Fs00018-016-2297-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=27342992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKnsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2016&pages=4397-4413&author=D.+Lakeauthor=S.+A.+L.+Corr%C3%AAaauthor=J.+M%C3%BCller&title=Negative+feedback+regulation+of+the+ERK1%2F2+MAPK+pathway&doi=10.1007%2Fs00018-016-2297-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Negative feedback regulation of the ERK1/2 MAPK pathway</span></div><div class="casAuthors">Lake, David; Correa, Sonia A. L.; Muller, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4397-4413</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">The extracellular signal-regulated kinase 1/2 (ERK1/2) mitogen-activated protein kinase (MAPK) signalling pathway regulates many cellular functions, including proliferation, differentiation, and transformation.  To reliably convert external stimuli into specific cellular responses and to adapt to environmental circumstances, the pathway must be integrated into the overall signalling activity of the cell.  Multiple mechanisms have evolved to perform this role.  In this review, we will focus on neg. feedback mechanisms and examine how they shape ERK1/2 MAPK signalling.  We will first discuss the extensive no. of neg. feedback loops targeting the different components of the ERK1/2 MAPK cascade, specifically the direct posttranslational modification of pathway components by downstream protein kinases and the induction of de novo gene synthesis of specific pathway inhibitors.  We will then evaluate how neg. feedback modulates the spatiotemporal signaling dynamics of the ERK1/2 pathway regarding signalling amplitude and duration as well as subcellular localization.  Aberrant ERK1/2 activation results in deregulated proliferation and malignant transformation in model systems and is commonly obsd. in human tumors.  Inhibition of the ERK1/2 pathway thus represents an attractive target for the treatment of malignant tumors with increased ERK1/2 activity.  We will, therefore, discuss the effect of ERK1/2 MAPK feedback regulation on cancer treatment and how it contributes to reduced clin. efficacy of therapeutic agents and the development of drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp87DxI-wQqDbVg90H21EOLACvtfcHk0lilSrDoYYHp6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKnsLrE&md5=d86b8f7d4e26d4421e65430ddd8a9cac</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs00018-016-2297-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-016-2297-8%26sid%3Dliteratum%253Aachs%26aulast%3DLake%26aufirst%3DD.%26aulast%3DCorr%25C3%25AAa%26aufirst%3DS.%2BA.%2BL.%26aulast%3DM%25C3%25BCller%26aufirst%3DJ.%26atitle%3DNegative%2520feedback%2520regulation%2520of%2520the%2520ERK1%252F2%2520MAPK%2520pathway%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2016%26volume%3D73%26spage%3D4397%26epage%3D4413%26doi%3D10.1007%2Fs00018-016-2297-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Misale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatherree, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timonina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Caraballo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nangia, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greninger, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClanaghan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murchie, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janes, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hata, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benes, C. H.</span></span> <span> </span><span class="NLM_article-title">KRAS G12C NSCLC models are sensitive to direct targeting of KRAS in combination with PI3K inhibition</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">796</span>– <span class="NLM_lpage">807</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-18-0368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1158%2F1078-0432.CCR-18-0368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=30327306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1KqsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=796-807&author=S.+Misaleauthor=J.+P.+Fatherreeauthor=E.+Cortezauthor=C.+Liauthor=S.+Biltonauthor=D.+Timoninaauthor=D.+T.+Myersauthor=D.+Leeauthor=M.+Gomez-Caraballoauthor=M.+Greenbergauthor=V.+Nangiaauthor=P.+Greningerauthor=R.+K.+Eganauthor=J.+McClanaghanauthor=G.+T.+Steinauthor=E.+Murchieauthor=P.+P.+Zarrinkarauthor=M.+R.+Janesauthor=L.-S.+Liauthor=Y.+Liuauthor=A.+N.+Hataauthor=C.+H.+Benes&title=KRAS+G12C+NSCLC+models+are+sensitive+to+direct+targeting+of+KRAS+in+combination+with+PI3K+inhibition&doi=10.1158%2F1078-0432.CCR-18-0368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">KRAS G12C NSCLC models are sensitive to direct targeting of KRAS in combination with PI3K inhibition</span></div><div class="casAuthors">Misale, Sandra; Fatherree, Jackson P.; Cortez, Eliane; Li, Chendi; Bilton, Samantha; Timonina, Daria; Myers, David T.; Lee, Dana; Gomez-Caraballo, Maria; Greenberg, Max; Nangia, Varuna; Greninger, Patricia; Egan, Regina K.; McClanaghan, Joseph; Stein, Giovanna T.; Murchie, Ellen; Zarrinkar, Patrick P.; Janes, Matthew R.; Li, Lian-Sheng; Liu, Yi; Hata, Aaron N.; Benes, Cyril H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">796-807</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: KRAS-mutant lung cancers have been recalcitrant to treatments including those targeting the MAPK pathway.  Covalent inhibitors of KRAS p.G12C allele allow for direct and specific inhibition of mutant KRAS in cancer cells.  However, as for other targeted therapies, the therapeutic potential of these inhibitors can be impaired by intrinsic resistance mechanisms.  Therefore, combination strategies are likely needed to improve efficacy.  Exptl. Design: To identify strategies to maximally leverage direct KRAS inhibition we defined the response of a panel of NSCLC models bearing the KRAS G12C-activating mutation in vitro and in vivo.  We used a second-generation KRAS G12C inhibitor, ARS1620 with improved bioavailability over the first generation.  We analyzed KRAS downstream effectors signaling to identify mechanisms underlying differential response.  To identify candidate combination strategies, we performed a high-throughput drug screening across 112 drugs in combination with ARS1620.  We validated the top hits in vitro and in vivo including patient-derived xenograft models.  Results: Response to direct KRAS G12C inhibition was heterogeneous across models.  Adaptive resistance mechanisms involving reactivation of MAPK pathway and failure to induce PI3K-AKT pathway inactivation were identified as likely resistance events.  We identified several model-specific effective combinations as well as a broad-sensitizing effect of PI3K-AKT-mTOR pathway inhibitors.  The G12Ci + PI3Ki combination was effective in vitro and in vivo on models resistant to single-agent ARS1620 including patient-derived xenografts models.  Conclusions: Our findings suggest that signaling adaptation can in some instances limit the efficacy of ARS1620 but combination with PI3K inhibitors can overcome this resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ9CSuz3bIGrVg90H21EOLACvtfcHk0lilSrDoYYHp6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1KqsLrL&md5=85f20279b886aadf5e1ece9806b58774</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-18-0368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-18-0368%26sid%3Dliteratum%253Aachs%26aulast%3DMisale%26aufirst%3DS.%26aulast%3DFatherree%26aufirst%3DJ.%2BP.%26aulast%3DCortez%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DBilton%26aufirst%3DS.%26aulast%3DTimonina%26aufirst%3DD.%26aulast%3DMyers%26aufirst%3DD.%2BT.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DGomez-Caraballo%26aufirst%3DM.%26aulast%3DGreenberg%26aufirst%3DM.%26aulast%3DNangia%26aufirst%3DV.%26aulast%3DGreninger%26aufirst%3DP.%26aulast%3DEgan%26aufirst%3DR.%2BK.%26aulast%3DMcClanaghan%26aufirst%3DJ.%26aulast%3DStein%26aufirst%3DG.%2BT.%26aulast%3DMurchie%26aufirst%3DE.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DJanes%26aufirst%3DM.%2BR.%26aulast%3DLi%26aufirst%3DL.-S.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHata%26aufirst%3DA.%2BN.%26aulast%3DBenes%26aufirst%3DC.%2BH.%26atitle%3DKRAS%2520G12C%2520NSCLC%2520models%2520are%2520sensitive%2520to%2520direct%2520targeting%2520of%2520KRAS%2520in%2520combination%2520with%2520PI3K%2520inhibition%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2019%26volume%3D25%26spage%3D796%26epage%3D807%26doi%3D10.1158%2F1078-0432.CCR-18-0368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Theard, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheffels, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sealover, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linke, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratico, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortum, R. L.</span></span> <span> </span><span class="NLM_article-title">Marked synergy by vertical inhibition of EGFR signaling in NSCLC spheroids shows SOS1 is a therapeutic target in EGFR-mutated cancer</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e58204</span> <span class="refDoi"> DOI: 10.7554/eLife.58204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.7554%2FeLife.58204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=32897190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisVegtL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2020&author=P.+L.+Theardauthor=E.+Sheffelsauthor=N.+E.+Sealoverauthor=A.+J.+Linkeauthor=D.+J.+Praticoauthor=R.+L.+Kortum&title=Marked+synergy+by+vertical+inhibition+of+EGFR+signaling+in+NSCLC+spheroids+shows+SOS1+is+a+therapeutic+target+in+EGFR-mutated+cancer&doi=10.7554%2FeLife.58204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Marked synergy by vertical inhibition of EGFR signaling in NSCLC spheroids shows SOS1 is a therapeutic target in EGFR-mutated cancer</span></div><div class="casAuthors">Theard, Patricia L.; Sheffels, Erin; Sealover, Nancy E.; Linke, Amanda J.; Pratico, David J.; Kortum, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e58204</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">Drug treatment of 3D cancer spheroids more accurately reflects in vivo therapeutic responses compared to adherent culture studies.  In EGFR-mutated lung adenocarcinoma, EGFR-TKIs show enhanced efficacy in spheroid cultures.  Simultaneous inhibition of multiple parallel RTKs further enhances EGFR-TKI effectiveness.  We show that the common RTK signaling intermediate SOS1 was required for 3D spheroid growth of EGFR-mutated NSCLC cells.  Using two distinct measures of pharmacol. synergy, we demonstrated that SOS1 inhibition strongly synergized with EGFR-TKI treatment only in 3D spheroid cultures.  Combined EGFR- and SOS1-inhibition markedly inhibited Raf/MEK/ERK and PI3K/AKT signaling.  Finally, broad assessment of the pharmacol. landscape of drug-drug interactions downstream of mutated EGFR revealed synergy when combining an EGFR-TKI with inhibitors of proximal signaling intermediates SOS1 and SHP2, but not inhibitors of downstream RAS effector pathways.  These data indicate that vertical inhibition of proximal EGFR signaling should be pursued as a potential therapy to treat EGFR-mutated tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa-zJDCCKbEbVg90H21EOLACvtfcHk0ljvHO-OVeeQYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisVegtL3E&md5=e0caec93215766d8dd633b45cd3b5997</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.7554%2FeLife.58204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.58204%26sid%3Dliteratum%253Aachs%26aulast%3DTheard%26aufirst%3DP.%2BL.%26aulast%3DSheffels%26aufirst%3DE.%26aulast%3DSealover%26aufirst%3DN.%2BE.%26aulast%3DLinke%26aufirst%3DA.%2BJ.%26aulast%3DPratico%26aufirst%3DD.%2BJ.%26aulast%3DKortum%26aufirst%3DR.%2BL.%26atitle%3DMarked%2520synergy%2520by%2520vertical%2520inhibition%2520of%2520EGFR%2520signaling%2520in%2520NSCLC%2520spheroids%2520shows%2520SOS1%2520is%2520a%2520therapeutic%2520target%2520in%2520EGFR-mutated%2520cancer%26jtitle%3DeLife%26date%3D2020%26volume%3D9%26doi%3D10.7554%2FeLife.58204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Landrieu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanoulle, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonachera, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibille, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieruszeski, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuagniaux, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippens, G.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the non-immunosuppressive character of the cyclosporin A analogue Debio 025</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4679</span>– <span class="NLM_lpage">4686</span>, <span class="refDoi"> DOI: 10.1021/bi1003266</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi1003266" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFyksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=4679-4686&author=I.+Landrieuauthor=X.+Hanoulleauthor=F.+Bonacheraauthor=A.+Hamelauthor=N.+Sibilleauthor=Y.+Yinauthor=J.-M.+Wieruszeskiauthor=D.+Horvathauthor=Q.+Weiauthor=G.+Vuagniauxauthor=G.+Lippens&title=Structural+basis+for+the+non-immunosuppressive+character+of+the+cyclosporin+A+analogue+Debio+025&doi=10.1021%2Fbi1003266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Non-Immunosuppressive Character of the Cyclosporin A Analogue Debio 025</span></div><div class="casAuthors">Landrieu, Isabelle; Hanoulle, Xavier; Bonachera, Fanny; Hamel, Arnaud; Sibille, Nathalie; Yin, Yanxia; Wieruszeski, Jean-Michel; Horvath, Dragos; Wei, Qun; Vuagniaux, Gregoire; Lippens, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4679-4686</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Debio 025 is a cyclosporin A (CsA) analog that interferes strongly with the hepatitis C viral life cycle.  Compared to CsA, Debio 025 has an addnl. Me group at position 3 of the cyclic undecapeptide and an N-ethylvaline instead of an N-methylleucine at position 4.  Unlike CsA, Debio 025 lacks immunosuppressive activity in vitro and in vivo.  We show here that, in vitro, the cyclophilin A (CypA)-Debio 025 complex cannot interact any longer with calcineurin (CaN), a determinant for the immunosuppressive activity of CsA.  We further use NMR spectroscopy to investigate at the mol. level the interaction of Debio 025 with CypA and thereby understand the basis for this loss of CaN interaction.  NMR data and mol. modeling indicate that Debio 025 optimally interacts with CypA, which underlies the anti-HCV properties of Debio 025.  However, the interaction between CaN and the CypA-Debio 025 complex is impeded by sterical hindrance of the CaN with the side chain of its Val4 residue.  This is in sharp contrast with the case for the CypA-CsA-CaN ternary complex, where the Leu4 side chain can enter a hydrophobic cavity at the CaN interface.  The structure of the CypA-Debio 025 complex thus provides a rational explanation for the non-immunosuppressive character of Debio 025.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaOhf7S4IKWLVg90H21EOLACvtfcHk0ljvHO-OVeeQYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFyksLg%253D&md5=755e75e9bed9f6497ffd656380abe96c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fbi1003266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi1003266%26sid%3Dliteratum%253Aachs%26aulast%3DLandrieu%26aufirst%3DI.%26aulast%3DHanoulle%26aufirst%3DX.%26aulast%3DBonachera%26aufirst%3DF.%26aulast%3DHamel%26aufirst%3DA.%26aulast%3DSibille%26aufirst%3DN.%26aulast%3DYin%26aufirst%3DY.%26aulast%3DWieruszeski%26aufirst%3DJ.-M.%26aulast%3DHorvath%26aufirst%3DD.%26aulast%3DWei%26aufirst%3DQ.%26aulast%3DVuagniaux%26aufirst%3DG.%26aulast%3DLippens%26aufirst%3DG.%26atitle%3DStructural%2520basis%2520for%2520the%2520non-immunosuppressive%2520character%2520of%2520the%2520cyclosporin%2520A%2520analogue%2520Debio%2520025%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D4679%26epage%3D4686%26doi%3D10.1021%2Fbi1003266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 3 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Erin Sheffels, <span class="NLM_string-name hlFld-ContribAuthor">Robert L. Kortum</span>. </span><span class="cited-content_cbyCitation_article-title">Breaking Oncogene Addiction: Getting RTK/RAS-Mutated Cancers off the SOS. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6566-6568. <a href="https://doi.org/10.1021/acs.jmedchem.1c00698" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00698</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00698%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBreaking%252BOncogene%252BAddiction%25253A%252BGetting%252BRTK%25252FRAS-Mutated%252BCancers%252Boff%252Bthe%252BSOS%26aulast%3DSheffels%26aufirst%3DErin%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D16042021%26date%3D07052021%26volume%3D64%26issue%3D10%26spage%3D6566%26epage%3D6568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dirk  Kessler</span>, <span class="hlFld-ContribAuthor ">Daniel  Gerlach</span>, <span class="hlFld-ContribAuthor ">Norbert  Kraut</span>, <span class="hlFld-ContribAuthor ">Darryl B.  McConnell</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Son of Sevenless 1: The pacemaker of KRAS. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2021,</strong> <em>62 </em>, 109-118. <a href="https://doi.org/10.1016/j.cbpa.2021.02.014" title="DOI URL">https://doi.org/10.1016/j.cbpa.2021.02.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2021.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2021.02.014%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DTargeting%252BSon%252Bof%252BSevenless%252B1%25253A%252BThe%252Bpacemaker%252Bof%252BKRAS%26aulast%3DKessler%26aufirst%3DDirk%26date%3D2021%26volume%3D62%26spage%3D109%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erin  Sheffels</span>, <span class="hlFld-ContribAuthor ">Robert L.  Kortum</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Wild-Type RAS in Oncogenic RAS Transformation. </span><span class="cited-content_cbyCitation_journal-name">Genes</span><span> <strong>2021,</strong> <em>12 </em>
                                    (5)
                                     , 662. <a href="https://doi.org/10.3390/genes12050662" title="DOI URL">https://doi.org/10.3390/genes12050662</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/genes12050662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fgenes12050662%26sid%3Dliteratum%253Aachs%26jtitle%3DGenes%26atitle%3DThe%252BRole%252Bof%252BWild-Type%252BRAS%252Bin%252BOncogenic%252BRAS%252BTransformation%26aulast%3DSheffels%26aufirst%3DErin%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D5%26spage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01949&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. SOS1/2-mediated nucleotide exchange of KRAS. Binding of inactive KRAS (GDP-bound) to the catalytic site of SOS1/2 catalyzes the exchange of GDP for GTP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01949&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SOS1::KRAS Hit Finding Campaign: Orthogonal assays significantly reduced the number of hits for SPR and X-ray.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01949&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Overlay of screening hit <b>1</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6SFR">6SFR</a>) with activator <b>3</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NMY">4NMY</a>) demonstrating binding to the same pocket. Helix α2 of RAS (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NYM">4NYM</a>)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> with the interacting amino acid R73 is depicted in yellow. RAS R73 and SOS Y884 interact in the activator-bound form (orange) in the ternary RAS-SOS1-RAS complex similar to apo RAS-SOS1-RAS, whereas in the inhibitor-bound structure (gray), Y884 moves toward the inhibitor, thereby preventing the Y884–R73 interaction. (B) AlphaScreen titration curves of inhibiting screening hit <b>1</b> (gray) and activating compound <b>3</b> (orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01949&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>1</b> docked into the EGFR crystal structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G5J">4G5J</a>) showing off-target kinase binding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01949&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Close-up of the SOS1 catalytic site with <b>2</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVI">7AVI</a>). (B) Overlay of compounds <b>2</b> and <b>4</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVI">7AVI</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVL">7AVL</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01949&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Close-ups of the SOS1 binding pocket with (A) compound <b>6</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVS">7AVS</a>) and (B) compound <b>7</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVT">7AVT</a>) with all important amino acids in close proximity. (C) Overlay of compounds <b>6</b> and <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01949&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Comparison of the displacement of tagged SOS1 wt (purple) and SOS1 Y884A (green) by its native untagged SOS1 analog. IC<sub>50</sub>(SOS1 wt) = 4.25 μM; IC<sub>50</sub>(SOS1 Y884A) = 0.13 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01949&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Close-up of the SOS1 binding pocket with (A) compound <b>9</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVV">7AVV</a>) and (B) overlay of compounds <b>8</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVU">7AVU</a>) and <b>9</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVV">7AVV</a>) highlighting the CH−π interaction of the methoxy substituent to the center of the aromatic Tyr with a distance of 2.9 Å. The small shift of compound <b>8</b> relative to compound <b>9</b> allows for optimal orientation of the methoxy substituent toward Y884.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01949&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/medium/jm0c01949_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Combined SOS1 and EGFR inhibition leads to stronger antitumor efficacy in KRAS-mutant tumors. (A) Cleaved PARP was analyzed 24 and 48 h following treatment with control, 0.1 nM trametinib, 100 nM afatinib, or the combination with <b>BI-3406</b> (<i>n</i> = 2, means ± s.d.). (B) Antitumor effect of <b>BI-3406</b> (37% TGI), afatinib (7% TGI), or the combination (78% TGI) in the DLD-1 xenograft model after <b>BI-3406</b> treatment (50 mg/kg, bid; <i>n</i> = 7 animals per group; violin dot plot; mean; second quartile; *<i>P</i> ≤ 0.05, one-tailed <i>t</i> test). (C) Proposed model of the effects of combined afatinib and SOS1 inhibition. Dual inhibition of the pathway results in a cytoreductive effect resulting in enhanced apoptosis, which results in stronger antitumor efficacy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01949&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53251" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53251" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 45 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wernersson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slodkowicz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapacki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stærfeldt, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lage, K.</span></span> <span> </span><span class="NLM_article-title">A scored human protein–protein interaction network to catalyze genomic interpretation</span>. <i>Nat. Methods</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">61</span>, <span class="refDoi"> DOI: 10.1038/nmeth.4083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1038%2Fnmeth.4083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=27892958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFShtrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=61&author=T.+Liauthor=R.+Wernerssonauthor=R.+B.+Hansenauthor=H.+Hornauthor=J.+Mercerauthor=G.+Slodkowiczauthor=C.+T.+Workmanauthor=O.+Riginaauthor=K.+Rapackiauthor=H.+H.+St%C3%A6rfeldtauthor=S.+Brunakauthor=T.+S.+Jensenauthor=K.+Lage&title=A+scored+human+protein%E2%80%93protein+interaction+network+to+catalyze+genomic+interpretation&doi=10.1038%2Fnmeth.4083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">A scored human protein-protein interaction network to catalyze genomic interpretation</span></div><div class="casAuthors">Li, Taibo; Wernersson, Rasmus; Hansen, Rasmus B.; Horn, Heiko; Mercer, Johnathan; Slodkowicz, Greg; Workman, Christopher T.; Rigina, Olga; Rapacki, Kristoffer; Staerfeldt, Hans H.; Brunak, Soeren; Jensen, Thomas S.; Lage, Kasper</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-64</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Genome-scale human protein-protein interaction networks are crit. to understanding cell biol. and interpreting genomic data, but challenging to produce exptl.  Through data integration and quality control, we provide a scored human protein-protein interaction network (InWeb_InBioMap, or InWeb_IM) with severalfold more interactions (>500,000) and better functional biol. relevance than comparable resources.  We illustrate that InWeb_InBioMap enables functional interpretation of >4,700 cancer genomes and genes involved in autism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpld1mzwEuUvbVg90H21EOLACvtfcHk0ljsgrBd59gJrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFShtrbN&md5=0c5efd419cfae7663c02c080c4ddfa02</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.4083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.4083%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DT.%26aulast%3DWernersson%26aufirst%3DR.%26aulast%3DHansen%26aufirst%3DR.%2BB.%26aulast%3DHorn%26aufirst%3DH.%26aulast%3DMercer%26aufirst%3DJ.%26aulast%3DSlodkowicz%26aufirst%3DG.%26aulast%3DWorkman%26aufirst%3DC.%2BT.%26aulast%3DRigina%26aufirst%3DO.%26aulast%3DRapacki%26aufirst%3DK.%26aulast%3DSt%25C3%25A6rfeldt%26aufirst%3DH.%2BH.%26aulast%3DBrunak%26aufirst%3DS.%26aulast%3DJensen%26aufirst%3DT.%2BS.%26aulast%3DLage%26aufirst%3DK.%26atitle%3DA%2520scored%2520human%2520protein%25E2%2580%2593protein%2520interaction%2520network%2520to%2520catalyze%2520genomic%2520interpretation%26jtitle%3DNat.%2520Methods%26date%3D2017%26volume%3D14%26spage%3D61%26doi%3D10.1038%2Fnmeth.4083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, J. M.</span></span> <span> </span><span class="NLM_article-title">Principles of protein-protein interactions</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.1.13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1073%2Fpnas.93.1.13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=8552589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADyaK28XjslOrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=13-20&author=S.+Jonesauthor=J.+M.+Thornton&title=Principles+of+protein-protein+interactions&doi=10.1073%2Fpnas.93.1.13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Principles of protein-protein interactions</span></div><div class="casAuthors">Jones, Susan; Thornton, Janet M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-20</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review, with 47 refs., examg. protein complexes in the Brookhaven Protein Databank to gain a better understanding of the principles governing the interactions involved in protein-protein recognition.  The factors that influence the formation of protein-protein complexes are explored in four different types of protein-protein complexes: homodimeric proteins, heterodimeric proteins, enzyme-inhibitor complexes, and antibody-protein complexes.  The comparison between the complexes highlights differences that reflect their biol. roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr13RlSj8fKFLVg90H21EOLACvtfcHk0ljt0LoxX8Ubrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjslOrsQ%253D%253D&md5=2b03d8f835104e5a7bf5da83afd4a8d1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.1.13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.1.13%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DS.%26aulast%3DThornton%26aufirst%3DJ.%2BM.%26atitle%3DPrinciples%2520of%2520protein-protein%2520interactions%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D13%26epage%3D20%26doi%3D10.1073%2Fpnas.93.1.13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nooren, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, J. M.</span></span> <span> </span><span class="NLM_article-title">Diversity of protein–protein interactions</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3486</span>– <span class="NLM_lpage">3492</span>, <span class="refDoi"> DOI: 10.1093/emboj/cdg359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1093%2Femboj%2Fcdg359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=12853464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlsl2lu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=3486-3492&author=I.+M.+Noorenauthor=J.+M.+Thornton&title=Diversity+of+protein%E2%80%93protein+interactions&doi=10.1093%2Femboj%2Fcdg359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Diversity of protein-protein interactions</span></div><div class="casAuthors">Nooren, Irene M. A.; Thornton, Janet M.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3486-3492</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  The structural and functional diversity of protein-protein interactions (PPIs) is discussed, based primarily on protein families for which 3-dimensional structural data are available.  PPIs play diverse roles in biol. and differ based on the compn., affinity and whether the assocn. is permanent or transient.  In vivo, the protomer localization, concn., and local environment can affect the interaction between protomers and are vital to control the compn. and oligomeric state of protein complexes.  Since a change in quaternary state is often coupled with biol. function or activity, transient PPIs are important biol. regulators.  Structural characteristics of different types of PPIs are discussed and related to their physiol. function, specificity, and evolution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPqeAimeGxIbVg90H21EOLACvtfcHk0ljt0LoxX8Ubrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlsl2lu7k%253D&md5=139bedaea418702fe5285ca580d14c5f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Femboj%2Fcdg359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252Fcdg359%26sid%3Dliteratum%253Aachs%26aulast%3DNooren%26aufirst%3DI.%2BM.%26aulast%3DThornton%26aufirst%3DJ.%2BM.%26atitle%3DDiversity%2520of%2520protein%25E2%2580%2593protein%2520interactions%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26spage%3D3486%26epage%3D3492%26doi%3D10.1093%2Femboj%2Fcdg359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors of protein–protein interactions: progressing towards the dream</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1038/nrd1343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1038%2Fnrd1343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=15060526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1GktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=301-317&author=M.+R.+Arkinauthor=J.+A.+Wells&title=Small-molecule+inhibitors+of+protein%E2%80%93protein+interactions%3A+progressing+towards+the+dream&doi=10.1038%2Fnrd1343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of protein-protein interactions: progressing towards the dream</span></div><div class="casAuthors">Arkin, Michelle R.; Wells, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">301-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein-protein interactions have a key role in most biol. processes, and offer attractive opportunities for therapeutic intervention.  Developing small mols. that modulate protein-protein interactions is difficult, owing to issues such as the lack of well-defined binding pockets.  Nevertheless, there was important progress in this endeavor in recent years.  Here, the authors use illustrative examples to discuss general strategies for addressing the challenges inherent in the discovery and characterization of small-mol. inhibitors of protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7MiFDdLJu27Vg90H21EOLACvtfcHk0ljt0LoxX8Ubrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1GktrY%253D&md5=3e102c6207be420b4232056b4acdea12</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd1343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1343%26sid%3Dliteratum%253Aachs%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520protein%25E2%2580%2593protein%2520interactions%253A%2520progressing%2520towards%2520the%2520dream%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D301%26epage%3D317%26doi%3D10.1038%2Fnrd1343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pawson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, P.</span></span> <span> </span><span class="NLM_article-title">Assembly of cell regulatory systems through protein interaction domains</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>300</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">452</span>, <span class="refDoi"> DOI: 10.1126/science.1083653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1126%2Fscience.1083653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=12702867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFymsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2003&pages=445-452&author=T.+Pawsonauthor=P.+Nash&title=Assembly+of+cell+regulatory+systems+through+protein+interaction+domains&doi=10.1126%2Fscience.1083653"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Assembly of Cell Regulatory Systems Through Protein Interaction Domains</span></div><div class="casAuthors">Pawson, Tony; Nash, Piers</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">300</span>
        (<span class="NLM_cas:issue">5618</span>),
    <span class="NLM_cas:pages">445-452</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  The sequencing of complete genomes provides a list that includes the proteins responsible for cellular regulation.  However, this does not immediately reveal what these proteins do, nor how they are assembled into the mol. machines and functional networks that control cellular behavior.  The regulation of many different cellular processes requires the use of protein interaction domains to direct the assocn. of polypeptides with one another and with phospholipids, small mols., or nucleic acids.  The modular nature of these domains, and the flexibility of their binding properties, have likely facilitated the evolution of cellular pathways.  Conversely, aberrant interactions can induce abnormal cellular behavior and disease.  The fundamental properties of protein interaction domains are discussed in this review and in detailed reviews on individual domains at Science's STKE at http://www.sciencemag.org/cgi/content/full/300/5618/445/DC1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrDUJdWBAiYrVg90H21EOLACvtfcHk0ljWJ6NrJZpm6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFymsL0%253D&md5=b500533683256e2a28e905e07961e68e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1083653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1083653%26sid%3Dliteratum%253Aachs%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DNash%26aufirst%3DP.%26atitle%3DAssembly%2520of%2520cell%2520regulatory%2520systems%2520through%2520protein%2520interaction%2520domains%26jtitle%3DScience%26date%3D2003%26volume%3D300%26spage%3D445%26epage%3D452%26doi%3D10.1126%2Fscience.1083653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolch, W.</span></span> <span> </span><span class="NLM_article-title">Meaningful relationships: the regulation of the RAS/RAF/MEK/ERK pathway by protein interactions</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>351</i></span>,  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1042/bj3510289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1042%2Fbj3510289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=11023813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvFSqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2000&pages=289-305&author=W.+Kolch&title=Meaningful+relationships%3A+the+regulation+of+the+RAS%2FRAF%2FMEK%2FERK+pathway+by+protein+interactions&doi=10.1042%2Fbj3510289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions</span></div><div class="casAuthors">Kolch, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">289-305</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review, with 184 refs.  The Ras/Raf/MEK (mitogen-activated protein kinase/ERK kinase)/ERK (extracellular-signal-regulated kinase) pathway is at the heart of signaling networks that govern proliferation, differentiation and cell survival.  Although the basic regulatory steps have been elucidated, many features of this pathway are only beginning to emerge.  This review focuses on the role of protein-protein interactions in the regulation of this pathway, and how they contribute to coordinate activation steps, subcellular redistribution, substrate phosphorylation and cross-talk with other signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Xj1Jp8fvHrVg90H21EOLACvtfcHk0ljWJ6NrJZpm6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvFSqt78%253D&md5=5d895f03da4dc6c64355a541185fe675</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1042%2Fbj3510289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3510289%26sid%3Dliteratum%253Aachs%26aulast%3DKolch%26aufirst%3DW.%26atitle%3DMeaningful%2520relationships%253A%2520the%2520regulation%2520of%2520the%2520RAS%252FRAF%252FMEK%252FERK%2520pathway%2520by%2520protein%2520interactions%26jtitle%3DBiochem.%2520J.%26date%3D2000%26volume%3D351%26spage%3D289%26epage%3D305%26doi%3D10.1042%2Fbj3510289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cerami, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogrusoz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumer, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aksoy, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byrne, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuer, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antipin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reva, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sander, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, N.</span></span> <span> </span><span class="NLM_article-title">The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">404</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-12-0095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1158%2F2159-8290.CD-12-0095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=22588877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A280%3ADC%252BC38njsVertQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=401-404&author=E.+Ceramiauthor=J.+Gaoauthor=U.+Dogrusozauthor=B.+E.+Grossauthor=S.+O.+Sumerauthor=B.+A.+Aksoyauthor=A.+Jacobsenauthor=C.+J.+Byrneauthor=M.+L.+Heuerauthor=E.+Larssonauthor=Y.+Antipinauthor=B.+Revaauthor=A.+P.+Goldbergauthor=C.+Sanderauthor=N.+Schultz&title=The+cBio+cancer+genomics+portal%3A+an+open+platform+for+exploring+multidimensional+cancer+genomics+data&doi=10.1158%2F2159-8290.CD-12-0095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data</span></div><div class="casAuthors">Cerami Ethan; Gao Jianjiong; Dogrusoz Ugur; Gross Benjamin E; Sumer Selcuk Onur; Aksoy Bulent Arman; Jacobsen Anders; Byrne Caitlin J; Heuer Michael L; Larsson Erik; Antipin Yevgeniy; Reva Boris; Goldberg Arthur P; Sander Chris; Schultz Nikolaus</div><div class="citationInfo"><span class="NLM_cas:title">Cancer discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">401-4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The cBio Cancer Genomics Portal (http://cbioportal.org) is an open-access resource for interactive exploration of multidimensional cancer genomics data sets, currently providing access to data from more than 5,000 tumor samples from 20 cancer studies.  The cBio Cancer Genomics Portal significantly lowers the barriers between complex genomic data and cancer researchers who want rapid, intuitive, and high-quality access to molecular profiles and clinical attributes from large-scale cancer genomics projects and empowers researchers to translate these rich data sets into biologic insights and clinical applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAgVg5djDIxr7NkxioyDXTfW6udTcc2eZ-kPLO3yR6hLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38njsVertQ%253D%253D&md5=d56ed7ecde08297f11dd0ae8e1c4b47c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-12-0095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-12-0095%26sid%3Dliteratum%253Aachs%26aulast%3DCerami%26aufirst%3DE.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DDogrusoz%26aufirst%3DU.%26aulast%3DGross%26aufirst%3DB.%2BE.%26aulast%3DSumer%26aufirst%3DS.%2BO.%26aulast%3DAksoy%26aufirst%3DB.%2BA.%26aulast%3DJacobsen%26aufirst%3DA.%26aulast%3DByrne%26aufirst%3DC.%2BJ.%26aulast%3DHeuer%26aufirst%3DM.%2BL.%26aulast%3DLarsson%26aufirst%3DE.%26aulast%3DAntipin%26aufirst%3DY.%26aulast%3DReva%26aufirst%3DB.%26aulast%3DGoldberg%26aufirst%3DA.%2BP.%26aulast%3DSander%26aufirst%3DC.%26aulast%3DSchultz%26aufirst%3DN.%26atitle%3DThe%2520cBio%2520cancer%2520genomics%2520portal%253A%2520an%2520open%2520platform%2520for%2520exploring%2520multidimensional%2520cancer%2520genomics%2520data%26jtitle%3DCancer%2520Discovery%26date%3D2012%26volume%3D2%26spage%3D401%26epage%3D404%26doi%3D10.1158%2F2159-8290.CD-12-0095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">AACR
Project Genie Consortium</span> <span> </span><span class="NLM_article-title">AACR Project GENIE: powering precision medicine through an international
consortium</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">818</span>– <span class="NLM_lpage">831</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-17-0151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1158%2F2159-8290.CD-17-0151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=28572459" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=818-831&author=AACR%0AProject+Genie+Consortium&title=AACR+Project+GENIE%3A+powering+precision+medicine+through+an+international%0Aconsortium&doi=10.1158%2F2159-8290.CD-17-0151"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-17-0151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-17-0151%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DAACR%2520Project%2520GENIE%253A%2520powering%2520precision%2520medicine%2520through%2520an%2520international%250Aconsortium%26jtitle%3DCancer%2520Discovery%26date%3D2017%26volume%3D7%26spage%3D818%26epage%3D831%26doi%3D10.1158%2F2159-8290.CD-17-0151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hallin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engstrom, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calinisan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aranda, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briere, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudhakar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowcut, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baer, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkard, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigers, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Banet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlicek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velastagui, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierobon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petricoin, E. F.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rybkin, I. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, S.-H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lito, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulos, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jänne, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, J. G.</span></span> <span> </span><span class="NLM_article-title">The KRAS<sup>G12C</sup> inhibitor MRTX849 provides insight toward therapeutic susceptibility of KRAS-mutant cancers in mouse models and patients</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">54</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-19-1167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1158%2F2159-8290.CD-19-1167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=31658955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtleitbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=54-71&author=J.+Hallinauthor=L.+D.+Engstromauthor=L.+Hargisauthor=A.+Calinisanauthor=R.+Arandaauthor=D.+M.+Briereauthor=N.+Sudhakarauthor=V.+Bowcutauthor=B.+R.+Baerauthor=J.+A.+Ballardauthor=M.+R.+Burkardauthor=J.+B.+Fellauthor=J.+P.+Fischerauthor=G.+P.+Vigersauthor=Y.+Xueauthor=S.+Gattoauthor=J.+Fernandez-Banetauthor=A.+Pavlicekauthor=K.+Velastaguiauthor=R.+C.+Chaoauthor=J.+Bartonauthor=M.+Pierobonauthor=E.+Baldelliauthor=E.+F.+Petricoinauthor=D.+P.+Cassidyauthor=M.+A.+Marxauthor=I.+I.+Rybkinauthor=M.+L.+Johnsonauthor=S.-H.+I.+Ouauthor=P.+Litoauthor=K.+P.+Papadopoulosauthor=P.+A.+J%C3%A4nneauthor=P.+Olsonauthor=J.+G.+Christensen&title=The+KRASG12C+inhibitor+MRTX849+provides+insight+toward+therapeutic+susceptibility+of+KRAS-mutant+cancers+in+mouse+models+and+patients&doi=10.1158%2F2159-8290.CD-19-1167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The KRASG12C inhibitor MRTX849 provides insight toward therapeutic susceptibility of KRAS-mutant cancers in mouse models and patients</span></div><div class="casAuthors">Hallin, Jill; Engstrom, Lars D.; Hargis, Lauren; Calinisan, Andrew; Aranda, Ruth; Briere, David M.; Sudhakar, Niranjan; Bowcut, Vickie; Baer, Brian R.; Ballard, Joshua A.; Burkard, Michael R.; Fell, Jay B.; Fischer, John P.; Vigers, Guy P.; Xue, Yaohua; Gatto, Sole; Fernandez-Banet, Julio; Pavlicek, Adam; Velastagui, Karen; Chao, Richard C.; Barton, Jeremy; Pierobon, Mariaelena; Baldelli, Elisa; Patricoin, Emanuel F., III; Cassidy, Douglas P.; Marx, Matthew A.; Rybkin, Igor I.; Johnson, Melissa L.; Ou, Sai-Hong Ignatius; Lito, Piro; Papadopoulos, Kyriakos P.; Janne, Pasi A.; Olson, Peter; Christensen, James G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-71</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Despite decades of research, efforts to directly target KRAS have been challenging.  MRTX849 was identified as a potent, selective, and covalent KRASG12C inhibitor that exhibits favorable drug-like properties, selectively modifies mutant cysteine 12 in GDP-bound KRASG12C, and inhibits KRAS-dependent signaling.  MRTX849 demonstrated pronounced tumor regression in 17 of 26 (65%) KRASG12C-pos. cell line- and patient-derived xenograft models from multiple tumor types, and objective responses have been obsd. in patients with KRASG12C-pos. lung and colon adenocarcinomas.  Comprehensive pharmacodynamic and pharmacogenomic profiling in sensitive and partially resistant nonclin. models identified mechanisms implicated in limiting antitumor activity including KRAS nucleotide cycling and pathways that induce feedback reactivation and/or bypass KRAS dependence.  These factors included activation of receptor tyrosine kinases (RTK), bypass of KRAS dependence, and genetic dysregulation of cell cycle.  Combinations of MRTX849 with agents that target RTKs, mTOR, or cell cycle demonstrated enhanced response and marked tumor regression in several tumor models, including MRTX849-refractory models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxAUhi3n75ULVg90H21EOLACvtfcHk0linA2uFDtLdOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtleitbfL&md5=48f4c34e757385eed89b47f19cbb10db</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-19-1167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-19-1167%26sid%3Dliteratum%253Aachs%26aulast%3DHallin%26aufirst%3DJ.%26aulast%3DEngstrom%26aufirst%3DL.%2BD.%26aulast%3DHargis%26aufirst%3DL.%26aulast%3DCalinisan%26aufirst%3DA.%26aulast%3DAranda%26aufirst%3DR.%26aulast%3DBriere%26aufirst%3DD.%2BM.%26aulast%3DSudhakar%26aufirst%3DN.%26aulast%3DBowcut%26aufirst%3DV.%26aulast%3DBaer%26aufirst%3DB.%2BR.%26aulast%3DBallard%26aufirst%3DJ.%2BA.%26aulast%3DBurkard%26aufirst%3DM.%2BR.%26aulast%3DFell%26aufirst%3DJ.%2BB.%26aulast%3DFischer%26aufirst%3DJ.%2BP.%26aulast%3DVigers%26aufirst%3DG.%2BP.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DGatto%26aufirst%3DS.%26aulast%3DFernandez-Banet%26aufirst%3DJ.%26aulast%3DPavlicek%26aufirst%3DA.%26aulast%3DVelastagui%26aufirst%3DK.%26aulast%3DChao%26aufirst%3DR.%2BC.%26aulast%3DBarton%26aufirst%3DJ.%26aulast%3DPierobon%26aufirst%3DM.%26aulast%3DBaldelli%26aufirst%3DE.%26aulast%3DPetricoin%26aufirst%3DE.%2BF.%26aulast%3DCassidy%26aufirst%3DD.%2BP.%26aulast%3DMarx%26aufirst%3DM.%2BA.%26aulast%3DRybkin%26aufirst%3DI.%2BI.%26aulast%3DJohnson%26aufirst%3DM.%2BL.%26aulast%3DOu%26aufirst%3DS.-H.%2BI.%26aulast%3DLito%26aufirst%3DP.%26aulast%3DPapadopoulos%26aufirst%3DK.%2BP.%26aulast%3DJ%25C3%25A4nne%26aufirst%3DP.%2BA.%26aulast%3DOlson%26aufirst%3DP.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26atitle%3DThe%2520KRASG12C%2520inhibitor%2520MRTX849%2520provides%2520insight%2520toward%2520therapeutic%2520susceptibility%2520of%2520KRAS-mutant%2520cancers%2520in%2520mouse%2520models%2520and%2520patients%26jtitle%3DCancer%2520Discovery%26date%3D2020%26volume%3D10%26spage%3D54%26epage%3D71%26doi%3D10.1158%2F2159-8290.CD-19-1167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Canon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rex, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saiki, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knutson, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanman, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapaport, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">San Miguel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osgood, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarter, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volak, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houk, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakih, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falchook, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govindan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henary, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvedson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipford, J. R.</span></span> <span> </span><span class="NLM_article-title">The clinical KRAS (G12C) inhibitor AMG 510 drives anti-tumour immunity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>575</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1694-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1038%2Fs41586-019-1694-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=31666701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitV2hsb7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=575&publication_year=2019&pages=217-223&author=J.+Canonauthor=K.+Rexauthor=A.+Y.+Saikiauthor=C.+Mohrauthor=K.+Cookeauthor=D.+Bagalauthor=K.+Gaidaauthor=T.+Holtauthor=C.+G.+Knutsonauthor=N.+Koppadaauthor=B.+A.+Lanmanauthor=J.+Wernerauthor=A.+S.+Rapaportauthor=T.+San+Miguelauthor=R.+Ortizauthor=T.+Osgoodauthor=J.-R.+Sunauthor=X.+Zhuauthor=J.+D.+McCarterauthor=L.+P.+Volakauthor=B.+E.+Houkauthor=M.+G.+Fakihauthor=B.+H.+O%E2%80%99Neilauthor=T.+J.+Priceauthor=G.+S.+Falchookauthor=J.+Desaiauthor=J.+Kuoauthor=R.+Govindanauthor=D.+S.+Hongauthor=W.+Ouyangauthor=H.+Henaryauthor=T.+Arvedsonauthor=V.+J.+Ceeauthor=J.+R.+Lipford&title=The+clinical+KRAS+%28G12C%29+inhibitor+AMG+510+drives+anti-tumour+immunity&doi=10.1038%2Fs41586-019-1694-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity</span></div><div class="casAuthors">Canon, Jude; Rex, Karen; Saiki, Anne Y.; Mohr, Christopher; Cooke, Keegan; Bagal, Dhanashri; Gaida, Kevin; Holt, Tyler; Knutson, Charles G.; Koppada, Neelima; Lanman, Brian A.; Werner, Jonathan; Rapaport, Aaron S.; San Miguel, Tisha; Ortiz, Roberto; Osgood, Tao; Sun, Ji-Rong; Zhu, Xiaochun; McCarter, John D.; Volak, Laurie P.; Houk, Brett E.; Fakih, Marwan G.; O'Neil, Bert H.; Price, Timothy J.; Falchook, Gerald S.; Desai, Jayesh; Kuo, James; Govindan, Ramaswamy; Hong, David S.; Ouyang, Wenjun; Henary, Haby; Arvedson, Tara; Cee, Victor J.; Lipford, J. Russell</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">575</span>
        (<span class="NLM_cas:issue">7781</span>),
    <span class="NLM_cas:pages">217-223</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">KRAS is the most frequently mutated oncogene in cancer and encodes a key signalling protein in tumors1,2.  The KRAS(G12C) mutant has a cysteine residue that has been exploited to design covalent inhibitors that have promising preclin. activity3-5.  Here we optimized a series of inhibitors, using novel binding interactions to markedly enhance their potency and selectivity.  Our efforts have led to the discovery of AMG 510, which is, to our knowledge, the first KRAS(G12C) inhibitor in clin. development.  In preclin. analyses, treatment with AMG 510 led to the regression of KRASG12C tumors and improved the anti-tumor efficacy of chemotherapy and targeted agents.  In immune-competent mice, treatment with AMG 510 resulted in a pro-inflammatory tumor microenvironment and produced durable cures alone as well as in combination with immune-checkpoint inhibitors.  Cured mice rejected the growth of isogenic KRASG12D tumors, which suggests adaptive immunity against shared antigens.  Furthermore, in clin. trials, AMG 510 demonstrated anti-tumor activity in the first dosing cohorts and represents a potentially transformative therapy for patients for whom effective treatments are lacking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTHdBftQfnhbVg90H21EOLACvtfcHk0lj7_4kKBNgofQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitV2hsb7F&md5=3819175980905976ba87ff545b9506e1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1694-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1694-1%26sid%3Dliteratum%253Aachs%26aulast%3DCanon%26aufirst%3DJ.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DSaiki%26aufirst%3DA.%2BY.%26aulast%3DMohr%26aufirst%3DC.%26aulast%3DCooke%26aufirst%3DK.%26aulast%3DBagal%26aufirst%3DD.%26aulast%3DGaida%26aufirst%3DK.%26aulast%3DHolt%26aufirst%3DT.%26aulast%3DKnutson%26aufirst%3DC.%2BG.%26aulast%3DKoppada%26aufirst%3DN.%26aulast%3DLanman%26aufirst%3DB.%2BA.%26aulast%3DWerner%26aufirst%3DJ.%26aulast%3DRapaport%26aufirst%3DA.%2BS.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DOrtiz%26aufirst%3DR.%26aulast%3DOsgood%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DJ.-R.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DMcCarter%26aufirst%3DJ.%2BD.%26aulast%3DVolak%26aufirst%3DL.%2BP.%26aulast%3DHouk%26aufirst%3DB.%2BE.%26aulast%3DFakih%26aufirst%3DM.%2BG.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DB.%2BH.%26aulast%3DPrice%26aufirst%3DT.%2BJ.%26aulast%3DFalchook%26aufirst%3DG.%2BS.%26aulast%3DDesai%26aufirst%3DJ.%26aulast%3DKuo%26aufirst%3DJ.%26aulast%3DGovindan%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DD.%2BS.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DHenary%26aufirst%3DH.%26aulast%3DArvedson%26aufirst%3DT.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DLipford%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520clinical%2520KRAS%2520%2528G12C%2529%2520inhibitor%2520AMG%2520510%2520drives%2520anti-tumour%2520immunity%26jtitle%3DNature%26date%3D2019%26volume%3D575%26spage%3D217%26epage%3D223%26doi%3D10.1038%2Fs41586-019-1694-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boriack-Sjodin, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margarit, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bar-Sagi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuriyan, J.</span></span> <span> </span><span class="NLM_article-title">The structural basis of the activation of RAS by SOS</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>394</i></span>,  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1038/28548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1038%2F28548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=9690470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADyaK1cXkvFKnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=1998&pages=337-343&author=P.+A.+Boriack-Sjodinauthor=S.+M.+Margaritauthor=D.+Bar-Sagiauthor=J.+Kuriyan&title=The+structural+basis+of+the+activation+of+RAS+by+SOS&doi=10.1038%2F28548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The structural basis of the activation of Ras by Sos</span></div><div class="casAuthors">Boriack-Sjodin, P. Ann; Margarit, S. Mariana; Bar-Sagi, Dafna; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">6691</span>),
    <span class="NLM_cas:pages">337-343</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The crystal structure of human H-Ras complexed with the Ras guanine-nucleotide-exchange-factor region of the Son of sevenless (Sos) protein has been detd. at 2.8 Å resoln.  The normally tight interaction of nucleotides with Ras is disrupted by Sos in two ways.  First, the insertion into Ras of an α-helix from Sos results in the displacement of the Switch 1 region of Ras, opening up the nucleotide-binding site.  Second, side chains presented by this helix and by a distorted conformation of the Switch 2 region of Ras alter the chem. environment of the binding site for the phosphate groups of the nucleotide and the assocd. magnesium in, so that their binding is no longer favored.  Sos does not impede the binding sites for the base and the ribose of GTP or GDP, so the Ras-Sos complex adopts a structure that allows nucleotide release and rebinding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZY4Ffb8--JbVg90H21EOLACvtfcHk0lj7_4kKBNgofQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvFKnsLs%253D&md5=1b0a7879011c1fc1148e7f870e0ded11</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2F28548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F28548%26sid%3Dliteratum%253Aachs%26aulast%3DBoriack-Sjodin%26aufirst%3DP.%2BA.%26aulast%3DMargarit%26aufirst%3DS.%2BM.%26aulast%3DBar-Sagi%26aufirst%3DD.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DThe%2520structural%2520basis%2520of%2520the%2520activation%2520of%2520RAS%2520by%2520SOS%26jtitle%3DNature%26date%3D1998%26volume%3D394%26spage%3D337%26epage%3D343%26doi%3D10.1038%2F28548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sondermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedland, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortemme, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bar-Sagi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marqusee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuriyan, J.</span></span> <span> </span><span class="NLM_article-title">A RAS-induced conformational switch in the RAS activator Son of sevenless</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">16692</span>– <span class="NLM_lpage">16697</span>, <span class="refDoi"> DOI: 10.1073/pnas.0608127103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1073%2Fpnas.0608127103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=17075039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1egtbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=16692-16697&author=T.+S.+Freedmanauthor=H.+Sondermannauthor=G.+D.+Friedlandauthor=T.+Kortemmeauthor=D.+Bar-Sagiauthor=S.+Marquseeauthor=J.+Kuriyan&title=A+RAS-induced+conformational+switch+in+the+RAS+activator+Son+of+sevenless&doi=10.1073%2Fpnas.0608127103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A Ras-induced conformational switch in the Ras activator Son of sevenless</span></div><div class="casAuthors">Freedman, Tanya S.; Sondermann, Holger; Friedland, Gregory D.; Kortemme, Tanja; Bar-Sagi, Dafna; Marqusee, Susan; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">16692-16697</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The Ras-specific guanine nucleotide-exchange factors Son of sevenless (Sos) and Ras guanine nucleotide-releasing factor 1 (RasGRF1) transduce extracellular stimuli into Ras activation by catalyzing the exchange of Ras-bound GDP for GTP.  A truncated form of RasGRF1 contg. only the core catalytic Cdc25 domain is sufficient for stimulating Ras nucleotide exchange, whereas the isolated Cdc25 domain of Sos is inactive.  At a site distal to the catalytic site, nucleotide-bound Ras binds to Sos, making contacts with the Cdc25 domain and with a Ras exchanger motif (Rem) domain.  This allosteric Ras binding stimulates nucleotide exchange by Sos, but the mechanism by which this stimulation occurs has not been defined.  We present a crystal structure of the Rem and Cdc25 domains of Sos detd. at 2.0-Å resoln. in the absence of Ras.  Differences between this structure and that of Sos bound to two Ras mols. show that allosteric activation of Sos by Ras occurs through a rotation of the Rem domain that is coupled to a rotation of a helical hairpin at the Sos catalytic site.  This motion relieves steric occlusion of the catalytic site, allowing substrate Ras binding and nucleotide exchange.  A structure of the isolated RasGRF1 Cdc25 domain detd. at 2.2-Å resoln., combined with computational analyses, suggests that the Cdc25 domain of RasGRF1 is able to maintain an active conformation in isolation because the helical hairpin has strengthened interactions with the Cdc25 domain core.  These results indicate that RasGRF1 lacks the allosteric activation switch that is crucial for Sos activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozurSc1qOIr7Vg90H21EOLACvtfcHk0liIn0xM_xCdBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1egtbbP&md5=712e91319dd4f31eb4cc8f06978e7236</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0608127103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0608127103%26sid%3Dliteratum%253Aachs%26aulast%3DFreedman%26aufirst%3DT.%2BS.%26aulast%3DSondermann%26aufirst%3DH.%26aulast%3DFriedland%26aufirst%3DG.%2BD.%26aulast%3DKortemme%26aufirst%3DT.%26aulast%3DBar-Sagi%26aufirst%3DD.%26aulast%3DMarqusee%26aufirst%3DS.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DA%2520RAS-induced%2520conformational%2520switch%2520in%2520the%2520RAS%2520activator%2520Son%2520of%2520sevenless%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D16692%26epage%3D16697%26doi%3D10.1073%2Fpnas.0608127103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vigil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherfils, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossman, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Der, C. J.</span></span> <span> </span><span class="NLM_article-title">RAS superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">842</span>– <span class="NLM_lpage">857</span>, <span class="refDoi"> DOI: 10.1038/nrc2960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1038%2Fnrc2960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=21102635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOrsbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=842-857&author=D.+Vigilauthor=J.+Cherfilsauthor=K.+L.+Rossmanauthor=C.+J.+Der&title=RAS+superfamily+GEFs+and+GAPs%3A+validated+and+tractable+targets+for+cancer+therapy%3F&doi=10.1038%2Fnrc2960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?</span></div><div class="casAuthors">Vigil, Dominico; Cherfils, Jacqueline; Rossman, Kent L.; Der, Channing J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">842-857</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is now considerable and increasing evidence for a causal role for aberrant activity of the Ras superfamily of small GTPases in human cancers.  These GTPases function as GDP-GTP-regulated binary switches that control many fundamental cellular processes.  A common mechanism of GTPase deregulation in cancer is the deregulated expression and/or activity of their regulatory proteins, guanine nucleotide exchange factors (GEFs) that promote formation of the active GTP-bound state and GTPase-activating proteins (GAPs) that return the GTPase to its GDP-bound inactive state.  In this Review, we assess the assocn. of GEFs and GAPs with cancer and their druggability for cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwbf8B7sLmb7Vg90H21EOLACvtfcHk0liIn0xM_xCdBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOrsbrM&md5=b7ad81f2fe0f7f7eaa5f015188f62e85</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrc2960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2960%26sid%3Dliteratum%253Aachs%26aulast%3DVigil%26aufirst%3DD.%26aulast%3DCherfils%26aufirst%3DJ.%26aulast%3DRossman%26aufirst%3DK.%2BL.%26aulast%3DDer%26aufirst%3DC.%2BJ.%26atitle%3DRAS%2520superfamily%2520GEFs%2520and%2520GAPs%253A%2520validated%2520and%2520tractable%2520targets%2520for%2520cancer%2520therapy%253F%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D842%26epage%3D857%26doi%3D10.1038%2Fnrc2960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheffels, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sealover, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazirani, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrell, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortum, R. L.</span></span> <span> </span><span class="NLM_article-title">Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">eaar8371</span> <span class="refDoi"> DOI: 10.1126/scisignal.aar8371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1126%2Fscisignal.aar8371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=30181243" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2018&author=E.+Sheffelsauthor=N.+E.+Sealoverauthor=C.+Wangauthor=D.+H.+Kimauthor=I.+A.+Vaziraniauthor=E.+Leeauthor=E.+M.+Tyrellauthor=D.+K.+Morrisonauthor=J.+Luoauthor=R.+L.+Kortum&title=Oncogenic+RAS+isoforms+show+a+hierarchical+requirement+for+the+guanine+nucleotide+exchange+factor+SOS2+to+mediate+cell+transformation&doi=10.1126%2Fscisignal.aar8371"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.aar8371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.aar8371%26sid%3Dliteratum%253Aachs%26aulast%3DSheffels%26aufirst%3DE.%26aulast%3DSealover%26aufirst%3DN.%2BE.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DVazirani%26aufirst%3DI.%2BA.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DTyrell%26aufirst%3DE.%2BM.%26aulast%3DMorrison%26aufirst%3DD.%2BK.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DKortum%26aufirst%3DR.%2BL.%26atitle%3DOncogenic%2520RAS%2520isoforms%2520show%2520a%2520hierarchical%2520requirement%2520for%2520the%2520guanine%2520nucleotide%2520exchange%2520factor%2520SOS2%2520to%2520mediate%2520cell%2520transformation%26jtitle%3DSci.%2520Signaling%26date%3D2018%26volume%3D11%26doi%3D10.1126%2Fscisignal.aar8371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Margarit, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sondermann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirruccello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bar-Sagi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuriyan, J.</span></span> <span> </span><span class="NLM_article-title">Structural evidence for feedback activation by RAS· GTP of the RAS-specific nucleotide exchange factor SOS</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">685</span>– <span class="NLM_lpage">695</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(03)00149-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1016%2FS0092-8674%2803%2900149-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=12628188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitFyku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2003&pages=685-695&author=S.+M.+Margaritauthor=H.+Sondermannauthor=B.+E.+Hallauthor=B.+Nagarauthor=A.+Hoelzauthor=M.+Pirruccelloauthor=D.+Bar-Sagiauthor=J.+Kuriyan&title=Structural+evidence+for+feedback+activation+by+RAS%C2%B7+GTP+of+the+RAS-specific+nucleotide+exchange+factor+SOS&doi=10.1016%2FS0092-8674%2803%2900149-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Structural evidence for feedback activation by Ras·GTP of the Ras-specific nucleotide exchange factor SOS</span></div><div class="casAuthors">Margarit, S. Mariana; Sondermann, Holger; Hall, Brian E.; Nagar, Bhushan; Hoelz, Andre; Pirruccello, Michelle; Bar-Sagi, Dafna; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">685-695</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Growth factor receptors activate Ras by recruiting the nucleotide exchange factor son of sevenless (SOS) to the cell membrane, thereby triggering the prodn. of GTP-loaded Ras.  Crystallog. analyses of Ras bound to the catalytic module of SOS have led to the unexpected discovery of a highly conserved Ras binding site on SOS that is located distal to the active site and is specific for Ras·GTP.  The crystal structures suggest that Ras·GTP stabilizes the active site of SOS allosterically, and we show that Ras·GTP forms ternary complexes with SOScat in soln. and increases significantly the rate of SOScat-stimulated nucleotide release from Ras.  These results demonstrate the existence of a pos. feedback mechanism for the spatial and temporal regulation of Ras.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvs-3O6BC4lrVg90H21EOLACvtfcHk0lgmjI8rH0-q8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitFyku78%253D&md5=491026c9943c3d3cdec5b0ca90ff1b7c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2803%2900149-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252803%252900149-1%26sid%3Dliteratum%253Aachs%26aulast%3DMargarit%26aufirst%3DS.%2BM.%26aulast%3DSondermann%26aufirst%3DH.%26aulast%3DHall%26aufirst%3DB.%2BE.%26aulast%3DNagar%26aufirst%3DB.%26aulast%3DHoelz%26aufirst%3DA.%26aulast%3DPirruccello%26aufirst%3DM.%26aulast%3DBar-Sagi%26aufirst%3DD.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DStructural%2520evidence%2520for%2520feedback%2520activation%2520by%2520RAS%25C2%25B7%2520GTP%2520of%2520the%2520RAS-specific%2520nucleotide%2520exchange%2520factor%2520SOS%26jtitle%3DCell%26date%3D2003%26volume%3D112%26spage%3D685%26epage%3D695%26doi%3D10.1016%2FS0092-8674%2803%2900149-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corbalan-Garcia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degenhardt, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bar-Sagi, D.</span></span> <span> </span><span class="NLM_article-title">Identification of the mitogen-activated protein kinase phosphorylation sites on human SOS1 that regulate interaction with Grb2</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5674</span>– <span class="NLM_lpage">5682</span>, <span class="refDoi"> DOI: 10.1128/MCB.16.10.5674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1128%2FMCB.16.10.5674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=8816480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADyaK28XlvFamu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=5674-5682&author=S.+Corbalan-Garciaauthor=S.+S.+Yangauthor=K.+R.+Degenhardtauthor=D.+Bar-Sagi&title=Identification+of+the+mitogen-activated+protein+kinase+phosphorylation+sites+on+human+SOS1+that+regulate+interaction+with+Grb2&doi=10.1128%2FMCB.16.10.5674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the mitogen-activated protein kinase phosphorylation sites on human Sos1 that regulate interaction with Grb2</span></div><div class="casAuthors">Corbalan-Garcia, S.; Yang, S.-S.; Degenhardt, K. R.; Bar-Sagi, D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5674-5682</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The Son of sevenless proteins (Sos) are guanine nucleotide exchange factors involved in the activation of Ras by cytoplasmic and receptor tyrosine kinases.  Growth factor stimulation rapidly induces the phosphorylation of Sos on multiple serine and threonine sites.  Previous studies have demonstrated that growth factor-induced Sos phosphorylation occurs at the C-terminal region of the protein and is mediated, in part, by mitogen-activated protein (MAP) kinase.  In this report, we describe the identification of five MAP kinase sites (S-1137, S-1167, S-1178, S-1193, and S-1197) on hSos1.  We demonstrate that four of these sites, S-1132, S-1167, S-1178, and S-1193, become phosphorylated following growth factor stimulation.  The MAP kinase phosphorylation sites are clustered within a region encompassing three proline-rich SH3-binding sites in the C-terminal domain of hSos1.  Replacing the MAP kinase phosphorylation sites with alanine residues results in an increase in the binding affinity of Grb2 to hSos1.  Interestingly, hSos2 contains only one MAP kinase phosphorylation site and, as demonstrated previously, has an increased affinity toward Grb2 compared with hSos1.  These results suggest a role for MAP kinase in the regulation of Grb2-Sos interactions.  Since the binding of Grb2 is important for Sos function, the phosphorylation-dependent modulation of Grb2-Sos assocn. may provide a means of controlling Ras activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe0XtVYcEZ3LVg90H21EOLACvtfcHk0lgmjI8rH0-q8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvFamu70%253D&md5=ec1aa5ec4086858ce2dc2578c36b2e65</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1128%2FMCB.16.10.5674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.16.10.5674%26sid%3Dliteratum%253Aachs%26aulast%3DCorbalan-Garcia%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DS.%2BS.%26aulast%3DDegenhardt%26aufirst%3DK.%2BR.%26aulast%3DBar-Sagi%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520the%2520mitogen-activated%2520protein%2520kinase%2520phosphorylation%2520sites%2520on%2520human%2520SOS1%2520that%2520regulate%2520interaction%2520with%2520Grb2%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D16%26spage%3D5674%26epage%3D5682%26doi%3D10.1128%2FMCB.16.10.5674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rozakis-Adcock, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Geer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mbamalu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawson, T.</span></span> <span> </span><span class="NLM_article-title">MAP kinase phosphorylation of mSOS1 promotes dissociation of mSOS1-Shc and mSOS1-EGF receptor complexes</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1417</span>– <span class="NLM_lpage">1426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=7478566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADyaK2MXptVWntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1995&pages=1417-1426&author=M.+Rozakis-Adcockauthor=P.+Van+der+Geerauthor=G.+Mbamaluauthor=T.+Pawson&title=MAP+kinase+phosphorylation+of+mSOS1+promotes+dissociation+of+mSOS1-Shc+and+mSOS1-EGF+receptor+complexes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">MAP kinase phosphorylation of mSos1 promotes dissociation of mSos1-Shc and mSos1-EGF receptor complexes</span></div><div class="casAuthors">Rozakis-Adcock, Maria; van der Geer, Peter; Mbamalu, Geraldine; Pawson, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1417-26</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">The mouse protein mSos1 has a central Ras guanine nucleotide exchange domain, and a long proline-rich C-terminal tail which contains several potential binding sites for the SH3 domains of the adaptor protein, Grb2.  In fibroblasts, growth factor stimulation results in the recruitment of Grb-2-mSos1 into complexes with activated receptors and cytoplasmic phosphoproteins such as Shc, which are apparently involved in Ras activation, and subsequently to an increase in mSos1 phosphorylation on serine and threonine.  The catalytic and C-terminal domains of mSos1 contain several potential sites for phosphorylation by mitogen-activated protein kinases.  In vitro, purified p42/p44 MAP-kinase selectively phosphorylated the C-terminal tail of mSos1.  Comparative tryptic phosphopeptide mapping of mSos1 phosphorylated in vitro by MAP kinase and of mSos1 immunopptd. from EGF-stimulated cells, revealed several phosphopeptides in common.  These common phosphorylation sites have been mapped to a region encompassing the first three proline (pro)-rich motifs in the tail of mSos1.  Furthermore, a region of mSos1 contg. the first two pro-rich motifs could assoc. with MBP kinase activity in vitro.  Phosphorylation of mSos1 did not affect binding of Grb2 to mSos1, but appeared to decrease binding of the mSos1-Grb2 complex to Shc and the EGF-receptor.  These findings suggest a potential inhibitory role for MAP-kinase in attenuating nucleotide exchange on Ras, by uncoupling mSos1 from membrane-bound receptor complexes that lead to Ras activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5hvLyKdwZabVg90H21EOLACvtfcHk0lgmjI8rH0-q8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptVWntLg%253D&md5=b4b38ddb72bd899d9eba39f960fdfbbb</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRozakis-Adcock%26aufirst%3DM.%26aulast%3DVan%2Bder%2BGeer%26aufirst%3DP.%26aulast%3DMbamalu%26aufirst%3DG.%26aulast%3DPawson%26aufirst%3DT.%26atitle%3DMAP%2520kinase%2520phosphorylation%2520of%2520mSOS1%2520promotes%2520dissociation%2520of%2520mSOS1-Shc%2520and%2520mSOS1-EGF%2520receptor%2520complexes%26jtitle%3DOncogene%26date%3D1995%26volume%3D11%26spage%3D1417%26epage%3D1426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentires-Alj, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greulich, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grewal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yassin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iartchouk, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitman, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caligiuri, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliland, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Look, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucherlapati, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">SOS1 mutations are rare in human malignancies: implications for Noonan Syndrome patients</span>. <i>Genes, Chromosomes Cancer</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">259</span>, <span class="refDoi"> DOI: 10.1002/gcc.20527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1002%2Fgcc.20527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=18064648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFSgtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=253-259&author=K.+D.+Swansonauthor=J.+M.+Winterauthor=M.+Reisauthor=M.+Bentires-Aljauthor=H.+Greulichauthor=R.+Grewalauthor=R.+H.+Hrubanauthor=C.+J.+Yeoauthor=Y.+Yassinauthor=O.+Iartchoukauthor=K.+Montgomeryauthor=S.+P.+Whitmanauthor=M.+A.+Caligiuriauthor=M.+L.+Lohauthor=D.+G.+Gillilandauthor=A.+T.+Lookauthor=R.+Kucherlapatiauthor=S.+E.+Kernauthor=M.+Meyersonauthor=B.+G.+Neel&title=SOS1+mutations+are+rare+in+human+malignancies%3A+implications+for+Noonan+Syndrome+patients&doi=10.1002%2Fgcc.20527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">SOS1 mutations are rare in human malignancies: implications for Noonan Syndrome patients</span></div><div class="casAuthors">Swanson, Kenneth D.; Winter, Jordan M.; Reis, Marcelo; Bentires-Alj, Mohamed; Greulich, Heidi; Grewal, Rupinder; Hruban, Ralph H.; Yeo, Charles J.; Yassin, Yosuf; Iartchouk, Oleg; Montgomery, Kate; Whitman, Susan P.; Caligiuri, Michael A.; Loh, Mignon L.; Gilliland, D. Gary; Look, A. Thomas; Kucherlapati, Raju; Kern, Scott E.; Meyerson, Matthew; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Genes, Chromosomes & Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">253-259</span>CODEN:
                <span class="NLM_cas:coden">GCCAES</span>;
        ISSN:<span class="NLM_cas:issn">1045-2257</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Germ line gain-of-function mutations in several members of the RAS/ERK pathway, including PTPN11, KRAS, and RAF1, cause the autosomal dominant genetic disorder Noonan Syndrome (NS).  NS patients are at increased risk of leukemia/myeloproliferative disease and possibly some solid tumors, such as neuroblastoma.  Recently, SOS1 gain of function mutations were also shown to cause NS.  Somatic PTPN11, KRAS, and RAF1 mutations occur (although at different frequencies) in a variety of sporadic neoplasms, but whether SOS1 mutations are assocd. with human cancer was not evaluated.  The authors sequenced DNA from a total of 810 primary malignancies, including pancreatic, lung, breast, and colon carcinomas, and acute myelogenous leukemia, as well as several neuroblastoma cell lines.  From this large, diverse series, missense SOS1 mutations were identified in a single pancreatic tumor, one lung adenocarcinoma, and a T-cell acute lymphoblastic leukemia cell line.  The authors' findings suggest that SOS1 is not a significant human oncogene in most cancers.  Furthermore, NS patients with SOS1 mutations may not be at increased risk of developing cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK0B9lJSRpP7Vg90H21EOLACvtfcHk0lhVs7TUEwqdaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFSgtrs%253D&md5=5680adada422beac465b15ab26b3d87c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fgcc.20527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fgcc.20527%26sid%3Dliteratum%253Aachs%26aulast%3DSwanson%26aufirst%3DK.%2BD.%26aulast%3DWinter%26aufirst%3DJ.%2BM.%26aulast%3DReis%26aufirst%3DM.%26aulast%3DBentires-Alj%26aufirst%3DM.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DGrewal%26aufirst%3DR.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DYeo%26aufirst%3DC.%2BJ.%26aulast%3DYassin%26aufirst%3DY.%26aulast%3DIartchouk%26aufirst%3DO.%26aulast%3DMontgomery%26aufirst%3DK.%26aulast%3DWhitman%26aufirst%3DS.%2BP.%26aulast%3DCaligiuri%26aufirst%3DM.%2BA.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DLook%26aufirst%3DA.%2BT.%26aulast%3DKucherlapati%26aufirst%3DR.%26aulast%3DKern%26aufirst%3DS.%2BE.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DSOS1%2520mutations%2520are%2520rare%2520in%2520human%2520malignancies%253A%2520implications%2520for%2520Noonan%2520Syndrome%2520patients%26jtitle%3DGenes%252C%2520Chromosomes%2520Cancer%26date%3D2008%26volume%3D47%26spage%3D253%26epage%3D259%26doi%3D10.1002%2Fgcc.20527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tidyman, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauen, K. A.</span></span> <span> </span><span class="NLM_article-title">The RASopathies: developmental syndromes of RAS/MAPK pathway dysregulation</span>. <i>Curr. Opin. Genet. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1016/j.gde.2009.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1016%2Fj.gde.2009.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=19467855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Gmurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=230-236&author=W.+E.+Tidymanauthor=K.+A.+Rauen&title=The+RASopathies%3A+developmental+syndromes+of+RAS%2FMAPK+pathway+dysregulation&doi=10.1016%2Fj.gde.2009.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation</span></div><div class="casAuthors">Tidyman, William E.; Rauen, Katherine A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Genetics & Development</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">230-236</span>CODEN:
                <span class="NLM_cas:coden">COGDET</span>;
        ISSN:<span class="NLM_cas:issn">0959-437X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Ras/mitogen activated protein kinase (MAPK) pathway is essential in the regulation of the cell cycle, differentiation, growth and cell senescence, all of which are crit. to normal development.  It is therefore not surprising that its dysregulation has profound effects on development.  A class of developmental syndromes, the RASopathies', is caused by germline mutations in genes that encode protein components of the Ras/MAPK pathway.  The vast majority of these mutations result in increased signal transduction down the Ras/MAPK pathway, but usually to a lesser extent than somatic mutations assocd. with oncogenesis.  Each syndrome exhibits unique phenotypic features, however, since they all cause dysregulation of the Ras/MAPK pathway, there are numerous overlapping phenotypic features between the syndromes, including characteristic facial features, cardiac defects, cutaneous abnormalities, neurocognitive delay and a predisposition to malignancies.  Here we review the clin. and underlying mol. basis for each of these syndromes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQRPIBdM9nkbVg90H21EOLACvtfcHk0lhVs7TUEwqdaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Gmurs%253D&md5=765a765d743125af820969a502b246e6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2009.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2009.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DTidyman%26aufirst%3DW.%2BE.%26aulast%3DRauen%26aufirst%3DK.%2BA.%26atitle%3DThe%2520RASopathies%253A%2520developmental%2520syndromes%2520of%2520RAS%252FMAPK%2520pathway%2520dysregulation%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2009%26volume%3D19%26spage%3D230%26epage%3D236%26doi%3D10.1016%2Fj.gde.2009.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Medarde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, E.</span></span> <span> </span><span class="NLM_article-title">RAS in cancer and developmental diseases</span>. <i>Genes Cancer</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">344</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1177/1947601911411084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1177%2F1947601911411084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=21779504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFWlsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=344-358&author=A.+Fern%C3%A1ndez-Medardeauthor=E.+Santos&title=RAS+in+cancer+and+developmental+diseases&doi=10.1177%2F1947601911411084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Ras in cancer and developmental diseases</span></div><div class="casAuthors">Fernandez-Medarde, Alberto; Santos, Eugenio</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">344-358</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Somatic, gain-of-function mutations in ras genes were the first specific genetic alterations identified in human cancer about 3 decades ago.  Studies during the last quarter century have characterized the Ras proteins as essential components of signaling networks controlling cellular proliferation, differentiation, or survival.  The oncogenic mutations of the H-ras, N-ras, or K-ras genes frequently found in human tumors are known to throw off balance the normal outcome of those signaling pathways, thus leading to tumor development.  Oncogenic mutations in a no. of other upstream or downstream components of Ras signaling pathways (including membrane RTKs or cytosolic kinases) have been detected more recently in assocn. with a variety of cancers.  Interestingly, the oncogenic Ras mutations and the mutations in other components of Ras/MAPK signaling pathways appear to be mutually exclusive events in most tumors, indicating that deregulation of Ras-dependent signaling is the essential requirement for tumorigenesis.  In contrast to sporadic tumors, sep. studies have identified germline mutations in Ras and various other components of Ras signaling pathways that occur in specific assocn. with a no. of different familial, developmental syndromes frequently sharing common phenotypic cardiofaciocutaneous features.  Finally, even without being a causative force, defective Ras signaling has been cited as a contributing factor to many other human illnesses, including diabetes and immunol. and inflammatory disorders.  We aim this review at summarizing and updating current knowledge on the contribution of Ras mutations and altered Ras signaling to development of various tumoral and nontumoral pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC8FC347lm6bVg90H21EOLACvtfcHk0lhVs7TUEwqdaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFWlsbs%253D&md5=048ad92dd5959250e4a2b8e0319ff225</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1177%2F1947601911411084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1947601911411084%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Medarde%26aufirst%3DA.%26aulast%3DSantos%26aufirst%3DE.%26atitle%3DRAS%2520in%2520cancer%2520and%2520developmental%2520diseases%26jtitle%3DGenes%2520Cancer%26date%3D2011%26volume%3D2%26spage%3D344%26epage%3D358%26doi%3D10.1177%2F1947601911411084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiripo, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yassin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamburino, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucherlapati, R. S.</span></span> <span> </span><span class="NLM_article-title">Germline gain-of-function mutations in SOS1 cause Noonan syndrome</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1038/ng1926</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1038%2Fng1926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=17143285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252Fmtlyhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=70-74&author=A.+E.+Robertsauthor=T.+Arakiauthor=K.+D.+Swansonauthor=K.+T.+Montgomeryauthor=T.+A.+Schiripoauthor=V.+A.+Joshiauthor=L.+Liauthor=Y.+Yassinauthor=A.+M.+Tamburinoauthor=B.+G.+Neelauthor=R.+S.+Kucherlapati&title=Germline+gain-of-function+mutations+in+SOS1+cause+Noonan+syndrome&doi=10.1038%2Fng1926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Germline gain-of-function mutations in SOS1 cause Noonan syndrome</span></div><div class="casAuthors">Roberts Amy E; Araki Toshiyuki; Swanson Kenneth D; Montgomery Kate T; Schiripo Taryn A; Joshi Victoria A; Li Li; Yassin Yosuf; Tamburino Alex M; Neel Benjamin G; Kucherlapati Raju S</div><div class="citationInfo"><span class="NLM_cas:title">Nature genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-4</span>
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    </div><div class="casAbstract">Noonan syndrome, the most common single-gene cause of congenital heart disease, is characterized by short stature, characteristic facies, learning problems and leukemia predisposition.  Gain-of-function mutations in PTPN11, encoding the tyrosine phosphatase SHP2, cause approximately 50% of Noonan syndrome cases.  SHP2 is required for RAS-ERK MAP kinase (MAPK) cascade activation, and Noonan syndrome mutants enhance ERK activation ex vivo and in mice.  KRAS mutations account for <5% of cases of Noonan syndrome, but the gene(s) responsible for the remainder are unknown.  We identified missense mutations in SOS1, which encodes an essential RAS guanine nucleotide-exchange factor (RAS-GEF), in approximately 20% of cases of Noonan syndrome without PTPN11 mutation.  The prevalence of specific cardiac defects differs in SOS1 mutation-associated Noonan syndrome.  Noonan syndrome-associated SOS1 mutations are hypermorphs encoding products that enhance RAS and ERK activation.  Our results identify SOS1 mutants as a major cause of Noonan syndrome, representing the first example of activating GEF mutations associated with human disease and providing new insights into RAS-GEF regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRksUzgn8R7h0NoizSOkG_FfW6udTcc2eb-yAXd3sdiRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252Fmtlyhsg%253D%253D&md5=98b41bbffcb21bb5303dab02e3eaecd3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fng1926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1926%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DA.%2BE.%26aulast%3DAraki%26aufirst%3DT.%26aulast%3DSwanson%26aufirst%3DK.%2BD.%26aulast%3DMontgomery%26aufirst%3DK.%2BT.%26aulast%3DSchiripo%26aufirst%3DT.%2BA.%26aulast%3DJoshi%26aufirst%3DV.%2BA.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DYassin%26aufirst%3DY.%26aulast%3DTamburino%26aufirst%3DA.%2BM.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26aulast%3DKucherlapati%26aufirst%3DR.%2BS.%26atitle%3DGermline%2520gain-of-function%2520mutations%2520in%2520SOS1%2520cause%2520Noonan%2520syndrome%26jtitle%3DNat.%2520Genet.%26date%3D2007%26volume%3D39%26spage%3D70%26epage%3D74%26doi%3D10.1038%2Fng1926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tartaglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennacchio, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodale, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkozy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schackwitz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ustaszewska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasta, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siguero, J. P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Digilio, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zampino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallapiccola, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bar-Sagi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, B. D.</span></span> <span> </span><span class="NLM_article-title">Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.1038/ng1939</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1038%2Fng1939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=17143282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A280%3ADC%252BD28jlsF2gtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=75-79&author=M.+Tartagliaauthor=L.+A.+Pennacchioauthor=C.+Zhaoauthor=K.+K.+Yadavauthor=V.+Fodaleauthor=A.+Sarkozyauthor=B.+Panditauthor=K.+Oishiauthor=S.+Martinelliauthor=W.+Schackwitzauthor=A.+Ustaszewskaauthor=J.+Martinauthor=J.+Bristowauthor=C.+Cartaauthor=F.+Lepriauthor=C.+Neriauthor=I.+Vastaauthor=K.+Gibsonauthor=C.+J.+Curryauthor=J.+P.+L.+Sigueroauthor=M.+C.+Digilioauthor=G.+Zampinoauthor=B.+Dallapiccolaauthor=D.+Bar-Sagiauthor=B.+D.+Gelb&title=Gain-of-function+SOS1+mutations+cause+a+distinctive+form+of+Noonan+syndrome&doi=10.1038%2Fng1939"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome</span></div><div class="casAuthors">Tartaglia Marco; Pennacchio Len A; Zhao Chen; Yadav Kamlesh K; Fodale Valentina; Sarkozy Anna; Pandit Bhaswati; Oishi Kimihiko; Martinelli Simone; Schackwitz Wendy; Ustaszewska Anna; Martin Joel; Bristow James; Carta Claudio; Lepri Francesca; Neri Cinzia; Vasta Isabella; Gibson Kate; Curry Cynthia J; Siguero Juan Pedro Lopez; Digilio Maria Cristina; Zampino Giuseppe; Dallapiccola Bruno; Bar-Sagi Dafna; Gelb Bruce D</div><div class="citationInfo"><span class="NLM_cas:title">Nature genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-9</span>
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    </div><div class="casAbstract">Noonan syndrome is a developmental disorder characterized by short stature, facial dysmorphia, congenital heart defects and skeletal anomalies.  Increased RAS-mitogen-activated protein kinase (MAPK) signaling due to PTPN11 and KRAS mutations causes 50% of cases of Noonan syndrome.  Here, we report that 22 of 129 individuals with Noonan syndrome without PTPN11 or KRAS mutation have missense mutations in SOS1, which encodes a RAS-specific guanine nucleotide exchange factor.  SOS1 mutations cluster at codons encoding residues implicated in the maintenance of SOS1 in its autoinhibited form.  In addition, ectopic expression of two Noonan syndrome-associated mutants induces enhanced RAS and ERK activation.  The phenotype associated with SOS1 defects lies within the Noonan syndrome spectrum but is distinctive, with a high prevalence of ectodermal abnormalities but generally normal development and linear growth.  Our findings implicate gain-of-function mutations in a RAS guanine nucleotide exchange factor in disease for the first time and define a new mechanism by which upregulation of the RAS pathway can profoundly change human development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHWugWFFBYm9-cVm4E2RlLfW6udTcc2eb-yAXd3sdiRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jlsF2gtA%253D%253D&md5=6640f23266076d6746f118bf7fd73cd3</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fng1939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1939%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DPennacchio%26aufirst%3DL.%2BA.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DYadav%26aufirst%3DK.%2BK.%26aulast%3DFodale%26aufirst%3DV.%26aulast%3DSarkozy%26aufirst%3DA.%26aulast%3DPandit%26aufirst%3DB.%26aulast%3DOishi%26aufirst%3DK.%26aulast%3DMartinelli%26aufirst%3DS.%26aulast%3DSchackwitz%26aufirst%3DW.%26aulast%3DUstaszewska%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DJ.%26aulast%3DBristow%26aufirst%3DJ.%26aulast%3DCarta%26aufirst%3DC.%26aulast%3DLepri%26aufirst%3DF.%26aulast%3DNeri%26aufirst%3DC.%26aulast%3DVasta%26aufirst%3DI.%26aulast%3DGibson%26aufirst%3DK.%26aulast%3DCurry%26aufirst%3DC.%2BJ.%26aulast%3DSiguero%26aufirst%3DJ.%2BP.%2BL.%26aulast%3DDigilio%26aufirst%3DM.%2BC.%26aulast%3DZampino%26aufirst%3DG.%26aulast%3DDallapiccola%26aufirst%3DB.%26aulast%3DBar-Sagi%26aufirst%3DD.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DGain-of-function%2520SOS1%2520mutations%2520cause%2520a%2520distinctive%2520form%2520of%2520Noonan%2520syndrome%26jtitle%3DNat.%2520Genet.%26date%3D2007%26volume%3D39%26spage%3D75%26epage%3D79%26doi%3D10.1038%2Fng1939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hart, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorry, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marazita, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortelli, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallos, D.</span></span> <span> </span><span class="NLM_article-title">A mutation in the SOS1 gene causes hereditary gingival fibromatosis type 1</span>. <i>Am. J. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">943</span>– <span class="NLM_lpage">954</span>, <span class="refDoi"> DOI: 10.1086/339689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1086%2F339689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=11868160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BD38XivFClu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2002&pages=943-954&author=T.+C.+Hartauthor=Y.+Zhangauthor=M.+C.+Gorryauthor=P.+S.+Hartauthor=M.+Cooperauthor=M.+L.+Marazitaauthor=J.+M.+Marksauthor=J.+R.+Cortelliauthor=D.+Pallos&title=A+mutation+in+the+SOS1+gene+causes+hereditary+gingival+fibromatosis+type+1&doi=10.1086%2F339689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in the SOS1 gene causes hereditary gingival fibromatosis type 1</span></div><div class="casAuthors">Hart, Thomas C.; Zhang, Yingze; Gorry, Michael C.; Hart, P. Suzanne; Cooper, Margaret; Marazita, Mary L.; Marks, Jared M.; Cortelli, Jose R.; Pallos, Debora</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">943-954</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Hereditary gingival fibromatosis (HGF) is a rare, autosomal dominant form of gingival overgrowth.  Affected individuals have a benign, slowly progressive, nonhemorrhagic, fibrous enlargement of the oral masticatory mucosa.  Genetic loci for autosomal dominant forms of HGF have been localized to chromosome 2p21-p22 (HGF1) and chromosome 5q13-q22 (HGF2).  To identify the gene responsible for HGF1, the authors extended genetic linkage studies to refine the chromosome 2p21-p22 candidate interval to ∼2.3 Mb.  Development of an integrated phys. and genetic map of the interval identified 16 genes.  Sequencing of these genes, in affected and unaffected HGF1 family members, identified a mutation in the Son of sevenless-1 (SOS1) gene in affected individuals.  In this report, the authors describe the genomic structure of the SOS1 gene and present evidence that insertion of a cytosine between nucleotides 126,142 and 126,143 in codon 1083 of the SOS1 gene is responsible for HGF1.  This insertion mutation, which segregates in a dominant manner over four generations, introduces a frameshift and creates a premature stop codon, abolishing four functionally important proline-rich SH3 binding domains normally present in the carboxyl-terminal region of the SOS1 protein.  The resultant protein chimera contains the wild-type SOS1 protein for the N-terminal amino acids 1-1083 fused to a novel 22-amino acid carboxyl terminus.  Similar SOS1 deletion constructs are functional in animal models, and a transgenic mouse construct with a comparable SOS1 chimera produces a phenotype with skin hypertrophy.  Clarification of the functional role of this SOS1 mutant has implications for understanding other forms of gingival fibromatosis and corrective gingival-tissue management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrws-ZFkg6I0LVg90H21EOLACvtfcHk0liWGzh3k-VHNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivFClu74%253D&md5=e552fc8803afabaebd8dd3aca8f63707</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1086%2F339689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F339689%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DT.%2BC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGorry%26aufirst%3DM.%2BC.%26aulast%3DHart%26aufirst%3DP.%2BS.%26aulast%3DCooper%26aufirst%3DM.%26aulast%3DMarazita%26aufirst%3DM.%2BL.%26aulast%3DMarks%26aufirst%3DJ.%2BM.%26aulast%3DCortelli%26aufirst%3DJ.%2BR.%26aulast%3DPallos%26aufirst%3DD.%26atitle%3DA%2520mutation%2520in%2520the%2520SOS1%2520gene%2520causes%2520hereditary%2520gingival%2520fibromatosis%2520type%25201%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2002%26volume%3D70%26spage%3D943%26epage%3D954%26doi%3D10.1086%2F339689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camper, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Approach for targeting RAS with small molecules that activate SOS-mediated nucleotide exchange</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">3401</span>– <span class="NLM_lpage">3406</span>, <span class="refDoi"> DOI: 10.1073/pnas.1315798111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1073%2Fpnas.1315798111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=24550516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtl2mtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=3401-3406&author=M.+C.+Burnsauthor=Q.+Sunauthor=R.+N.+Danielsauthor=D.+Camperauthor=J.+P.+Kennedyauthor=J.+Phanauthor=E.+T.+Olejniczakauthor=T.+Leeauthor=A.+G.+Watersonauthor=O.+W.+Rossaneseauthor=S.+W.+Fesik&title=Approach+for+targeting+RAS+with+small+molecules+that+activate+SOS-mediated+nucleotide+exchange&doi=10.1073%2Fpnas.1315798111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Approach for targeting Ras with small molecules that activate SOS-mediated nucleotide exchange</span></div><div class="casAuthors">Burns, Michael C.; Sun, Qi; Daniels, R. Nathan; Camper, DeMarco; Kennedy, J. Phillip; Phan, Jason; Olejniczak, Edward T.; Lee, Taekyu; Waterson, Alex G.; Rossanese, Olivia W.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3401-3406</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Aberrant activation of the small GTPase Ras by oncogenic mutation or constitutively active upstream receptor tyrosine kinases results in the deregulation of cellular signals governing growth and survival in ∼30% of all human cancers.  However, the discovery of potent inhibitors of Ras has been difficult to achieve.  Here, we report the identification of small mols. that bind to a unique pocket on the Ras:Son of Sevenless (SOS):Ras complex, increase the rate of SOS-catalyzed nucleotide exchange in vitro, and modulate Ras signaling pathways in cells.  X-ray crystallog. of Ras:SOS:Ras in complex with these mols. reveals that the compds. bind in a hydrophobic pocket in the CDC25 domain of SOS adjacent to the Switch II region of Ras.  The structure-activity relationships exhibited by these compds. can be rationalized on the basis of multiple x-ray cocrystal structures.  Mutational analyses confirmed the functional relevance of this binding site and showed it to be essential for compd. activity.  These mols. increase Ras-GTP levels and disrupt MAPK and PI3K signaling in cells at low micromolar concns.  These small mols. represent tools to study the acute activation of Ras and highlight a pocket on SOS that may be exploited to modulate Ras signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl9pTZ-cO_8rVg90H21EOLACvtfcHk0ljraA1V2VTNmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtl2mtrc%253D&md5=aefb332e4acb9de6731f206383bcca6f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1315798111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1315798111%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DDaniels%26aufirst%3DR.%2BN.%26aulast%3DCamper%26aufirst%3DD.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DApproach%2520for%2520targeting%2520RAS%2520with%2520small%2520molecules%2520that%2520activate%2520SOS-mediated%2520nucleotide%2520exchange%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D3401%26epage%3D3406%26doi%3D10.1073%2Fpnas.1315798111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camper, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">High-throughput screening identifies small molecules that bind to the RAS: SOS: RAS complex and perturb RAS signaling</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>548</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2018.01.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1016%2Fj.ab.2018.01.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=29444450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFaju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=548&publication_year=2018&pages=44-52&author=M.+C.+Burnsauthor=J.+E.+Howesauthor=Q.+Sunauthor=A.+J.+Littleauthor=D.+V.+Camperauthor=J.+R.+Abbottauthor=J.+Phanauthor=T.+Leeauthor=A.+G.+Watersonauthor=O.+W.+Rossaneseauthor=S.+W.+Fesik&title=High-throughput+screening+identifies+small+molecules+that+bind+to+the+RAS%3A+SOS%3A+RAS+complex+and+perturb+RAS+signaling&doi=10.1016%2Fj.ab.2018.01.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput screening identifies small molecules that bind to the RAS:SOS:RAS complex and perturb RAS signaling</span></div><div class="casAuthors">Burns, Michael C.; Howes, Jennifer E.; Sun, Qi; Little, Andrew J.; Camper, DeMarco V.; Abbott, Jason R.; Phan, Jason; Lee, Taekyu; Waterson, Alex G.; Rossanese, Olivia W.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">548</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44-52</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">K-RAS is mutated in approx. 30% of human cancers, resulting in increased RAS signaling and tumor growth.  Thus, RAS is a highly validated therapeutic target, esp. in tumors of the pancreas, lung and colon.  Although directly targeting RAS has proven to be challenging, it may be possible to target other proteins involved in RAS signaling, such as the guanine nucleotide exchange factor Son of Sevenless (SOS).  We have previously reported on the discovery of small mols. that bind to SOS1, activate SOS-mediated nucleotide exchange on RAS, and paradoxically inhibit ERK phosphorylation (Burns et al., PNAS, 2014).  Here, we describe the discovery of addnl., structurally diverse small mols. that also bind to SOS1 in the same pocket and elicit similar biol. effects.  We tested >160,000 compds. in a fluorescence-based assay to assess their effects on SOS-mediated nucleotide exchange.  X-Ray structures revealed that these small mols. bind to the CDC25 domain of SOS1.  Compds. that elicited high levels of nucleotide exchange activity in vitro increased RAS-GTP levels in cells, and inhibited phospho ERK levels at higher treatment concns.  The identification of structurally diverse SOS1 binding ligands may assist in the discovery of new mols. designed to target RAS-driven tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdp7gmEwzlMLVg90H21EOLACvtfcHk0ljUHEYEAjCTTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFaju70%253D&md5=af853c79022b68839f53bfb11303b97a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2018.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2018.01.025%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DHowes%26aufirst%3DJ.%2BE.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DLittle%26aufirst%3DA.%2BJ.%26aulast%3DCamper%26aufirst%3DD.%2BV.%26aulast%3DAbbott%26aufirst%3DJ.%2BR.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DHigh-throughput%2520screening%2520identifies%2520small%2520molecules%2520that%2520bind%2520to%2520the%2520RAS%253A%2520SOS%253A%2520RAS%2520complex%2520and%2520perturb%2520RAS%2520signaling%26jtitle%3DAnal.%2520Biochem.%26date%3D2018%26volume%3D548%26spage%3D44%26epage%3D52%26doi%3D10.1016%2Fj.ab.2018.01.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Small molecule–mediated activation of RAS elicits biphasic modulation of phospho-ERK levels that are regulated through negative feedback on SOS1</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1051</span>– <span class="NLM_lpage">1060</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-17-0666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1158%2F1535-7163.MCT-17-0666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=29440291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosF2qsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=1051-1060&author=J.+E.+Howesauthor=D.+T.+Akanauthor=M.+C.+Burnsauthor=O.+W.+Rossaneseauthor=A.+G.+Watersonauthor=S.+W.+Fesik&title=Small+molecule%E2%80%93mediated+activation+of+RAS+elicits+biphasic+modulation+of+phospho-ERK+levels+that+are+regulated+through+negative+feedback+on+SOS1&doi=10.1158%2F1535-7163.MCT-17-0666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule-Mediated Activation of RAS Elicits Biphasic Modulation of Phospho-ERK Levels that Are Regulated through Negative Feedback on SOS1</span></div><div class="casAuthors">Howes, Jennifer E.; Akan, Denis T.; Burns, Michael C.; Rossanese, Olivia W.; Waterson, Alex G.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1051-1060</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Oncogenic mutation of RAS results in aberrant cellular signaling and is responsible for more than 30% of all human tumors.  Therefore, pharmacol. modulation of RAS has attracted great interest as a therapeutic strategy.  Our lab. has recently discovered small mols. that activate Son of Sevenless (SOS)-catalyzed nucleotide exchange on RAS and inhibit downstream signaling.  Here, we describe how pharmacol. targeting SOS1 induced biphasic modulation of RAS-GTP and ERK phosphorylation levels, which we obsd. in a variety of cell lines expressing different RAS-mutant isoforms.  We show that compd. treatment caused an increase in phosphorylation at ERK consensus motifs on SOS1 that was not obsd. with the expression of a non-phosphorylatable S1178A SOS1 mutant or after pretreatment with an ERK inhibitor.  Phosphorylation at S1178 on SOS1 is known to inhibit the assocn. between SOS1 and GRB2 and disrupt SOS1 membrane localization.  Consistent with this, we show that wild-type SOS1 and GRB2 dissocd. in a time-dependent fashion in response to compd. treatment, and conversely, this interaction was enhanced with the expression of an S1178A SOS1 mutant.  Furthermore, in cells expressing either S1178A SOS1 or a constitutively membrane-bound CAAX box tagged SOS1 mutant, we obsd. elevated RAS-GTP levels over time in response to compd., as compared with the biphasic changes in RAS-GTP exhibited in cells expressing wild-type SOS1.  These results suggest that small mol. targeting of SOS1 can elicit a biphasic modulation of RAS-GTP and phospho-ERK levels through neg. feedback on SOS1 that regulates the interaction between SOS1 and GRB2.  Mol Cancer Ther; 17(5); 1051-60. ©2018 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa-L8W-8tgq7Vg90H21EOLACvtfcHk0ljUHEYEAjCTTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosF2qsLc%253D&md5=e9a4fedac54fd873438cde20ce28f37d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-17-0666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-17-0666%26sid%3Dliteratum%253Aachs%26aulast%3DHowes%26aufirst%3DJ.%2BE.%26aulast%3DAkan%26aufirst%3DD.%2BT.%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DSmall%2520molecule%25E2%2580%2593mediated%2520activation%2520of%2520RAS%2520elicits%2520biphasic%2520modulation%2520of%2520phospho-ERK%2520levels%2520that%2520are%2520regulated%2520through%2520negative%2520feedback%2520on%2520SOS1%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2018%26volume%3D17%26spage%3D1051%26epage%3D1060%26doi%3D10.1158%2F1535-7163.MCT-17-0666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodges, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobolik, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beesetty, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of aminopiperidine indoles that activate the guanine nucleotide exchange factor SOS1 and modulate RAS signaling</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6002</span>– <span class="NLM_lpage">6017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00360</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00360" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKktbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6002-6017&author=J.+R.+Abbottauthor=T.+R.+Hodgesauthor=R.+N.+Danielsauthor=P.+A.+Patelauthor=J.+P.+Kennedyauthor=J.+E.+Howesauthor=D.+T.+Akanauthor=M.+C.+Burnsauthor=J.+Saiauthor=T.+Sobolikauthor=Y.+Beesettyauthor=T.+Leeauthor=O.+W.+Rossaneseauthor=J.+Phanauthor=A.+G.+Watersonauthor=S.+W.+Fesik&title=Discovery+of+aminopiperidine+indoles+that+activate+the+guanine+nucleotide+exchange+factor+SOS1+and+modulate+RAS+signaling&doi=10.1021%2Facs.jmedchem.8b00360"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Aminopiperidine Indoles That Activate the Guanine Nucleotide Exchange Factor SOS1 and Modulate RAS Signaling</span></div><div class="casAuthors">Abbott, Jason R.; Hodges, Timothy R.; Daniels, R. Nathan; Patel, Pratiq A.; Kennedy, J. Phillip; Howes, Jennifer E.; Akan, Denis T.; Burns, Michael C.; Sai, Jiqing; Sobolik, Tammy; Beesetty, Yugandhar; Lee, Taekyu; Rossanese, Olivia W.; Phan, Jason; Waterson, Alex G.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6002-6017</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indole-substituted tryptophan amides such as I were prepd. through optimization of aminopiperidine-substituted indoles as activators of the guanine nucleotide exchange factor (GEF) son of sevenless homolog 1 (SOS1) for use in modulating RAS signaling and thus as potential antitumor agents.  Substitution patterns on the indole nucleus, the pendant amino acid moiety, and the linker unit connecting these two fragments were modified to det. structure-activity relations for the SOS1-mediated activation of nucleotide exchange.  Effective compds. such as I activated the nucleotide exchange process at sub-micromolar concns. in vitro (IC50 for I = 0.8 ± 0.36 μM), increased levels of active RAS-GTP in HeLa cells, and elicited signaling changes in the mitogen-activated protein kinase/extracellular regulated kinase (MAPK/ERK) pathway, resulting in a decrease in pERK1/2T202/Y204 protein levels at higher compd. concns.  The structures of selected compds. bound to the ternary complex of RAS, SOS1, and RAS were detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKmqxqetLkarVg90H21EOLACvtfcHk0lhYyfVSa8hKGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKktbvN&md5=cc878f4907f63c0a397b11a4e044654d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00360%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DJ.%2BR.%26aulast%3DHodges%26aufirst%3DT.%2BR.%26aulast%3DDaniels%26aufirst%3DR.%2BN.%26aulast%3DPatel%26aufirst%3DP.%2BA.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DHowes%26aufirst%3DJ.%2BE.%26aulast%3DAkan%26aufirst%3DD.%2BT.%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DSai%26aufirst%3DJ.%26aulast%3DSobolik%26aufirst%3DT.%26aulast%3DBeesetty%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520aminopiperidine%2520indoles%2520that%2520activate%2520the%2520guanine%2520nucleotide%2520exchange%2520factor%2520SOS1%2520and%2520modulate%2520RAS%2520signaling%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6002%26epage%3D6017%26doi%3D10.1021%2Facs.jmedchem.8b00360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browning, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of quinazolines that activate SOS1-mediated nucleotide exchange on RAS</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">941</span>– <span class="NLM_lpage">946</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00296</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00296" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOjsLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=941-946&author=J.+R.+Abbottauthor=P.+A.+Patelauthor=J.+E.+Howesauthor=D.+T.+Akanauthor=J.+P.+Kennedyauthor=M.+C.+Burnsauthor=C.+F.+Browningauthor=Q.+Sunauthor=O.+W.+Rossaneseauthor=J.+Phanauthor=A.+G.+Watersonauthor=S.+W.+Fesik&title=Discovery+of+quinazolines+that+activate+SOS1-mediated+nucleotide+exchange+on+RAS&doi=10.1021%2Facsmedchemlett.8b00296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Quinazolines That Activate SOS1-Mediated Nucleotide Exchange on RAS</span></div><div class="casAuthors">Abbott, Jason R.; Patel, Pratiq A.; Howes, Jennifer E.; Akan, Denis T.; Kennedy, J. Phillip; Burns, Michael C.; Browning, Carrie F.; Sun, Qi; Rossanese, Olivia W.; Phan, Jason; Waterson, Alex G.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">941-946</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proteins in the RAS family are important regulators of cellular signaling and, when mutated, can drive cancer pathogenesis.  Despite considerable effort over the last 30 years, RAS proteins have proven to be recalcitrant therapeutic targets.  One approach for modulating RAS signaling is to target proteins that interact with RAS, such as the guanine nucleotide exchange factor (GEF) son of sevenless homolog 1 (SOS1).  Here, we report hit-to-lead studies on quinazoline-contg. compds. that bind to SOS1 and activate nucleotide exchange on RAS.  Using structure-based design, we refined the substituents attached to the quinazoline nucleus and built in addnl. interactions not present in the initial HTS hit.  Optimized compds. activate nucleotide exchange at single-digit micromolar concns. in vitro.  In HeLa cells, these quinazolines increase the levels of RAS-GTP and cause signaling changes in the mitogen-activated protein kinase/extracellular regulated kinase (MAPK/ERK) pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQa6QZIgWHVrVg90H21EOLACvtfcHk0lhYyfVSa8hKGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOjsLzN&md5=54b395566e713f8debbc2de33cb92363</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00296%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DJ.%2BR.%26aulast%3DPatel%26aufirst%3DP.%2BA.%26aulast%3DHowes%26aufirst%3DJ.%2BE.%26aulast%3DAkan%26aufirst%3DD.%2BT.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DBrowning%26aufirst%3DC.%2BF.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520quinazolines%2520that%2520activate%2520SOS1-mediated%2520nucleotide%2520exchange%2520on%2520RAS%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D941%26epage%3D946%26doi%3D10.1021%2Facsmedchemlett.8b00296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hodges, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salovich, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browning, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobolik, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beesetty, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scharn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stadtmueller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure-based optimization of benzimidazole-derived activators of SOS1-mediated nucleotide exchange on RAS</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8875</span>– <span class="NLM_lpage">8894</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01108</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01108" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs12isrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8875-8894&author=T.+R.+Hodgesauthor=J.+R.+Abbottauthor=A.+J.+Littleauthor=D.+Sarkarauthor=J.+M.+Salovichauthor=J.+E.+Howesauthor=D.+T.+Akanauthor=J.+Saiauthor=A.+L.+Arnoldauthor=C.+Browningauthor=M.+C.+Burnsauthor=T.+Sobolikauthor=Q.+Sunauthor=Y.+Beesettyauthor=J.+A.+Cokerauthor=D.+Scharnauthor=H.+Stadtmuellerauthor=O.+W.+Rossaneseauthor=J.+Phanauthor=A.+G.+Watersonauthor=D.+B.+McConnellauthor=S.+W.+Fesik&title=Discovery+and+structure-based+optimization+of+benzimidazole-derived+activators+of+SOS1-mediated+nucleotide+exchange+on+RAS&doi=10.1021%2Facs.jmedchem.8b01108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Structure-Based Optimization of Benzimidazole-Derived Activators of SOS1-Mediated Nucleotide Exchange on RAS</span></div><div class="casAuthors">Hodges, Timothy R.; Abbott, Jason R.; Little, Andrew J.; Sarkar, Dhruba; Salovich, James M.; Howes, Jennifer E.; Akan, Denis T.; Sai, Jiqing; Arnold, Allison L.; Browning, Carrie; Burns, Michael C.; Sobolik, Tammy; Sun, Qi; Beesetty, Yugandhar; Coker, Jesse A.; Scharn, Dirk; Stadtmueller, Heinz; Rossanese, Olivia W.; Phan, Jason; Waterson, Alex G.; McConnell, Darryl B.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8875-8894</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Son of sevenless homolog 1 (SOS1) is a guanine nucleotide exchange factor that catalyzes the exchange of GDP for GTP on RAS.  In its active form, GTP-bound RAS is responsible for numerous crit. cellular processes.  Aberrant RAS activity is involved in ∼30% of all human cancers; hence, SOS1 is an attractive therapeutic target for its role in modulating RAS activation.  Here, we describe a new series of benzimidazole-derived SOS1 agonists.  Using structure-guided design, we discovered small mols. that increase nucleotide exchange on RAS in vitro at submicromolar concns., bind to SOS1 with low double-digit nanomolar affinity, rapidly enhance cellular RAS-GTP levels, and invoke biphasic signaling changes in phosphorylation of ERK 1/2.  These compds. represent the most potent series of SOS1 agonists reported to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnQbL1ADAtRrVg90H21EOLACvtfcHk0lhYyfVSa8hKGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs12isrnL&md5=3051827da87f015c260000ea7b2c7c34</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01108%26sid%3Dliteratum%253Aachs%26aulast%3DHodges%26aufirst%3DT.%2BR.%26aulast%3DAbbott%26aufirst%3DJ.%2BR.%26aulast%3DLittle%26aufirst%3DA.%2BJ.%26aulast%3DSarkar%26aufirst%3DD.%26aulast%3DSalovich%26aufirst%3DJ.%2BM.%26aulast%3DHowes%26aufirst%3DJ.%2BE.%26aulast%3DAkan%26aufirst%3DD.%2BT.%26aulast%3DSai%26aufirst%3DJ.%26aulast%3DArnold%26aufirst%3DA.%2BL.%26aulast%3DBrowning%26aufirst%3DC.%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DSobolik%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DBeesetty%26aufirst%3DY.%26aulast%3DCoker%26aufirst%3DJ.%2BA.%26aulast%3DScharn%26aufirst%3DD.%26aulast%3DStadtmueller%26aufirst%3DH.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DMcConnell%26aufirst%3DD.%2BB.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520and%2520structure-based%2520optimization%2520of%2520benzimidazole-derived%2520activators%2520of%2520SOS1-mediated%2520nucleotide%2520exchange%2520on%2520RAS%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8875%26epage%3D8894%26doi%3D10.1021%2Facs.jmedchem.8b01108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beesetty, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Small molecule SOS1 agonists modulate MAPK and PI3K signaling via independent cellular responses</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">331</span>, <span class="refDoi"> DOI: 10.1021/acschembio.8b00869</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.8b00869" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC1MXis1antLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=325-331&author=D.+T.+Akanauthor=J.+E.+Howesauthor=J.+Saiauthor=A.+L.+Arnoldauthor=Y.+Beesettyauthor=J.+Phanauthor=E.+T.+Olejniczakauthor=A.+G.+Watersonauthor=S.+W.+Fesik&title=Small+molecule+SOS1+agonists+modulate+MAPK+and+PI3K+signaling+via+independent+cellular+responses&doi=10.1021%2Facschembio.8b00869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule SOS1 Agonists Modulate MAPK and PI3K Signaling via Independent Cellular Responses</span></div><div class="casAuthors">Akan, Denis T.; Howes, Jennifer E.; Sai, Jiqing; Arnold, Allison L.; Beesetty, Yugandhar; Phan, Jason; Olejniczak, Edward T.; Waterson, Alex G.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">325-331</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activating mutations in RAS can lead to oncogenesis by enhancing downstream signaling, such as through the MAPK and PI3K pathways.  Therefore, therapeutically targeting RAS may perturb multiple signaling pathways simultaneously.  One method for modulating RAS signaling is to target the activity of the guanine nucleotide exchange factor SOS1.  Our lab. has discovered compds. that bind to SOS1 and activate RAS.  Interestingly, these SOS1 agonist compds. elicit biphasic modulation of ERK phosphorylation and simultaneous inhibition of AKT phosphorylation levels.  Here, we utilized multiple chem. distinct compds. to elucidate whether these effects on MAPK and PI3K signaling by SOS1 agonists were mechanistically linked.  In addn., we used CRISPR/Cas9 gene-editing to generate clonally derived SOS1 knockout cells and identified a potent SOS1 agonist that rapidly elicited on-target mol. effects at substantially lower concns. than those causing off-target effects.  Our findings will allow us to further define the on-target utility of SOS1 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM2e71hyVUI7Vg90H21EOLACvtfcHk0lgw_8fGYuq3mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXis1antLo%253D&md5=7363a92e067335fbeeaef3c8ab12120f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facschembio.8b00869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.8b00869%26sid%3Dliteratum%253Aachs%26aulast%3DAkan%26aufirst%3DD.%2BT.%26aulast%3DHowes%26aufirst%3DJ.%2BE.%26aulast%3DSai%26aufirst%3DJ.%26aulast%3DArnold%26aufirst%3DA.%2BL.%26aulast%3DBeesetty%26aufirst%3DY.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DSmall%2520molecule%2520SOS1%2520agonists%2520modulate%2520MAPK%2520and%2520PI3K%2520signaling%2520via%2520independent%2520cellular%2520responses%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2019%26volume%3D14%26spage%3D325%26epage%3D331%26doi%3D10.1021%2Facschembio.8b00869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beesetty, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of sulfonamide-derived agonists of SOS1-mediated nucleotide exchange on RAS using fragment-based methods</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">8325</span>– <span class="NLM_lpage">8337</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00511</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00511" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVSms7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=8325-8337&author=D.+Sarkarauthor=E.+T.+Olejniczakauthor=J.+Phanauthor=J.+A.+Cokerauthor=J.+Saiauthor=A.+Arnoldauthor=Y.+Beesettyauthor=A.+G.+Watersonauthor=S.+W.+Fesik&title=Discovery+of+sulfonamide-derived+agonists+of+SOS1-mediated+nucleotide+exchange+on+RAS+using+fragment-based+methods&doi=10.1021%2Facs.jmedchem.0c00511"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Sulfonamide-Derived Agonists of SOS1-Mediated Nucleotide Exchange on RAS Using Fragment-Based Methods</span></div><div class="casAuthors">Sarkar, Dhruba; Olejniczak, Edward T.; Phan, Jason; Coker, Jesse A.; Sai, Jiqing; Arnold, Allison; Beesetty, Yugandhar; Waterson, Alex G.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8325-8337</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The nucleotide exchange factor Son of Sevenless (SOS) catalyzes the activation of RAS by converting it from its inactive GDP-bound state to its active GTP-bound state.  Recently, we have reported the discovery of small-mol. allosteric activators of SOS1 that can increase the amt. of RAS-GTP in cells.  The compds. can inhibit ERK phosphorylation at higher concns. by engaging a feedback mechanism.  To further study this process, we sought different chem. matter from an NMR-based fragment screen using selective Me labeling.  To aid this process, several Ile Me groups located in different binding sites of the protein were assigned and used to categorize the NMR hits into different classes.  Hit to lead optimization using an iterative structure-based design paradigm resulted in compds. with improvements in binding affinity.  These improved mols. of a different chem. class increase SOS1cat-mediated nucleotide exchange on RAS and display cellular action consistent with our prior results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPzTCn-rMbv7Vg90H21EOLACvtfcHk0lgw_8fGYuq3mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVSms7rJ&md5=e317ae691b93e62df16db2cade902a1a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00511%26sid%3Dliteratum%253Aachs%26aulast%3DSarkar%26aufirst%3DD.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DCoker%26aufirst%3DJ.%2BA.%26aulast%3DSai%26aufirst%3DJ.%26aulast%3DArnold%26aufirst%3DA.%26aulast%3DBeesetty%26aufirst%3DY.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520sulfonamide-derived%2520agonists%2520of%2520SOS1-mediated%2520nucleotide%2520exchange%2520on%2520RAS%2520using%2520fragment-based%2520methods%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D8325%26epage%3D8337%26doi%3D10.1021%2Facs.jmedchem.0c00511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winter, J. J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blades, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brassington, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breeze, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chresta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Embrey, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairley, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faulder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, M. R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettle, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spadola, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigley, G.</span></span> <span> </span><span class="NLM_article-title">Small molecule binding sites on the RAS: SOS complex can be exploited for inhibition of RAS activation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2265</span>– <span class="NLM_lpage">2274</span>, <span class="refDoi"> DOI: 10.1021/jm501660t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501660t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivF2qu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2265-2274&author=J.+J.+G.+Winterauthor=M.+Andersonauthor=K.+Bladesauthor=C.+Brassingtonauthor=A.+L.+Breezeauthor=C.+Chrestaauthor=K.+Embreyauthor=G.+Fairleyauthor=P.+Faulderauthor=M.+R.+V.+Finlayauthor=J.+G.+Kettleauthor=T.+Nowakauthor=R.+Overmanauthor=S.+J.+Patelauthor=P.+Perkinsauthor=L.+Spadolaauthor=J.+Tartauthor=J.+A.+Tuckerauthor=G.+Wrigley&title=Small+molecule+binding+sites+on+the+RAS%3A+SOS+complex+can+be+exploited+for+inhibition+of+RAS+activation&doi=10.1021%2Fjm501660t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Binding Sites on the Ras:SOS Complex Can Be Exploited for Inhibition of Ras Activation</span></div><div class="casAuthors">Winter, Jon J. G.; Anderson, Malcolm; Blades, Kevin; Brassington, Claire; Breeze, Alexander L.; Chresta, Christine; Embrey, Kevin; Fairley, Gary; Faulder, Paul; Finlay, M. Raymond V.; Kettle, Jason G.; Nowak, Thorsten; Overman, Ross; Patel, S. Joe; Perkins, Paula; Spadola, Loredana; Tart, Jonathan; Tucker, Julie A.; Wrigley, Gail</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2265-2274</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Constitutively active mutant KRas displays a reduced rate of GTP hydrolysis via both intrinsic and GTPase-activating protein-catalyzed mechanisms, resulting in the perpetual activation of Ras pathways.  We describe a fragment screening campaign using X-ray crystallog. that led to the discovery of three fragment binding sites on the Ras:SOS complex.  The identification of tool compds. binding at each of these sites allowed exploration of two new approaches to Ras pathway inhibition by stabilizing or covalently modifying the Ras:SOS complex to prevent the reloading of Ras with GTP.  Initially, we identified ligands that bound reversibly to the Ras:SOS complex in two distinct sites, but these compds. were not sufficiently potent inhibitors to validate our stabilization hypothesis.  We conclude by demonstrating that covalent modification of Cys118 on Ras leads to a novel mechanism of inhibition of the SOS-mediated interaction between Ras and Raf and is effective at inhibiting the exchange of labeled GDP in both mutant (G12C and G12V) and wild type Ras.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfpT9XplX1v7Vg90H21EOLACvtfcHk0lgw_8fGYuq3mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivF2qu7w%253D&md5=b3747c8c9bb530d39c03ad56998d90f1</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm501660t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501660t%26sid%3Dliteratum%253Aachs%26aulast%3DWinter%26aufirst%3DJ.%2BJ.%2BG.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DBrassington%26aufirst%3DC.%26aulast%3DBreeze%26aufirst%3DA.%2BL.%26aulast%3DChresta%26aufirst%3DC.%26aulast%3DEmbrey%26aufirst%3DK.%26aulast%3DFairley%26aufirst%3DG.%26aulast%3DFaulder%26aufirst%3DP.%26aulast%3DFinlay%26aufirst%3DM.%2BR.%2BV.%26aulast%3DKettle%26aufirst%3DJ.%2BG.%26aulast%3DNowak%26aufirst%3DT.%26aulast%3DOverman%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%2BJ.%26aulast%3DPerkins%26aufirst%3DP.%26aulast%3DSpadola%26aufirst%3DL.%26aulast%3DTart%26aufirst%3DJ.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DWrigley%26aufirst%3DG.%26atitle%3DSmall%2520molecule%2520binding%2520sites%2520on%2520the%2520RAS%253A%2520SOS%2520complex%2520can%2520be%2520exploited%2520for%2520inhibition%2520of%2520RAS%2520activation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2265%26epage%3D2274%26doi%3D10.1021%2Fjm501660t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmachl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramharter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savarese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marszalek, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnhof, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumpel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botesteanu, D.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ettmayer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerstberger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kofink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wunberg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoephel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teh, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böttcher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pototschnig, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schachinger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schipany, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieb, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellano, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendes, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moll, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petronczki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heffernan, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraut, N.</span></span> <span> </span><span class="NLM_article-title">BI-3406, a potent and selective SOS1–KRAS interaction inhibitor, is effective in KRAS-driven cancers through combined MEK inhibition</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">142</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-20-0142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1158%2F2159-8290.CD-20-0142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=32816843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BB3MXmvVaksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2021&pages=142-157&author=M.+H.+Hofmannauthor=M.+Gmachlauthor=J.+Ramharterauthor=F.+Savareseauthor=D.+Gerlachauthor=J.+R.+Marszalekauthor=M.+P.+Sandersonauthor=D.+Kesslerauthor=F.+Trapaniauthor=H.+Arnhofauthor=K.+Rumpelauthor=D.-A.+Botesteanuauthor=P.+Ettmayerauthor=T.+Gerstbergerauthor=C.+Kofinkauthor=T.+Wunbergauthor=A.+Zoephelauthor=S.-C.+Fuauthor=J.+L.+Tehauthor=J.+B%C3%B6ttcherauthor=N.+Pototschnigauthor=F.+Schachingerauthor=K.+Schipanyauthor=S.+Liebauthor=C.+P.+Vellanoauthor=J.+C.+O%E2%80%99Connellauthor=R.+L.+Mendesauthor=J.+Mollauthor=M.+Petronczkiauthor=T.+P.+Heffernanauthor=M.+Pearsonauthor=D.+B.+McConnellauthor=N.+Kraut&title=BI-3406%2C+a+potent+and+selective+SOS1%E2%80%93KRAS+interaction+inhibitor%2C+is+effective+in+KRAS-driven+cancers+through+combined+MEK+inhibition&doi=10.1158%2F2159-8290.CD-20-0142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">BI-3406, a potent and selective S0S1-KRAS interaction inhibitor, is effective in KRAS-driven cancers through combined MEK inhibition</span></div><div class="casAuthors">Hofmann, Marco H.; Gmachl, Michael; Ramharter, Juergen; Savarese, Fabio; Gerlach, Daniel; Marszalek, Joseph R.; Sanderson, Michael P.; Kessler, Dirk; Trapani, Francesca; Arnhof, Heribert; Rumpel, Klaus; Botesteanu, Dana-Adriana; Ettmayer, Peter; Gerstberger, Thomas; Kofink, Christiane; Wunberg, Tobias; Zoephel, Andreas; Fu, Szu-Chin; Teh, Jessica L.; Bottcher, Jark; Pototschnig, Nikolai; Schachinger, Franziska; Schipany, Katharina; Lieb, Simone; Vellano, Christopher P.; O'Connell, Jonathan C.; Mendes, Rachel L.; Moll, Jurgen; Petronczki, Mark; Heffernan, Timothy R.; Pearson, Mark; McConnell, Darryl B.; Kraut, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">142-157</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">KRAS is the most frequently mutated driver of pancreatic, colorectal, and non-small cell lung cancers.  Direct KRAS blockade has proved challenging, and inhibition of a key downstream effector pathway, the RAF-MEK-ERK cascade, has shown limited success because of activation of feedback networks that keep the pathway in check.  We hypothesized that inhibiting SOS1, a KRAS activator and important feedback node, represents an effective approach to treat KRAS-driven cancers.  We report the discovery of a highly potent, selective, and orally bioavailable small-mol. SOS1 inhibitor, BI-3406, that binds to the catalytic domain of SOS1, thereby preventing the interaction with KRAS.  BI-3406 reduces formation of GTP-loaded RAS and limits cellular proliferation of a broad range of KRAS-driven cancers.  Importantly, BI-3406 attenuates feedback reactivation induced by MEK inhibitors and thereby enhances sensitivity of KRAS-dependent cancers to MEK inhibition.  Combined SOS1 and MEK inhibition represents a novel and effective therapeutic concept to address KRAS-driven tumors.  SIGNIFICANCE: To date, there are no effective targeted pan-KRAS therapies.  In-depth characterization of BI-3406 activity and identification of MEK inhibitors as effective combination partners provide an attractive therapeutic concept for the majority of KRAS-mutant cancers, including those fueled by the most prevalent mutant KRAS oncoproteins, G12D, G12V, G12C, and G13D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpniXCOKijflrVg90H21EOLACvtfcHk0lh1AVNNb1MlOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXmvVaksrY%253D&md5=3585ea93f4caddfe09e30b396c286e60</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-20-0142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-20-0142%26sid%3Dliteratum%253Aachs%26aulast%3DHofmann%26aufirst%3DM.%2BH.%26aulast%3DGmachl%26aufirst%3DM.%26aulast%3DRamharter%26aufirst%3DJ.%26aulast%3DSavarese%26aufirst%3DF.%26aulast%3DGerlach%26aufirst%3DD.%26aulast%3DMarszalek%26aufirst%3DJ.%2BR.%26aulast%3DSanderson%26aufirst%3DM.%2BP.%26aulast%3DKessler%26aufirst%3DD.%26aulast%3DTrapani%26aufirst%3DF.%26aulast%3DArnhof%26aufirst%3DH.%26aulast%3DRumpel%26aufirst%3DK.%26aulast%3DBotesteanu%26aufirst%3DD.-A.%26aulast%3DEttmayer%26aufirst%3DP.%26aulast%3DGerstberger%26aufirst%3DT.%26aulast%3DKofink%26aufirst%3DC.%26aulast%3DWunberg%26aufirst%3DT.%26aulast%3DZoephel%26aufirst%3DA.%26aulast%3DFu%26aufirst%3DS.-C.%26aulast%3DTeh%26aufirst%3DJ.%2BL.%26aulast%3DB%25C3%25B6ttcher%26aufirst%3DJ.%26aulast%3DPototschnig%26aufirst%3DN.%26aulast%3DSchachinger%26aufirst%3DF.%26aulast%3DSchipany%26aufirst%3DK.%26aulast%3DLieb%26aufirst%3DS.%26aulast%3DVellano%26aufirst%3DC.%2BP.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%2BC.%26aulast%3DMendes%26aufirst%3DR.%2BL.%26aulast%3DMoll%26aufirst%3DJ.%26aulast%3DPetronczki%26aufirst%3DM.%26aulast%3DHeffernan%26aufirst%3DT.%2BP.%26aulast%3DPearson%26aufirst%3DM.%26aulast%3DMcConnell%26aufirst%3DD.%2BB.%26aulast%3DKraut%26aufirst%3DN.%26atitle%3DBI-3406%252C%2520a%2520potent%2520and%2520selective%2520SOS1%25E2%2580%2593KRAS%2520interaction%2520inhibitor%252C%2520is%2520effective%2520in%2520KRAS-driven%2520cancers%2520through%2520combined%2520MEK%2520inhibition%26jtitle%3DCancer%2520Discovery%26date%3D2021%26volume%3D11%26spage%3D142%26epage%3D157%26doi%3D10.1158%2F2159-8290.CD-20-0142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hillig, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moosmayer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmann, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werbeck, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briem, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boemer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiske, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badock, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mastouri, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemeister, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahmann, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegener, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böhnke, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wortmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Nussbaum, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, B.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS–SOS1 interaction</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">2551</span>– <span class="NLM_lpage">2560</span>, <span class="refDoi"> DOI: 10.1073/pnas.1812963116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1073%2Fpnas.1812963116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=30683722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivVajs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=2551-2560&author=R.+C.+Hilligauthor=B.+Sautierauthor=J.+Schroederauthor=D.+Moosmayerauthor=A.+Hilpmannauthor=C.+M.+Stegmannauthor=N.+D.+Werbeckauthor=H.+Briemauthor=U.+Boemerauthor=J.+Weiskeauthor=V.+Badockauthor=J.+Mastouriauthor=K.+Petersenauthor=G.+Siemeisterauthor=J.+D.+Kahmannauthor=D.+Wegenerauthor=N.+B%C3%B6hnkeauthor=K.+Eisauthor=K.+Grahamauthor=L.+Wortmannauthor=F.+von+Nussbaumauthor=B.+Bader&title=Discovery+of+potent+SOS1+inhibitors+that+block+RAS+activation+via+disruption+of+the+RAS%E2%80%93SOS1+interaction&doi=10.1073%2Fpnas.1812963116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interaction</span></div><div class="casAuthors">Hillig, Roman C.; Sautier, Brice; Schroeder, Jens; Moosmayer, Dieter; Hilpmann, AndrA; Stegmann, Christian M.; Werbeck, Nicolas D.; Briem, Hans; Boemer, Ulf; Weiske, Joerg; Badock, Volker; Mastouri, Julia; Petersen, Kirstin; Siemeister, Gerhard; Kahmann, Jan D.; Wegener, Dennis; Boehnke, Niels; Eis, Knut; Graham, Keith; Wortmann, Lars; von Nussbaum, Franz; Bader, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2551-2560</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Since the late 1980s, mutations in the RAS genes have been recognized as major oncogenes with a high occurrence rate in human cancers.  Such mutations reduce the ability of the small GTPase RAS to hydrolyze GTP, keeping this mol. switch in a constitutively active GTP-bound form that drives, unchecked, oncogenic downstream signaling.  One strategy to reduce the levels of active RAS is to target guanine nucleotide exchange factors, which allow RAS to cycle from the inactive GDP-bound state to the active GTP-bound form.  Here, we describe the identification of potent and cell-active small-mol. inhibitors which efficiently disrupt the interaction between KRAS and its exchange factor SOS1, a mode of action confirmed by a series of biophys. techniques.  The binding sites, mode of action, and selectivity were elucidated using crystal structures of KRASG12C-SOS1, SOS1, and SOS2.  By preventing formation of the KRAS-SOS1 complex, these inhibitors block reloading of KRAS with GTP, leading to antiproliferative activity.  The final compd. 23(I, BAY-293) selectively inhibits the KRAS-SOS1 interaction with an IC50 of 21 nM and is a valuable chem. probe for future investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTMAcBZFHkBrVg90H21EOLACvtfcHk0lh1AVNNb1MlOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivVajs7w%253D&md5=f3150723049c15986cea1d7f93cb89af</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1812963116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1812963116%26sid%3Dliteratum%253Aachs%26aulast%3DHillig%26aufirst%3DR.%2BC.%26aulast%3DSautier%26aufirst%3DB.%26aulast%3DSchroeder%26aufirst%3DJ.%26aulast%3DMoosmayer%26aufirst%3DD.%26aulast%3DHilpmann%26aufirst%3DA.%26aulast%3DStegmann%26aufirst%3DC.%2BM.%26aulast%3DWerbeck%26aufirst%3DN.%2BD.%26aulast%3DBriem%26aufirst%3DH.%26aulast%3DBoemer%26aufirst%3DU.%26aulast%3DWeiske%26aufirst%3DJ.%26aulast%3DBadock%26aufirst%3DV.%26aulast%3DMastouri%26aufirst%3DJ.%26aulast%3DPetersen%26aufirst%3DK.%26aulast%3DSiemeister%26aufirst%3DG.%26aulast%3DKahmann%26aufirst%3DJ.%2BD.%26aulast%3DWegener%26aufirst%3DD.%26aulast%3DB%25C3%25B6hnke%26aufirst%3DN.%26aulast%3DEis%26aufirst%3DK.%26aulast%3DGraham%26aufirst%3DK.%26aulast%3DWortmann%26aufirst%3DL.%26aulast%3Dvon%2BNussbaum%26aufirst%3DF.%26aulast%3DBader%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520potent%2520SOS1%2520inhibitors%2520that%2520block%2520RAS%2520activation%2520via%2520disruption%2520of%2520the%2520RAS%25E2%2580%2593SOS1%2520interaction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26spage%3D2551%26epage%3D2560%26doi%3D10.1073%2Fpnas.1812963116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gort, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dünzinger, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riemann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitzing, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janne, P. A.</span></span> <span> </span><span class="NLM_article-title">A phase I, open-label, dose-escalation trial of BI 1701963 as monotherapy and in combination with trametinib in patients with KRAS mutated advanced or metastatic solid tumors</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">TPS3651</span>, <span class="refDoi"> DOI: 10.1200/JCO.2020.38.15_suppl.TPS3651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1200%2FJCO.2020.38.15_suppl.TPS3651" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=TPS3651&author=E.+Gortauthor=M.+L.+Johnsonauthor=J.+J.+Hwangauthor=S.+Pantauthor=U.+D%C3%BCnzingerauthor=K.+Riemannauthor=T.+Kitzingauthor=P.+A.+Janne&title=A+phase+I%2C+open-label%2C+dose-escalation+trial+of+BI+1701963+as+monotherapy+and+in+combination+with+trametinib+in+patients+with+KRAS+mutated+advanced+or+metastatic+solid+tumors&doi=10.1200%2FJCO.2020.38.15_suppl.TPS3651"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1200%2FJCO.2020.38.15_suppl.TPS3651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2020.38.15_suppl.TPS3651%26sid%3Dliteratum%253Aachs%26aulast%3DGort%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DM.%2BL.%26aulast%3DHwang%26aufirst%3DJ.%2BJ.%26aulast%3DPant%26aufirst%3DS.%26aulast%3DD%25C3%25BCnzinger%26aufirst%3DU.%26aulast%3DRiemann%26aufirst%3DK.%26aulast%3DKitzing%26aufirst%3DT.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26atitle%3DA%2520phase%2520I%252C%2520open-label%252C%2520dose-escalation%2520trial%2520of%2520BI%25201701963%2520as%2520monotherapy%2520and%2520in%2520combination%2520with%2520trametinib%2520in%2520patients%2520with%2520KRAS%2520mutated%2520advanced%2520or%2520metastatic%2520solid%2520tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2020%26spage%3DTPS3651%26doi%3D10.1200%2FJCO.2020.38.15_suppl.TPS3651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vo, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajpai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flavell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobby, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breeze, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Embrey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golovanov, A. P.</span></span> <span> </span><span class="NLM_article-title">Monitoring RAS interactions with the nucleotide exchange factor Son of Sevenless (SOS) using site-specific NMR reporter signals and intrinsic fluorescence</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">1703</span>– <span class="NLM_lpage">1718</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.691238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1074%2Fjbc.M115.691238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=26565026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Oiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=1703-1718&author=U.+Voauthor=N.+Vajpaiauthor=L.+Flavellauthor=R.+Bobbyauthor=A.+L.+Breezeauthor=K.+J.+Embreyauthor=A.+P.+Golovanov&title=Monitoring+RAS+interactions+with+the+nucleotide+exchange+factor+Son+of+Sevenless+%28SOS%29+using+site-specific+NMR+reporter+signals+and+intrinsic+fluorescence&doi=10.1074%2Fjbc.M115.691238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Monitoring Ras Interactions with the Nucleotide Exchange Factor Son of Sevenless (Sos) Using Site-specific NMR Reporter Signals and Intrinsic Fluorescence</span></div><div class="casAuthors">Vo, Uybach; Vajpai, Navratna; Flavell, Liz; Bobby, Romel; Breeze, Alexander L.; Embrey, Kevin J.; Golovanov, Alexander P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1703-1718</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The activity of Ras is controlled by the interconversion between GTP- and GDP-bound forms partly regulated by the binding of the guanine nucleotide exchange factor Son of Sevenless (Sos).  The details of Sos binding, leading to nucleotide exchange and subsequent dissocn. of the complex, are not completely understood.  Here, we used uniformly 15N-labeled Ras as well as [13C]methyl-Met,Ile-labeled Sos for observing site-specific details of Ras-Sos interactions in soln.  Binding of various forms of Ras (loaded with GDP and mimics of GTP or nucleotide-free) at the allosteric and catalytic sites of Sos was comprehensively characterized by monitoring signal perturbations in the NMR spectra.  The overall affinity of binding between these protein variants as well as their selected functional mutants was also investigated using intrinsic fluorescence.  The data support a pos. feedback activation of Sos by Ras·GTP with Ras·GTP binding as a substrate for the catalytic site of activated Sos more weakly than Ras·GDP, suggesting that Sos should actively promote unidirectional GDP → GTP exchange on Ras in preference of passive homonucleotide exchange.  Ras·GDP weakly binds to the catalytic but not to the allosteric site of Sos.  This confirms that Ras·GDP cannot properly activate Sos at the allosteric site.  The novel site-specific assay described may be useful for design of drugs aimed at perturbing Ras-Sos interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC4WLlh0gWRrVg90H21EOLACvtfcHk0liXe6IGPUpYSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Oiu7c%253D&md5=b18d6754805fed13189f663eef60d704</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.691238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.691238%26sid%3Dliteratum%253Aachs%26aulast%3DVo%26aufirst%3DU.%26aulast%3DVajpai%26aufirst%3DN.%26aulast%3DFlavell%26aufirst%3DL.%26aulast%3DBobby%26aufirst%3DR.%26aulast%3DBreeze%26aufirst%3DA.%2BL.%26aulast%3DEmbrey%26aufirst%3DK.%2BJ.%26aulast%3DGolovanov%26aufirst%3DA.%2BP.%26atitle%3DMonitoring%2520RAS%2520interactions%2520with%2520the%2520nucleotide%2520exchange%2520factor%2520Son%2520of%2520Sevenless%2520%2528SOS%2529%2520using%2520site-specific%2520NMR%2520reporter%2520signals%2520and%2520intrinsic%2520fluorescence%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D1703%26epage%3D1718%26doi%3D10.1074%2Fjbc.M115.691238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ullman, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirakossian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvin, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pease, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Switchenko, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dafforn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skold, C. N.</span></span> <span> </span><span class="NLM_article-title">Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">5426</span>– <span class="NLM_lpage">5430</span>, <span class="refDoi"> DOI: 10.1073/pnas.91.12.5426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1073%2Fpnas.91.12.5426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=8202502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADyaK2cXkslOltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=5426-5430&author=E.+F.+Ullmanauthor=H.+Kirakossianauthor=S.+Singhauthor=Z.+P.+Wuauthor=B.+R.+Irvinauthor=J.+S.+Peaseauthor=A.+C.+Switchenkoauthor=J.+D.+Irvineauthor=A.+Daffornauthor=C.+N.+Skold&title=Luminescent+oxygen+channeling+immunoassay%3A+measurement+of+particle+binding+kinetics+by+chemiluminescence&doi=10.1073%2Fpnas.91.12.5426"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence</span></div><div class="casAuthors">Ullman, Edwin F.; Kirakossian, Hrair; Singh, Sharat; Wu, Z. Ping; Irvin, Benjamin R.; Pease, John S.; Switchenko, Arthur C.; Irvine, Jennifer D.; Dafforn, Alan; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5426-30</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A method for monitoring formation of latex particle pairs by chemiluminescence is described.  Mol. oxygen is excited by a photosensitizer and an antenna dye that are dissolved in one of the particles.  1ΔgO2 diffuses to the second particle and initiates a high quantum yield chemiluminescent reaction of an olefin that is dissolved in it.  The efficiency of 1ΔgO2 transfer between particles is ≈3.5%.  The technique permits real-time measurement of particle binding kinetics.  Second-order rate consts. increase with the no. of receptor binding sites on the particles and approach diffusion control.  By using antibody-coated particles, a homogeneous immunoassay capable of detecting ≈4 amol of TSH in 12 min was demonstrated.  Single mols. of analyte produce particle heterodimers that are detected even when no larger aggregates are formed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwMnBw0EdzeLVg90H21EOLACvtfcHk0liXe6IGPUpYSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslOltLc%253D&md5=3e4120f789cab9d35dbe7586c584fcbe</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.12.5426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.12.5426%26sid%3Dliteratum%253Aachs%26aulast%3DUllman%26aufirst%3DE.%2BF.%26aulast%3DKirakossian%26aufirst%3DH.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DZ.%2BP.%26aulast%3DIrvin%26aufirst%3DB.%2BR.%26aulast%3DPease%26aufirst%3DJ.%2BS.%26aulast%3DSwitchenko%26aufirst%3DA.%2BC.%26aulast%3DIrvine%26aufirst%3DJ.%2BD.%26aulast%3DDafforn%26aufirst%3DA.%26aulast%3DSkold%26aufirst%3DC.%2BN.%26atitle%3DLuminescent%2520oxygen%2520channeling%2520immunoassay%253A%2520measurement%2520of%2520particle%2520binding%2520kinetics%2520by%2520chemiluminescence%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D5426%26epage%3D5430%26doi%3D10.1073%2Fpnas.91.12.5426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manly, S. P.</span></span> <span> </span><span class="NLM_article-title">Use of a novel homogeneous fluorescent technology in high throughput screening</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1177/108705719600100407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1177%2F108705719600100407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADyaK2sXkslentQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1996&pages=203-210&author=J.+M.+Kolbauthor=G.+Yamanakaauthor=S.+P.+Manly&title=Use+of+a+novel+homogeneous+fluorescent+technology+in+high+throughput+screening&doi=10.1177%2F108705719600100407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Use of a novel homogeneous fluorescent technology in high throughput screening</span></div><div class="casAuthors">Kolb, Janet M.; Yamanaka, Gregory; Manly, Susan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">203-210</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Liebert</span>)
        </div><div class="casAbstract">A new fluorescent technol. called homogeneous time-resolved fluorescence (HTRF) is sensitive, homogeneous, and quite tolerant to extremes in reaction conditions.  These characteristics make this technique an attractive candidate for use in high throughput screens.  The assay system uses a pair of fluorescent compds. to label biomols.  The long-lived nature of the fluorescence of one of them, europium cryptate, facilitates the homogeneous nature of the assay.  Furthermore, the introduction of a time delay in reading the signal eliminates the principal difficulty in applying fluorescence to screening formats, that of endogenous fluorescence of samples tested (esp. natural products).  This technique is robust and sensitive, and we report here its utility in a high throughput screening format.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR0vwlq8y4nrVg90H21EOLACvtfcHk0lgjDXvSoDXduA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkslentQ%253D%253D&md5=a5987378faf61c2baebfb2d9fd3d58be</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1177%2F108705719600100407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705719600100407%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DJ.%2BM.%26aulast%3DYamanaka%26aufirst%3DG.%26aulast%3DManly%26aufirst%3DS.%2BP.%26atitle%3DUse%2520of%2520a%2520novel%2520homogeneous%2520fluorescent%2520technology%2520in%2520high%2520throughput%2520screening%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D1996%26volume%3D1%26spage%3D203%26epage%3D210%26doi%3D10.1177%2F108705719600100407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruns, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, I. A.</span></span> <span> </span><span class="NLM_article-title">Rules for identifying potentially reactive or promiscuous compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9763</span>– <span class="NLM_lpage">9772</span>, <span class="refDoi"> DOI: 10.1021/jm301008n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301008n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFSgs7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9763-9772&author=R.+F.+Brunsauthor=I.+A.+Watson&title=Rules+for+identifying+potentially+reactive+or+promiscuous+compounds&doi=10.1021%2Fjm301008n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Rules for Identifying Potentially Reactive or Promiscuous Compounds</span></div><div class="casAuthors">Bruns, Robert F.; Watson, Ian A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9763-9772</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This article describes a set of 275 rules, developed over an 18-yr period, used to identify compds. that may interfere with biol. assays, allowing their removal from screening sets.  Reasons for rejection include reactivity (e.g., acyl halides), interference with assay measurements (fluorescence, absorbance, quenching), activities that damage proteins (oxidizers, detergents), instability (e.g., latent aldehydes), and lack of druggability (e.g., compds. lacking both oxygen and nitrogen).  The structural queries were profiled for frequency of occurrence in druglike and nondruglike compd. sets and were extensively reviewed by a panel of experienced medicinal chemists.  As a means of profiling the rules and as a filter in its own right, an index of biol. promiscuity was developed.  The 584 gene targets with screening data at Lilly were assigned to 17 subfamilies, and the no. of subfamilies at which a compd. was active was used as a promiscuity index.  For certain compds., promiscuous activity disappeared after sample repurifn., indicating interference from occult contaminants.  Because this type of interference is not amenable to substructure search, a "nuisance list" was developed to flag interfering compds. that passed the substructure rules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNvXr0QeH2l7Vg90H21EOLACvtfcHk0lgjDXvSoDXduA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFSgs7bP&md5=3c37f5513b3859e0180686e99d83d30c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm301008n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301008n%26sid%3Dliteratum%253Aachs%26aulast%3DBruns%26aufirst%3DR.%2BF.%26aulast%3DWatson%26aufirst%3DI.%2BA.%26atitle%3DRules%2520for%2520identifying%2520potentially%2520reactive%2520or%2520promiscuous%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9763%26epage%3D9772%26doi%3D10.1021%2Fjm301008n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoephel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraemer, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himmelsbach, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haaksma, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adolf, G. R.</span></span> <span> </span><span class="NLM_article-title">Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blocker</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>343</i></span>,  <span class="NLM_fpage">342</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1124/jpet.112.197756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1124%2Fjpet.112.197756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=22888144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKktbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2012&pages=342-350&author=F.+Solcaauthor=G.+Dahlauthor=A.+Zoephelauthor=G.+Baderauthor=M.+Sandersonauthor=C.+Kleinauthor=O.+Kraemerauthor=F.+Himmelsbachauthor=E.+Haaksmaauthor=G.+R.+Adolf&title=Target+binding+properties+and+cellular+activity+of+afatinib+%28BIBW+2992%29%2C+an+irreversible+ErbB+family+blocker&doi=10.1124%2Fjpet.112.197756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blocker</span></div><div class="casAuthors">Solca, Flavio; Dahl, Goeran; Zoephel, Andreas; Bader, Gerd; Sanderson, Michael; Klein, Christian; Kraemer, Oliver; Himmelsbach, Frank; Haaksma, Eric; Adolf, Guenther R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">342-350</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Deregulation of the ErbB (proto-oncogene B of the avian erythroblastosis virus AEV-H strain) receptor network is well recognized as an oncogenic driver in epithelial cancers.  Several targeted drugs have been developed, including antibodies and small-mol. kinase inhibitors, each of them characterized by distinct patterns of ErbB receptor interactions.  Understanding the precise pharmacol. properties of these compds. is important for optimal use in clin. practice.  Afatinib [BIBW 2992; N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide] is an ATP-competitive anilinoquinazoline deriv. harboring a reactive acrylamide group.  It was designed to covalently bind and irreversibly block enzymically active ErbB receptor family members.  Here, we show by X-ray crystallog. the covalent binding of afatinib to wild-type epidermal growth factor receptor (EGFR) and by mass spectrometry the covalent interaction with EGFR, EGFRL858R/T790M, human epidermal growth factor receptor 2 (HER2), and ErbB-4.  Afatinib potently inhibits the enzymatic activity of ErbB-4 (EC50 = 1 nM) and the proliferation of cancer cell lines driven by multiple ErbB receptor aberrations at concns. below 100 nM.  N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butanamide (BI 37781), a close analog of afatinib lacking the acrylamide group and thus incapable of covalent bond formation, had similar potency on cells driven by EGFR or EGFRL858R, but less or no detectable activity on cells expressing EGFRL858R/T790M HER2 or ErbB-4.  These results stress the importance of the acrylamide group and show that afatinib differs from approved ErbB targeting agents by irreversibly inhibiting the kinase activity of all ErbB family members.  They provide a mechanistic rationale for the distinct pharmacol. features of this compd. and explain the clin. activity seen in some patients who are resistant to antibody or kinase inhibitor therapy because of secondary mutations or ErbB receptor "reprogramming.".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofXgQqaKXv-bVg90H21EOLACvtfcHk0lgjDXvSoDXduA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKktbzE&md5=4a57df32abe8101f287fc6251f63f92d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.197756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.197756%26sid%3Dliteratum%253Aachs%26aulast%3DSolca%26aufirst%3DF.%26aulast%3DDahl%26aufirst%3DG.%26aulast%3DZoephel%26aufirst%3DA.%26aulast%3DBader%26aufirst%3DG.%26aulast%3DSanderson%26aufirst%3DM.%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DKraemer%26aufirst%3DO.%26aulast%3DHimmelsbach%26aufirst%3DF.%26aulast%3DHaaksma%26aufirst%3DE.%26aulast%3DAdolf%26aufirst%3DG.%2BR.%26atitle%3DTarget%2520binding%2520properties%2520and%2520cellular%2520activity%2520of%2520afatinib%2520%2528BIBW%25202992%2529%252C%2520an%2520irreversible%2520ErbB%2520family%2520blocker%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D343%26spage%3D342%26epage%3D350%26doi%3D10.1124%2Fjpet.112.197756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krissinel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrick, K.</span></span> <span> </span><span class="NLM_article-title">Inference of macromolecular assemblies from crystalline state</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>372</i></span>,  <span class="NLM_fpage">774</span>– <span class="NLM_lpage">797</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2007.05.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1016%2Fj.jmb.2007.05.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=17681537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvFGktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2007&pages=774-797&author=E.+Krissinelauthor=K.+Henrick&title=Inference+of+macromolecular+assemblies+from+crystalline+state&doi=10.1016%2Fj.jmb.2007.05.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Inference of Macromolecular Assemblies from Crystalline State</span></div><div class="casAuthors">Krissinel, Evgeny; Henrick, Kim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">774-797</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The authors discuss basic phys.-chem. principles underlying the formation of stable macromol. complexes, which in many cases are likely to be the biol. units performing a certain physiol. function.  The authors also consider available theor. approaches to the calcn. of macromol. affinity and entropy of complexation.  The latter is shown to play an important role and make a major effect on complex size and symmetry.  The authors develop a new method, based on chem. thermodn., for automatic detection of macromol. assemblies in the Protein Data Bank (PDB) entries that are the results of x-ray diffraction expts.  As found, biol. units may be recovered at 80-90% success rate, which makes x-ray crystallog. an important source of exptl. data on macromol. complexes and protein-protein interactions.  The method is implemented as a public WWW service (http://www.ebi.ac.uk/msd-srv/prot_int/pistart.html).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3cilBvVoBS7Vg90H21EOLACvtfcHk0lgjDXvSoDXduA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvFGktb8%253D&md5=a5c764cfc7dc129f53ddc31ef9d475fa</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2007.05.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2007.05.022%26sid%3Dliteratum%253Aachs%26aulast%3DKrissinel%26aufirst%3DE.%26aulast%3DHenrick%26aufirst%3DK.%26atitle%3DInference%2520of%2520macromolecular%2520assemblies%2520from%2520crystalline%2520state%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2007%26volume%3D372%26spage%3D774%26epage%3D797%26doi%3D10.1016%2Fj.jmb.2007.05.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lake, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corrêa, S. A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, J.</span></span> <span> </span><span class="NLM_article-title">Negative feedback regulation of the ERK1/2 MAPK pathway</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">4397</span>– <span class="NLM_lpage">4413</span>, <span class="refDoi"> DOI: 10.1007/s00018-016-2297-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1007%2Fs00018-016-2297-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=27342992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKnsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2016&pages=4397-4413&author=D.+Lakeauthor=S.+A.+L.+Corr%C3%AAaauthor=J.+M%C3%BCller&title=Negative+feedback+regulation+of+the+ERK1%2F2+MAPK+pathway&doi=10.1007%2Fs00018-016-2297-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Negative feedback regulation of the ERK1/2 MAPK pathway</span></div><div class="casAuthors">Lake, David; Correa, Sonia A. L.; Muller, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4397-4413</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">The extracellular signal-regulated kinase 1/2 (ERK1/2) mitogen-activated protein kinase (MAPK) signalling pathway regulates many cellular functions, including proliferation, differentiation, and transformation.  To reliably convert external stimuli into specific cellular responses and to adapt to environmental circumstances, the pathway must be integrated into the overall signalling activity of the cell.  Multiple mechanisms have evolved to perform this role.  In this review, we will focus on neg. feedback mechanisms and examine how they shape ERK1/2 MAPK signalling.  We will first discuss the extensive no. of neg. feedback loops targeting the different components of the ERK1/2 MAPK cascade, specifically the direct posttranslational modification of pathway components by downstream protein kinases and the induction of de novo gene synthesis of specific pathway inhibitors.  We will then evaluate how neg. feedback modulates the spatiotemporal signaling dynamics of the ERK1/2 pathway regarding signalling amplitude and duration as well as subcellular localization.  Aberrant ERK1/2 activation results in deregulated proliferation and malignant transformation in model systems and is commonly obsd. in human tumors.  Inhibition of the ERK1/2 pathway thus represents an attractive target for the treatment of malignant tumors with increased ERK1/2 activity.  We will, therefore, discuss the effect of ERK1/2 MAPK feedback regulation on cancer treatment and how it contributes to reduced clin. efficacy of therapeutic agents and the development of drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp87DxI-wQqDbVg90H21EOLACvtfcHk0lg6xJoETfUmHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKnsLrE&md5=d86b8f7d4e26d4421e65430ddd8a9cac</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs00018-016-2297-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-016-2297-8%26sid%3Dliteratum%253Aachs%26aulast%3DLake%26aufirst%3DD.%26aulast%3DCorr%25C3%25AAa%26aufirst%3DS.%2BA.%2BL.%26aulast%3DM%25C3%25BCller%26aufirst%3DJ.%26atitle%3DNegative%2520feedback%2520regulation%2520of%2520the%2520ERK1%252F2%2520MAPK%2520pathway%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2016%26volume%3D73%26spage%3D4397%26epage%3D4413%26doi%3D10.1007%2Fs00018-016-2297-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Misale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatherree, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timonina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Caraballo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nangia, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greninger, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClanaghan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murchie, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janes, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hata, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benes, C. H.</span></span> <span> </span><span class="NLM_article-title">KRAS G12C NSCLC models are sensitive to direct targeting of KRAS in combination with PI3K inhibition</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">796</span>– <span class="NLM_lpage">807</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-18-0368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.1158%2F1078-0432.CCR-18-0368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=30327306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1KqsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=796-807&author=S.+Misaleauthor=J.+P.+Fatherreeauthor=E.+Cortezauthor=C.+Liauthor=S.+Biltonauthor=D.+Timoninaauthor=D.+T.+Myersauthor=D.+Leeauthor=M.+Gomez-Caraballoauthor=M.+Greenbergauthor=V.+Nangiaauthor=P.+Greningerauthor=R.+K.+Eganauthor=J.+McClanaghanauthor=G.+T.+Steinauthor=E.+Murchieauthor=P.+P.+Zarrinkarauthor=M.+R.+Janesauthor=L.-S.+Liauthor=Y.+Liuauthor=A.+N.+Hataauthor=C.+H.+Benes&title=KRAS+G12C+NSCLC+models+are+sensitive+to+direct+targeting+of+KRAS+in+combination+with+PI3K+inhibition&doi=10.1158%2F1078-0432.CCR-18-0368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">KRAS G12C NSCLC models are sensitive to direct targeting of KRAS in combination with PI3K inhibition</span></div><div class="casAuthors">Misale, Sandra; Fatherree, Jackson P.; Cortez, Eliane; Li, Chendi; Bilton, Samantha; Timonina, Daria; Myers, David T.; Lee, Dana; Gomez-Caraballo, Maria; Greenberg, Max; Nangia, Varuna; Greninger, Patricia; Egan, Regina K.; McClanaghan, Joseph; Stein, Giovanna T.; Murchie, Ellen; Zarrinkar, Patrick P.; Janes, Matthew R.; Li, Lian-Sheng; Liu, Yi; Hata, Aaron N.; Benes, Cyril H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">796-807</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: KRAS-mutant lung cancers have been recalcitrant to treatments including those targeting the MAPK pathway.  Covalent inhibitors of KRAS p.G12C allele allow for direct and specific inhibition of mutant KRAS in cancer cells.  However, as for other targeted therapies, the therapeutic potential of these inhibitors can be impaired by intrinsic resistance mechanisms.  Therefore, combination strategies are likely needed to improve efficacy.  Exptl. Design: To identify strategies to maximally leverage direct KRAS inhibition we defined the response of a panel of NSCLC models bearing the KRAS G12C-activating mutation in vitro and in vivo.  We used a second-generation KRAS G12C inhibitor, ARS1620 with improved bioavailability over the first generation.  We analyzed KRAS downstream effectors signaling to identify mechanisms underlying differential response.  To identify candidate combination strategies, we performed a high-throughput drug screening across 112 drugs in combination with ARS1620.  We validated the top hits in vitro and in vivo including patient-derived xenograft models.  Results: Response to direct KRAS G12C inhibition was heterogeneous across models.  Adaptive resistance mechanisms involving reactivation of MAPK pathway and failure to induce PI3K-AKT pathway inactivation were identified as likely resistance events.  We identified several model-specific effective combinations as well as a broad-sensitizing effect of PI3K-AKT-mTOR pathway inhibitors.  The G12Ci + PI3Ki combination was effective in vitro and in vivo on models resistant to single-agent ARS1620 including patient-derived xenografts models.  Conclusions: Our findings suggest that signaling adaptation can in some instances limit the efficacy of ARS1620 but combination with PI3K inhibitors can overcome this resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ9CSuz3bIGrVg90H21EOLACvtfcHk0lg6xJoETfUmHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1KqsLrL&md5=85f20279b886aadf5e1ece9806b58774</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-18-0368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-18-0368%26sid%3Dliteratum%253Aachs%26aulast%3DMisale%26aufirst%3DS.%26aulast%3DFatherree%26aufirst%3DJ.%2BP.%26aulast%3DCortez%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DBilton%26aufirst%3DS.%26aulast%3DTimonina%26aufirst%3DD.%26aulast%3DMyers%26aufirst%3DD.%2BT.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DGomez-Caraballo%26aufirst%3DM.%26aulast%3DGreenberg%26aufirst%3DM.%26aulast%3DNangia%26aufirst%3DV.%26aulast%3DGreninger%26aufirst%3DP.%26aulast%3DEgan%26aufirst%3DR.%2BK.%26aulast%3DMcClanaghan%26aufirst%3DJ.%26aulast%3DStein%26aufirst%3DG.%2BT.%26aulast%3DMurchie%26aufirst%3DE.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DJanes%26aufirst%3DM.%2BR.%26aulast%3DLi%26aufirst%3DL.-S.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHata%26aufirst%3DA.%2BN.%26aulast%3DBenes%26aufirst%3DC.%2BH.%26atitle%3DKRAS%2520G12C%2520NSCLC%2520models%2520are%2520sensitive%2520to%2520direct%2520targeting%2520of%2520KRAS%2520in%2520combination%2520with%2520PI3K%2520inhibition%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2019%26volume%3D25%26spage%3D796%26epage%3D807%26doi%3D10.1158%2F1078-0432.CCR-18-0368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Theard, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheffels, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sealover, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linke, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratico, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortum, R. L.</span></span> <span> </span><span class="NLM_article-title">Marked synergy by vertical inhibition of EGFR signaling in NSCLC spheroids shows SOS1 is a therapeutic target in EGFR-mutated cancer</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e58204</span> <span class="refDoi"> DOI: 10.7554/eLife.58204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=10.7554%2FeLife.58204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=32897190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisVegtL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2020&author=P.+L.+Theardauthor=E.+Sheffelsauthor=N.+E.+Sealoverauthor=A.+J.+Linkeauthor=D.+J.+Praticoauthor=R.+L.+Kortum&title=Marked+synergy+by+vertical+inhibition+of+EGFR+signaling+in+NSCLC+spheroids+shows+SOS1+is+a+therapeutic+target+in+EGFR-mutated+cancer&doi=10.7554%2FeLife.58204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Marked synergy by vertical inhibition of EGFR signaling in NSCLC spheroids shows SOS1 is a therapeutic target in EGFR-mutated cancer</span></div><div class="casAuthors">Theard, Patricia L.; Sheffels, Erin; Sealover, Nancy E.; Linke, Amanda J.; Pratico, David J.; Kortum, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e58204</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">Drug treatment of 3D cancer spheroids more accurately reflects in vivo therapeutic responses compared to adherent culture studies.  In EGFR-mutated lung adenocarcinoma, EGFR-TKIs show enhanced efficacy in spheroid cultures.  Simultaneous inhibition of multiple parallel RTKs further enhances EGFR-TKI effectiveness.  We show that the common RTK signaling intermediate SOS1 was required for 3D spheroid growth of EGFR-mutated NSCLC cells.  Using two distinct measures of pharmacol. synergy, we demonstrated that SOS1 inhibition strongly synergized with EGFR-TKI treatment only in 3D spheroid cultures.  Combined EGFR- and SOS1-inhibition markedly inhibited Raf/MEK/ERK and PI3K/AKT signaling.  Finally, broad assessment of the pharmacol. landscape of drug-drug interactions downstream of mutated EGFR revealed synergy when combining an EGFR-TKI with inhibitors of proximal signaling intermediates SOS1 and SHP2, but not inhibitors of downstream RAS effector pathways.  These data indicate that vertical inhibition of proximal EGFR signaling should be pursued as a potential therapy to treat EGFR-mutated tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa-zJDCCKbEbVg90H21EOLACvtfcHk0lg6xJoETfUmHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisVegtL3E&md5=e0caec93215766d8dd633b45cd3b5997</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.7554%2FeLife.58204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.58204%26sid%3Dliteratum%253Aachs%26aulast%3DTheard%26aufirst%3DP.%2BL.%26aulast%3DSheffels%26aufirst%3DE.%26aulast%3DSealover%26aufirst%3DN.%2BE.%26aulast%3DLinke%26aufirst%3DA.%2BJ.%26aulast%3DPratico%26aufirst%3DD.%2BJ.%26aulast%3DKortum%26aufirst%3DR.%2BL.%26atitle%3DMarked%2520synergy%2520by%2520vertical%2520inhibition%2520of%2520EGFR%2520signaling%2520in%2520NSCLC%2520spheroids%2520shows%2520SOS1%2520is%2520a%2520therapeutic%2520target%2520in%2520EGFR-mutated%2520cancer%26jtitle%3DeLife%26date%3D2020%26volume%3D9%26doi%3D10.7554%2FeLife.58204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Landrieu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanoulle, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonachera, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibille, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieruszeski, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuagniaux, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippens, G.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the non-immunosuppressive character of the cyclosporin A analogue Debio 025</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4679</span>– <span class="NLM_lpage">4686</span>, <span class="refDoi"> DOI: 10.1021/bi1003266</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi1003266" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFyksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=4679-4686&author=I.+Landrieuauthor=X.+Hanoulleauthor=F.+Bonacheraauthor=A.+Hamelauthor=N.+Sibilleauthor=Y.+Yinauthor=J.-M.+Wieruszeskiauthor=D.+Horvathauthor=Q.+Weiauthor=G.+Vuagniauxauthor=G.+Lippens&title=Structural+basis+for+the+non-immunosuppressive+character+of+the+cyclosporin+A+analogue+Debio+025&doi=10.1021%2Fbi1003266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Non-Immunosuppressive Character of the Cyclosporin A Analogue Debio 025</span></div><div class="casAuthors">Landrieu, Isabelle; Hanoulle, Xavier; Bonachera, Fanny; Hamel, Arnaud; Sibille, Nathalie; Yin, Yanxia; Wieruszeski, Jean-Michel; Horvath, Dragos; Wei, Qun; Vuagniaux, Gregoire; Lippens, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4679-4686</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Debio 025 is a cyclosporin A (CsA) analog that interferes strongly with the hepatitis C viral life cycle.  Compared to CsA, Debio 025 has an addnl. Me group at position 3 of the cyclic undecapeptide and an N-ethylvaline instead of an N-methylleucine at position 4.  Unlike CsA, Debio 025 lacks immunosuppressive activity in vitro and in vivo.  We show here that, in vitro, the cyclophilin A (CypA)-Debio 025 complex cannot interact any longer with calcineurin (CaN), a determinant for the immunosuppressive activity of CsA.  We further use NMR spectroscopy to investigate at the mol. level the interaction of Debio 025 with CypA and thereby understand the basis for this loss of CaN interaction.  NMR data and mol. modeling indicate that Debio 025 optimally interacts with CypA, which underlies the anti-HCV properties of Debio 025.  However, the interaction between CaN and the CypA-Debio 025 complex is impeded by sterical hindrance of the CaN with the side chain of its Val4 residue.  This is in sharp contrast with the case for the CypA-CsA-CaN ternary complex, where the Leu4 side chain can enter a hydrophobic cavity at the CaN interface.  The structure of the CypA-Debio 025 complex thus provides a rational explanation for the non-immunosuppressive character of Debio 025.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaOhf7S4IKWLVg90H21EOLACvtfcHk0li5wQvuVYHCuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFyksLg%253D&md5=755e75e9bed9f6497ffd656380abe96c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fbi1003266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi1003266%26sid%3Dliteratum%253Aachs%26aulast%3DLandrieu%26aufirst%3DI.%26aulast%3DHanoulle%26aufirst%3DX.%26aulast%3DBonachera%26aufirst%3DF.%26aulast%3DHamel%26aufirst%3DA.%26aulast%3DSibille%26aufirst%3DN.%26aulast%3DYin%26aufirst%3DY.%26aulast%3DWieruszeski%26aufirst%3DJ.-M.%26aulast%3DHorvath%26aufirst%3DD.%26aulast%3DWei%26aufirst%3DQ.%26aulast%3DVuagniaux%26aufirst%3DG.%26aulast%3DLippens%26aufirst%3DG.%26atitle%3DStructural%2520basis%2520for%2520the%2520non-immunosuppressive%2520character%2520of%2520the%2520cyclosporin%2520A%2520analogue%2520Debio%2520025%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D4679%26epage%3D4686%26doi%3D10.1021%2Fbi1003266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6SFR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6SFR','PDB','6SFR'); return false;">PDB: 6SFR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NMY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NMY','PDB','4NMY'); return false;">PDB: 4NMY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NYM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NYM','PDB','4NYM'); return false;">PDB: 4NYM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G5J" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G5J','PDB','4G5J'); return false;">PDB: 4G5J</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVI','PDB','7AVI'); return false;">PDB: 7AVI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVL','PDB','7AVL'); return false;">PDB: 7AVL</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVS','PDB','7AVS'); return false;">PDB: 7AVS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVT','PDB','7AVT'); return false;">PDB: 7AVT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVV','PDB','7AVV'); return false;">PDB: 7AVV</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7AVU','PDB','7AVU'); return false;">PDB: 7AVU</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i22"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01949">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_81410"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01949?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01949</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Schemes S1 and S2 illustrating the synthesis of all compounds; protein expression and purification; protein crystallization and structure solution; Tables S1–S6 showing the crystallographic data of all compounds; Figure S1 illustrating the electron density maps of ligands; assay descriptions; HPLC traces of all synthesized compounds; sensorgrams for compounds <b>1</b>–<b>13</b>; data on kinase activity of selected compounds; Table S7 showing the kinase activity of compounds; analysis of cleaved PARP (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01949/suppl_file/jm0c01949_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01949/suppl_file/jm0c01949_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01949/suppl_file/jm0c01949_si_001.pdf">jm0c01949_si_001.pdf (2.99 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01949/suppl_file/jm0c01949_si_002.csv">jm0c01949_si_002.csv (0.86 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01949&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-10%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01949%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01949" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a7e73d8bda294","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
